<SEC-DOCUMENT>0001178913-20-001553.txt : 20200520
<SEC-HEADER>0001178913-20-001553.hdr.sgml : 20200520
<ACCEPTANCE-DATETIME>20200520163123
ACCESSION NUMBER:		0001178913-20-001553
CONFORMED SUBMISSION TYPE:	F-1
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20200520
DATE AS OF CHANGE:		20200520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		F-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238532
		FILM NUMBER:		20898513

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1
<SEQUENCE>1
<FILENAME>zk2024445.htm
<DESCRIPTION>F-1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">As filed with the Securities and Exchange Commission on May 20, 2020</div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES<br>
        SECURITIES AND EXCHANGE COMMISSION</font><br>
      Washington, D.C. 20549<br>
      <br>
      <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">FORM F-1</font><br>
      &#160;<br>
      REGISTRATION STATEMENT<br>
      UNDER<br>
      THE SECURITIES ACT OF 1933</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">Check-Cap Ltd.</font><br>
      (Exact name of registrant as specified in its charter)</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z49bfe8b185834748aa9298224c30a6c8">

        <tr>
          <td style="width: 32.01%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">State of Israel</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">3844</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Not applicable</div>
          </td>
        </tr>
        <tr>
          <td style="width: 32.01%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(State or other jurisdiction of<br>
              incorporation or organization)</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(Primary Standard Industrial<br>
              Classification Code Number)</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(I.R.S. Employer<br>
              Identification No.)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Check-Cap Building</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">29 Abba Hushi Avenue</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">P.O. Box 1271</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Isfiya, 3009000, Israel</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">&#160;</font>(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Puglisi &amp; Associates</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">850 Library Avenue</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Newark, Delaware 19711</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(302) 738-6680</div>
    <div style="text-align: center; line-height: 1.25;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Copies to:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za17c43fe5a2a43d5a63e7d9c621b2751">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Mark Selinger, Esq.</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Gary Emmanuel, Esq.</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">McDermott Will &amp; Emery LLP</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">340 Madison Avenue</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">New York, NY 10173</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">+1 212 547 5400</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Sharon Rosen, Adv.</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Fischer Behar Chen Well</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Orion &amp; Co.</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">3 Daniel Frisch Street</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tel Aviv, 6473104, Israel</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">+972 3 6944111</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">Approximate date of commencement of proposed sale to the public:</font> As soon as practicable after this registration statement is declared
      effective.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
      box. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act
      registration statement number of the earlier effective registration statement for the same offering. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number
      of the earlier effective registration statement for the same offering. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number
      of the earlier effective registration statement for the same offering. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Emerging growth company <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended
      transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a
      further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on
      such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160; <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" id="z07de3ad961ff468a81583258f9123d78" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-weight: bold;">Title of Each Class of Securities to be Registered</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Amount<br>
                to be<br>
                Registered<br>
                (1)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proposed<br>
                Maximum<br>
                Offering<br>
                Price per<br>
                Security<br>
                (2)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proposed<br>
                Maximum<br>
                Aggregate<br>
                Offering Price<br>
                (3)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Amount of<br>
                Registration<br>
                Fee</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Ordinary shares, par value NIS 2.40 per share, underlying Warrants to Purchase Ordinary Share</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">20,508,337</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">0.544</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">11,156,535.33</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">1,448.12</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF; width: 52%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">Total</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">20,508,337</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">0.544</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">11,156,535.33</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="line-height: 1.25;">1,448.12</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>

      </table>
    </div>
    &#160;&#160;
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z83613cf7d09e40d785f9af22863fdcef">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">This registration statement also includes an indeterminate number of shares that may become offered, issuable or sold to prevent dilution resulting from share splits, share dividends and similar transactions,
                which are included pursuant to Rule&#160;416 under the Securities Act of 1933, as amended.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z89af74e87ed445ccb383427330d47d9f">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) promulgated under the Securities Act of 1933, as amended, based on the average of the equivalent
              high and low sales prices of the ordinary shares on the Nasdaq Capital Market on May 15, 2020.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z00049b55f999425289592a43a644af96">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(3)</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div>Consists of (i) 6,666,669 ordinary shares issuable upon the exercise of warrants originally issued in a private placement on April 22, 2020, or the April 2020 Private Placement, (ii) 466,667 ordinary shares issuable upon the exercise
                  of placement agent warrants issued in the April 2020 Private Placement, (iii) 7,500,001 ordinary shares issuable upon the exercise of warrants originally issued in a private placement on May 4, 2020, or the First May 2020 Private
                  Placement, (iv) 525,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the First May 2020 Private Placement, (v) 5,000,000 ordinary shares issuable upon the exercise of warrants originally issued in a
                  private placement on May 13, 2020, or the Second May 2020 Private Placement, and (vi) 350,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the Second May 2020 Private Placement.</div>
              </div>
            </div>
          </td>
        </tr>

    </table>
  </div>
  <div>
    <div><br>
    </div>
    <div style="text-align: center;">ii<br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(192, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: normal; font-variant: normal; text-transform: none;">The
      information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is
      not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd92d4f1b0ea841c9a4a85c9f105339e6">

        <tr>
          <td style="width: 33%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">PRELIMINARY PROSPECTUS</div>
          </td>
          <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">SUBJECT TO COMPLETION</div>
          </td>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25; font-weight: bold; color: rgb(192, 0, 0);">DATED MAY 20, 2020</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><img width="250" height="133" src="image0.jpg"></div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">20,508,337 Ordinary Shares</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">This prospectus relates to the resale, by the selling shareholders identified in this prospectus, of up to an aggregate of 20,508,337 ordinary shares, par value NIS 2.40 per share of Check-Cap
          Ltd., consisting of (1) 6,666,669 ordinary shares issuable upon the exercise of warrants originally issued in a private placement on April 22, 2020, or the April 2020 Private Placement, (ii) 466,667 ordinary shares issuable upon the exercise of
          placement agent warrants issued in the April 2020 Private Placement, (iii) 7,500,001 ordinary shares issuable upon the exercise of warrants originally issued in a private placement on May 4, 2020, or the First May 2020 Private Placement, (iv)
          525,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the First May 2020 Private Placement, (v) 5,000,000 ordinary shares issuable upon the exercise of warrants originally issued in a private placement on May
          13, 2020, or the Second May 2020 Private Placement, and (vi) 350,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the Second May 2020 Private Placement.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The selling shareholders are identified in the table commencing on page 10. We will not receive any proceeds from the sale of the ordinary shares by the selling shareholders. All
      net proceeds from the sale of the ordinary shares covered by this prospectus will go to the selling shareholders. However, we may receive the proceeds from any exercise of warrants if the selling shareholders do not exercise the warrants on a
      cashless basis, if and when exercised. See &#8220;Use of Proceeds.&#8221;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The selling shareholders may sell all or a portion of the ordinary shares from time to time in market transactions through any market on which our ordinary shares are then traded,
      in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal or by a combination
      of such methods of sale. We will bear all of the expenses incurred in connection with the registration of these shares. The selling shareholders will pay any underwriting discounts and selling commissions and/or similar charges incurred in connection
      with the sale of the shares. See &#8220;Plan of Distribution&#8221;.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Our ordinary shares are listed on the Nasdaq Capital Market under the symbol &#8220;CHEK.&#8221; The last reported sale price of our ordinary shares on May 19, 2020 was $0.608 per share.</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">The securities offered in this prospectus involve a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 6</font> <font style="font-weight: bold;">of this prospectus to read about factors you should consider before purchasing any of our securities.</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">Neither the U.S. Securities and Exchange Commission, the Israel Securities Authority nor any state or other foreign securities commission has approved or
      disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">The date of this prospectus is May &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2020.</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">iii<br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160; <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">TABLE OF CONTENTS<a name="TABLEOFCONTENTS"><!--Anchor--></a></div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zab7a2333e43a44ed82b12007203dff0e">

        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#AboutThisProspectus">About this Prospectus</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">1<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#PROSPECTUSSUMMARY">Prospectus Summary</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">2<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#RISKFACTORS">Risk Factors</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">6<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#SPECIALNOTEREGARDINGFORWA">Special Note Regarding Forward-Looking Statements</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">7<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#USEOFPROCEEDS">Use of Proceeds</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">8<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#USEOFPROCEEDS">Capitalization</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">8<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#SELLINGSHAREHOLDERS">Selling Shareholders</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">10<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#DESCRIPTIONOFSHARECAPITAL">Description of Share Capital</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">13<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#PLANOFDISTRIBUTION">Plan of Distribution</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">22<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#LEGALMATTERS">Legal Matters</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">24<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#LEGALMATTERS">Experts</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">24<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#LEGALMATTERS">Where You Can Find More Information</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(255, 255, 255); text-align: right;">24<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#INCORPORATIONOFCERTAININF">Incorporation By Reference</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">25<br>
          </td>
        </tr>
        <tr>
          <td style="width: 92%; vertical-align: top; background-color: #FFFFFF;">
            <div style="line-height: 1.25;"><a href="#ENFORCEABILITYOFCIVILLIAB">Enforceability of Civil Liabilities</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">26<br>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; text-indent: 27.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; text-indent: 27.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">iv<br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="AboutThisProspectus"><!--Anchor--></a>About This Prospectus</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus is part of a registration statement that we filed with the SEC. As permitted by the rules and regulations of the SEC, the registration statement filed by us
      includes additional information not contained in this prospectus. You may read the registration statement and the other reports we file with the SEC at the SEC&#8217;s website or its offices described below under the heading &#8220;Where You Can Find More
      Information&#8221;.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should rely only on the information that is contained in this prospectus or that is incorporated by reference into this prospectus. Neither we nor the selling shareholders have
      authorized anyone to provide you with information that is in addition to or different from that contained in, or incorporated by reference into, this prospectus. If anyone provides you with different or inconsistent information, you should not rely
      on it.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information contained in this prospectus is accurate as of the date on the front of this prospectus only, regardless of the time of delivery of this prospectus or of any sale
      of our ordinary shares. Our business, financial condition, results of operations and prospects may have changed since that date.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We obtained statistical data, market data and other industry data and forecasts used or incorporated by reference in this prospectus from market research, publicly available
      information and industry publications.&#160; While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data. While we are not aware of any misstatements regarding the
      industry data presented in this prospectus, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk Factors&#8221; in this prospectus. Our financial statements are
      prepared and presented in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP. Our historical results do not necessarily indicate our expected results for any future periods.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Certain figures included in this prospectus have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be an arithmetic aggregation
      of the figures that precede them</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In this prospectus, unless the context otherwise requires:</div>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfb8fb2fce7a140f1af95cc511772f733">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;Check-Cap Ltd.&#8221; refer to Check-Cap Ltd.,&#160;an Israeli company, together with Check-Cap US, Inc., its U.S. subsidiary;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf373b5ceb6834ec78a7254a386cf4057">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div>references to the &#8220;Companies Law&#8221; or &#8220;Israeli Companies Law&#8221; are to the Israeli Companies Law, 5759-1999, as amended;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4e009a65c153405886f73199a598e1e4">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">references to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to United States Dollars;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2c9c0a8e577c43beacda8f3b4a81b21b">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">references to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221; and similar expressions refer to the Registrant&#8217;s Ordinary Shares, NIS 2.40 nominal (par) value per share;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1712110b87d14c349083c77681f08715">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">references to &#8220;shekels&#8221; and &#8220;NIS&#8221; are to New Israeli Shekels, the Israeli currency; and</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7ab67d2bf248459cbf27df4f328c757d">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">references to the &#8220;SEC&#8221; are to the United States Securities and Exchange Commission.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We effected a 1-for-12 reverse share split of our ordinary shares on April 4, 2018. Unless indicated otherwise by the context, all ordinary share, option, warrant and per share
      amounts as well as share prices appearing in this prospectus have been adjusted to give retroactive effect to the share split for all periods presented.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160; <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PROSPECTUSSUMMARY"><!--Anchor--></a>PROSPECTUS SUMMARY</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">This summary highlights information contained in other parts of this prospectus or incorporated by reference into this prospectus from our filings with the SEC, listed in the
      section of the prospectus entitled &#8220;Incorporation of Certain Information by Reference.&#8221; Because it is only a summary, it does not contain all of the information that you should consider before purchasing our securities in this offering and it is
      qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere or incorporated by reference into this prospectus.&#160; You should read the entire prospectus, the registration statement of which
      this prospectus is a part, and the information incorporated by reference herein in their entirety, including the &#8220;Risk Factors&#8221; and our financial statements and the related notes incorporated by reference into this prospectus, before making an
      investment decision.&#160; Some of the statements in this prospectus and the documents incorporated by reference herein constitute forward-looking statements that involve risks and uncertainties.&#160; See information set forth under the section &#8220;Cautionary
      Note Regarding Forward-Looking Statements.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Our Company</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are a clinical stage medical diagnostics company aiming to redefine colorectal cancer, or CRC, prevention through the introduction of C-Scan&#174;, the first and only
      patient-friendly preparation-free test designed to detect polyps&#160; before they transform into cancer. The disruptive capsule-based screening technology aims to increase screening adherence worldwide and enable millions of people to stay healthy. The
      system utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities. CRC is the third most commonly diagnosed cancer, with more than 1.8 million new cases identified every year
      globally. Nearly 881,000 deaths occur annually worldwide as a result of CRC.&#160; While approximately 0.5% of the average-risk screening population presents cancerous polyps in the colon and rectum at a given time, approximately 25% of the same
      population presents benign polyps that could potentially turn into cancer over time. It can take up to 10 years before a pre-cancerous polyp develops into invasive cancer. As such, there is a crucial detection window for the prevention of colorectal
      cancer, through the detection of these benign polyps. While routine screening is recommended by The American Cancer Society for healthy people aged 45 years and older, screening adherence remains low. About 1 in 3 adults among the targeted screening
      population avoids having a colonoscopy in the U.S., and adherence in other regions of the world such as Europe and Asia are even lower. Unlike other screening modalities that are designed for direct visualization and imaging of the internal colon,
      such as optical colonoscopy and other capsule-based technologies, C-Scan is designed to function without any laxative preparation, and to transit the gastrointestinal tract by natural motility while the patient continues his or her daily routine.
      Furthermore, the C-Scan system does not require fasting prior to or during capsule transit. C-Scan is comprised of three main components: (1) C-Scan Cap, a ingestible X-ray scanning capsule; (2) C-Scan Track, three miniaturized patches worn on the
      patient&#8217;s back for integrated positioning, control and data recording; and (3) C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.&#160; We believe that this solution has the potential to become
      an alternative for both physicians and patients and, to increase the number of people completing CRC screening.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Since our formation, we have not generated any revenue. We do not anticipate generating any significant revenue for the foreseeable future and we do not yet have any specific
      launch dates for our product. We incurred net losses of $13.8 million in 2019, $10.6 million in 2018 and $9.8 million in 2017.&#160; As of December 31, 2019, we had an accumulated deficit of $77.1 million and a total shareholders&#8217; equity of $6.2 million.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Public health epidemics or outbreaks could adversely impact our business. In late 2019, a novel strain of COVID-19, also known as coronavirus, was reported in Wuhan, China. While initially the
          outbreak was largely concentrated in China, it has now spread to Israel and the United States, and infections have been reported globally. Many countries around the world, including in Israel, have significant governmental measures implemented to
          control the spread of the virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material limitations on the conduct of business. As a consequence, we have experienced temporary
          disruptions to our operations and we have temporarily suspended our clinical studies. In accordance with the directive of the Israel Ministry of Health, the majority of our employees have been working remotely while a select few continue to work
          from our headquarters Also, we have temporarily suspended interactions between hospitals and healthcare professionals and its employees and clinical trial patients. In addition, to manage this crisis, we implemented several cost reduction
          measures, including a 15% reduction in salaries for all employees and management and the fees of the members of our board of directors and lowered monthly expenditures by placing a number of operational employees on unpaid leave. As a result of
          lowering infection rates in Israel, the lifting of many of the government restrictions to control the spread of the virus and our recent registered direct offerings, we have begun to resume normal operations and are in the process of restoring
          salaries to their pre-crisis levels.&#160; It is still too early to assess the full impact of the coronavirus outbreak, but coronavirus is affecting our ability to initiate our planned pivotal study and commence pilot sales in Israel and Europe in our
          original timeframe.&#160; The extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, the&#160;
          impact on the global economy, the impact of a second wave of COVID-19 that may occur in the fall or winter, and the actions that may be required to contain the coronavirus or treat its impact. In particular, the continued spread of the
          coronavirus globally, could materially adversely impact our operations and workforce, including our research and clinical trials and our ability to raise capital, could affect the operations of key governmental agencies, such as the FDA, which
          may delay our development plans, and could result in the inability of our suppliers to deliver components or raw materials on a timely basis or at all, each of which in turn could have a material adverse impact on our business, financial
          condition and results of operation.<font style="font-weight: bold;"> <br>
          </font></div>
        <font style="font-weight: bold;"> </font></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Corporate Information</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are incorporated in Israel.&#160; Our principal executive offices at located at Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel.&#160; Our telephone
      number is +972-4-8303400 and our website is located at www.check-cap.com (the information contained therein or linked thereto shall not be considered incorporated by reference in this prospectus).&#160; Our U.S. agent in connection with this offering is
      Puglisi &amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware 19711.</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">April&#160; 2020 Financing</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On April 22, 2020, we sold to certain institutional investors an aggregate of 6,666,669 ordinary shares in a registered direct offering at a purchase price of $0.60 per share,
      resulting in gross proceeds of approximately $4,000,000. In addition, we issued to the investors unregistered warrants to purchase up to an aggregate of 6,666,669 ordinary shares in a concurrent private placement. The warrants are immediately
      exercisable and will expire five and one-half years from the issuance date at an exercise price of $0.80 per ordinary share, subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if at the time of exercise
      thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. We paid an aggregate of $280,000 in placement agent fees, a management fee equal to 1.0% of the gross proceeds raised in the offering, a
      non-accountable expense allowance of $65,000 and clearing expenses of $12,900. We also issued unregistered placement agent warrants to purchase up to an aggregate of 466,667 ordinary shares on the same terms as the warrants issued to the investors in
      the private placement, except they have a term of five years and an exercise price of $0.75 per share.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the April&#160; 2020 financing, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 7,133,336 ordinary shares issuable upon
      exercise of these warrants.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">First May 2020 Financing</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 4, 2020, we sold to certain institutional investors an aggregate of 7,500,001 ordinary shares in a registered direct offering at a purchase price of $0.60 per share,
      resulting in gross proceeds of approximately $4,500,000. In addition, we issued to the investors unregistered warrants to purchase up to an aggregate of 7,500,001 ordinary shares in a concurrent private placement. The warrants are immediately
      exercisable and will expire five and one-half years from the issuance date at an exercise price of $0.80 per ordinary share, subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if at the time of exercise
      thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. We paid an aggregate of $315,000 in placement agent fees, a management fee equal to 1.0% of the gross proceeds raised in the offering, a
      non-accountable expense allowance of $65,000 and clearing expenses of $12,900. We also issued unregistered placement agent warrants to purchase up to an aggregate of 525,000 ordinary shares on the same terms as the warrants issued to the investors in
      the private placement, except they have a term of five years and an exercise price of $0.75 per share.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the First May 2020 financing, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 8,025,001 ordinary shares issuable upon
      exercise of these warrants.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Second May 2020 Financing</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 13, 2020, we sold to certain institutional investors an aggregate of 5,000,000 ordinary shares in a registered direct offering at a purchase price of $0.60 per share,
      resulting in gross proceeds of $3,000,000. In addition, we issued to the investors unregistered warrants to purchase up to an aggregate of 5,000,000 ordinary shares in a concurrent private placement. The warrants are immediately exercisable and will
      expire five and one-half years from the issuance date at an exercise price of $0.80 per ordinary share, subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no
      effective registration statement registering the ordinary shares underlying the warrants. We paid an aggregate of $210,000 in placement agent fees, a management fee equal to 1.0% of the gross proceeds raised in the offering, a non-accountable expense
      allowance of $32,500 and clearing expenses of $12,900. We also issued unregistered placement agent warrants to purchase up to an aggregate of 350,000 ordinary shares on the same terms as the warrants issued to the investors in the private placement,
      except they have a term of five years and an exercise price of $0.75 per share.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the Second May&#160; 2020 financing, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 5,350,000 ordinary shares issuable
      upon exercise of these warrants.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Throughout this prospectus, when we refer to our ordinary shares being registered on behalf of the selling shareholders, we are referring to the ordinary shares that may be
      issuable upon exercise of investor warrants and placement agent warrants. Throughout this prospectus, when we refer to the selling shareholders, we are referring to the selling shareholders named herein and, as applicable, any donees, pledgees,
      transferees or other successors-in-interest selling shares received after the date of this prospectus from a selling shareholder as a gift, pledge, or other non-sale related transfer that may be identified in a supplement to this prospectus or, if
      required, a post-effective amendment to the registration statement of which this prospectus is a part.</div>
    <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">The Offering</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z80210e3897a5497b9e6851df2428bdb4">

          <tr>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z91fcc49c5bc6471fbacde59be8e983e5">

          <tr>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8b78d534428e4339b999e8eef7cc581b">

        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Offered Shares</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">Up to an aggregate of up to 20,508,337 ordinary shares, par value NIS 2.40 per share of Check-Cap Ltd., consisting of (i) 6,666,669 ordinary shares issuable upon the exercise of warrants originally issued in
                the April 2020 Private Placement, (ii) 466,667 ordinary shares issuable upon the exercise of placement agent warrants issued in the April 2020 Private Placement, (iii) 7,500,001 ordinary shares issuable upon the exercise of warrants
                originally issued in the First May 2020 Private Placement, (iv) 525,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the First May 2020 Private Placement, (v) 5,000,000 ordinary shares issuable upon the
                exercise of warrants originally issued in the Second May 2020 Private Placement, and (vi) 350,000 ordinary shares issuable upon the exercise of placement agent warrants issued in the Second May 2020 Private Placement. The selling
                shareholders are identified in the table commencing on page 10.</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Ordinary Shares Outstanding at May&#160;20, 2020</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">30,171,012 ordinary shares.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Use of proceeds</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">We will not receive any proceeds from the sale of the ordinary shares by the selling shareholders. All net proceeds from the sale of the ordinary shares covered by this prospectus will go to the selling
                shareholders. However, we may receive the proceeds from any exercise of investor warrants and placement agent warrants if the selling shareholders do not exercise the warrants on a cashless basis, if and when exercised. See the section of
                this prospectus titled &#8220;Use of Proceeds.&#8221;</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Nasdaq Capital Market Symbol</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Our ordinary shares are listed on the Nasdaq Capital Market under the symbol &#8220;CHEK.&#8221;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Risk factors</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 72%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Before investing in our securities, you should carefully read and consider the &#8220;Risk Factors&#8221; beginning on page 6 of this prospectus.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless otherwise indicated, the number of ordinary shares outstanding prior to and after this offering is based on 30,171,012 ordinary shares outstanding as of May 20, 2020, and
      excludes:</div>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb0f61c07b0d34457a3e9cf8498fa7de4">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">26,327,751 ordinary shares issuable upon the exercise of outstanding warrants, with a weighted average exercise price of $2.82 per ordinary share;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze499783b50b24e4e8cebb706f1782c15">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">531,301 ordinary shares issuable upon the exercise of outstanding options, with a weighted average exercise price of $9.48 per ordinary share, granted under our option and equity incentive plans;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze2030ca0199b455bbf3f1b771aad8bb4">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">88,274 restricted stock units issued to employees, consultants and directors; and</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">360,710 ordinary shares that are available for future option grants under our 2015 Equity Incentive Plan and 2015 U.S. Sub-Plan to the 2015 Equity Incentive Plan, or the 2015 Plan.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless otherwise indicated, all information in this prospectus assumes no exercise of the outstanding options or warrants described above.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="RISKFACTORS"><!--Anchor--></a>RISK FACTORS</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">An investment in our securities involves a high degree of risk, you should carefully consider the risk factors set forth in our most recent Annual Report on
      Form 20-F on file with the SEC, which is incorporated by reference into this prospectus, as well as the following risk factors, which supplement or augment the risk factors set forth in our Annual Report on Form 20-F. Before making an investment
      decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus. The risks and uncertainties not presently known to us or that we currently deem immaterial may also materially
      harm our business, operating results and financial condition and could result in a complete loss of your investment.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;"><font style="font-weight: bold;">T</font><font style="font-weight: bold;">he sale of a substantial amount of our ordinary shares, including resale of the
        ordinary shares issuable upon the exercise of the warrants held by the selling shareholders in the public market could adversely affect the prevailing market price of our ordinary shares.</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">We are registering for resale an aggregate of 20,508,337 ordinary issuable upon the exercise of warrants held by the selling shareholders. Sales of substantial amounts of our ordinary shares in the
        public market, or the perception that such sales might occur, could adversely affect the market price of our ordinary shares, and the market value of our other securities. We cannot predict if and when selling shareholders may sell such shares in
        the public markets. Furthermore, in the future, we may issue additional ordinary shares or other equity or debt securities convertible into ordinary shares. Any such issuance could result in substantial dilution to our existing shareholders and
        could cause our share price to decline.</div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SPECIALNOTEREGARDINGFORWA"><!--Anchor--></a>SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus and the documents incorporated herein by reference contain statements that may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of the federal
      securities laws.&#160; These statements relate to anticipated future events, future results of operations and/or future financial performance.&#160; In some cases, you can identify forward-looking statements by their use of terminology such as &#8220;anticipate,&#8221;
      &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;target&#8221;, &#8220;future,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;ought to,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potentially,&#8221; &#8220;predicts,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; negatives of such terms or other similar terms.&#160; These forward-looking
      statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the
      forward-looking statements including, without limitation, the risks identified above in &#8220;Risk Factors&#8221; and those contained in our Annual Report on Form 20-F for the fiscal year ended December 31, 2019, or the 2019 Annual Report.&#160; The forward-looking
      statements in this prospectus and the documents incorporated herein by reference include, without limitation, statements relating to:&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb0caa24449674896add14a0240820d67">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our history of losses and our ability to continue as a going concern;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the impact of the recent outbreak of coronavirus;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the initiation, timing, progress and results of our clinical trials and other product development efforts;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our reliance on one product or product line;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the clinical development, commercialization and market acceptance of C-Scan;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our ability to receive de novo classification and other regulatory approvals for C-Scan;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our ability to successfully complete clinical trials;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our reliance on single-source suppliers;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our reliance on third parties, such as for purposes of our clinical trials and clinical development and the manufacturing, marketing and distribution of our C-Scan system;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our ability to establish and maintain strategic partnerships and other corporate collaborations;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">our ability to achieve reimbursement and coverage from government and private third-party payors;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the implementation of our business model and strategic plans for our business;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the scope of protection we are able to establish and maintain for intellectual property rights covering C-Scan and our ability to operate our business without infringing the intellectual property rights of
              others;</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">competitive companies, technologies and our industry; and</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">statements as to the impact of the political and security situation in Israel on our business.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The preceding list is not intended to be an exhaustive list of all of our forward-looking statements.&#160; Forward-looking statements reflect our current views with respect to future
      events and are based on assumptions and subject to risks and uncertainties.</div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should not unduly rely on any forward-looking statements.&#160; Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot
      guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur.&#160; Except as required by law, we undertake no obligation to update publicly any
      forward-looking statements for any reason after the date of this prospectus, to conform these statements to actual results or to changes in our expectations.<font style="font-weight: bold;">&#160;</font></div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt; font-weight: bold;">&#160;<br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="USEOFPROCEEDS"><!--Anchor--></a>USE OF PROCEEDS</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We will not receive any proceeds from the sale of the ordinary shares by the selling shareholders. All net proceeds from the sale of the ordinary shares covered by this prospectus will go to the
          selling shareholders. We expect that the selling shareholders will sell their ordinary shares as described under &#8220;Plan of Distribution.&#8221;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">We may receive proceeds from the exercise of the warrants and placement agent warrants to the extent that these warrants are exercised for cash by the selling shareholders. Warrants, however, are
        exercisable on a cashless basis under certain circumstances. If all of the warrants mentioned above were exercised for cash in full, the proceeds would be approximately $16.3 million. We intend to use the net proceeds of such warrant exercise, if
        any, to advance the ongoing clinical development of C-Scan&#174;, including preparations for our U.S. pivotal study, and for general corporate purposes. Pending such uses, we intend to invest the net proceeds in short-term, interest-bearing securities,
        investment grade securities, certificates of deposit or direct or guaranteed obligations of the U.S. government. We can make no assurances that any of the warrants and placement agent warrants will be exercised, or if exercised, that they will be
        exercised for cash, the quantity which will be exercised or in the period in which they will be exercised.</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CAPITALIZATION</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth our capitalization:</div>
    <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9a1b2f519843470195e103dbc1e6e66d">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">on an actual basis as of December 31, 2019; and</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z28c3c076027a4f0d9cbbeff65620a1b4">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div>
                <div>
                  <div style="line-height: 1.25;">on an adjusted basis, giving effect to (i) the sale of 2,720,178 ordinary shares at the offering price of $1.75 per share in a private placement that closed in February 2020,&#160; (ii) the sale of 6,666,669
                    ordinary shares at the offering price of $0.60 per ordinary share in the April 2020 Financing,, (iii) the sale of 7,500,001 ordinary shares at the offering price of $0.60 per ordinary share in the First May 2020 Financing, and (iv) the
                    sale of 5,000,000 ordinary shares at the offering price of $0.60 per ordinary share in the Second May 2020 Financing.</div>
                </div>
              </div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;<br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following depiction of our capitalization on an adjusted basis as of December 31, 2019 reflects the net proceeds from the private placement that closed in February 2020 and the
      registered direct offerings that closed on each of April 22, 2020, May 4, 2020 and May 13, 2020, and does not reflect exercise of any options or warrants or any other transactions impacting our capital structure subsequent to December 31, 2019. The
      adjusted amounts shown below are unaudited and represent management&#8217;s estimate. The information in this table should be read in conjunction with and is qualified by reference to the financial statements and notes thereto and other financial
      information incorporated by reference into this prospectus.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zb4aed1da259d43f09658b2c64e5b6c0b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">As of<br>
              December 31,<br>
              2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Actual)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Adjusted)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(U.S.$ in thousands)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: top; padding-left: 9pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;">
            <div style="line-height: 1.25; font-weight: bold;">Shareholders&#8217; equity:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #FFFFFF; width: 76%;">
            <div style="line-height: 1.25;">Ordinary Share capital, 90,000,000&#160;shares authorized and 8,272,908&#160;shares issued, actual;&#160;30,159,756 shares issued, as adjusted</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">5,407</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">20,327</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
            <div style="line-height: 1.25;">Additional Paid in Capital&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">77,964</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">77,876</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #FFFFFF; width: 76%;">
            <div style="line-height: 1.25;">Accumulated deficit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(77,137</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(77,137</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #FFFFFF; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Total shareholders&#8217; equity&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">6,234</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">21,066</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 76%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">Total capitalization</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">6,234</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">21,066</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;">The number of issued and outstanding shares as of December 31, 2019 in the table excludes:</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zae4b4447baca443bb5a38ddc80d00fc3">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">6,012,594 ordinary shares issuable upon the exercise of outstanding warrants, with a weighted average exercise price of $12.39 per ordinary share;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z220b7b2863964870bf9213ac25087bb5">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">547,322 ordinary shares issuable upon the exercise of outstanding options, with a weighted average exercise price of $10.24 per ordinary share, granted under our option and equity incentive
              plans;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7270eb46493f46d8806099ef47f77627">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">99,530 restricted stock units issued to employees, consultants and directors;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2ee7d19571f64d52a1759430fdc7bb42">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">344,688 ordinary shares that are available for future option grants under the 2015 Plan;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf4ec36a4d73f4539a4c5c0cc2e989666">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">6,666,669 ordinary shares issuable upon exercise of the unregistered warrants issued to certain investors in the April 2020 Private Placement, at an exercise price of $0.80 per share;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z63833a579e364eb3b78c667896515f27">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">466,667 ordinary shares issuable upon exercise of the placement agent warrants issued to the placement agent as compensation in connection with the April 2020 Private Placement, at an exercise price of $0.75
                per share;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc9eca055bc2c4d7d97c7f5696ea8af5c">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">7,500,001 ordinary shares issuable upon exercise of the unregistered warrants issued to certain investors in the First May 2020 Private Placement, at an exercise price of $0.80 per share;</div>
            </div>
            <div style="text-align: justify; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">525,000 ordinary shares issuable upon exercise of the placement agent warrants issued to the placement agent as compensation in connection with the First May 2020 Private Placement, at an exercise price of
                $0.75 per share;</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">5,000,000 ordinary shares issuable upon exercise of the unregistered warrants issued to certain investors in the Second May 2020 Private Placement, at an exercise price of $0.80 per share; and</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">350,000 ordinary shares issuable upon exercise of the placement agent warrants issued to the placement agent as compensation in connection with the Second May 2020 Private Placement, at an exercise price of
                    $0.75 per share.</div>
                </div>
              </div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SELLINGSHAREHOLDERS"><!--Anchor--></a>SELLING SHAREHOLDERS</div>
    <br>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The ordinary shares being offered by the selling shareholders are those ordinary shares issuable upon exercise of warrants previously issued in connection with our private placements that closed on
        April 22, 2020, May 4, 2020 and May 13, 2020. For additional information regarding the issuance of those warrants to purchase ordinary shares, see &#8220;Prospectus Summary &#8211; April&#160; 2020 Financing,&#8221; &#8220;Prospectus Summary &#8211; First May 2020 Financing,&#8221; and
        &#8220;Prospectus Summary &#8211; Second May 2020 Financing&#8221; above. We are registering the ordinary shares in order to permit the selling shareholders to offer the ordinary shares for resale from time to time. Other than with respect to H.C. Wainwright &amp;
        Co. LLC, or H.C. Wainwright, which acted as our placement agent in each of the June 2017, November 2017, February 2019, April 2020, the First May 2020 and the Second May 2020 private placements, and as our underwriter in connection with our
        underwritten offering in May 2018, except for the ownership of the warrants and placement agent warrants issued, and the ordinary shares issued and issuable, pursuant to prior financings, the selling shareholders have not had any material
        relationship with us within the past three years.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The table below lists the selling shareholders and other information regarding the beneficial ownership of the ordinary shares by each of the selling shareholders. The second
      column lists the number of ordinary shares beneficially owned by each selling shareholder, based on its ownership of ordinary shares and investor warrants or placement agent warrants to purchase ordinary shares, as of May 20, 2020, assuming exercise
      of the investor warrants or placement agent warrants held by each selling shareholder on that date, without regard to any limitations on conversions or exercises. The third column lists the maximum number of ordinary shares being offered in this
      prospectus by the selling shareholders. The fourth and fifth columns list the amount of ordinary shares owned after the offering, by number of ordinary shares and percentage of outstanding ordinary shares, assuming in both cases the sale of all of
      the ordinary shares offered by the selling shareholders pursuant to this prospectus, and without regard to any limitations on conversions or exercises.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the terms of the investor warrants and placement agent warrants issued in the April, 2020 Private Placement, the First May 2020 Private Placement and the Second May 2020
      Private Placement, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its affiliates, to beneficially own a number of ordinary shares which would exceed 4.99% or 9.99%
      of our then outstanding ordinary shares following such exercise, excluding for purposes of such determination ordinary shares not yet issuable upon exercise of the warrants and placement agent warrants which have not been exercised. The number of
      shares does not reflect this limitation. The selling shareholders may sell all, some or none of their ordinary shares or investor warrants or placement agent warrants in this offering. See &#8220;Plan of Distribution.&#8221;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z13e90863a3814324b9f55566c65465af">

          <tr>
            <td style="width: 35.93%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="line-height: 1.25; font-weight: bold;">Selling Shareholder</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of Ordinary Shares Owned Prior to Offering</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Maximum Number of Ordinary Shares to be Sold Pursuant to this Prospectus</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of Ordinary Shares Owned After the Offering</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Percentage of Ordinary Shares Owned After the Offering</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">Armistice Capital Master Fund, Ltd. (1)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">7,352,273</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(2)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">6,500,000</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(3)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">852,273</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(4)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">&#160;&#160; &#160; &#160; &#160; 2.7</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Sabby Volatility Warrant Master Fund, Ltd. (5)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">1,000,000</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(6)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">1,000,000</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(6)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">-</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">Hudson Bay Master Fund Ltd. (7)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">1,317,830</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(8)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">833,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(9)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">484,496</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(10)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">1.6</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Bigger Capital Fund, LP (11)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">1,666,667</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(12)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">1,666,667</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(12)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">District 2 Capital Fund LP (13)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">833,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(14)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">833,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(14)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Intracoastal Capital, LLC (15)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">2,809,194</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(16)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">2,083,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(17)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">725,860</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(18)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">2.3</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">KBB Asset Management, LLC (19)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">833,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(20)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">833,334</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(20)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Anson Investments Master Fund LP (21)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">4,650,863</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(22)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">4,166,667</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(23)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">484,196</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(24)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">1.6</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">%&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">CVI Investments, Inc. (25)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">1,413,727</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(26)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">1,250,000</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(27)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">163,727</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(28)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">*</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Michael Vasinkevich (29)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">997,675</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(30)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">860,344</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(31)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">137,331</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(32)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">*</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">Noam Rubinstein (29)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">491,465</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(33)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">422,625</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(34)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">68,840</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(35)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">*</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">Craig Schwabe (29)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">45,281</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(36)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">45,281</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">(36)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="text-align: right; line-height: 1.25;">-</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35.93%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">Charles Worthman (29)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">15,546</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(37)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 8.97%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">13,417</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(38)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; line-height: 1.25;">2,129</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">(39)</div>
            </td>
            <td style="width: 0.53%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 9.08%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: right; line-height: 1.25;">*</div>
            </td>
            <td style="width: 2.32%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">*&#160;&#160;Denotes less than 1%</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zc5f779adab0b4efbbb99fa339f71a06c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(1)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Armistice Capital, LLC, the investment manager of Armistice Capital Master Fund Ltd., or Armistice, and Steven J. Boyd, the managing member of Armistice Capital, LLC, hold shared voting and dispositive power over the ordinary shares
                    held by Armistice. The principal business address of Armistice is c/o Armistice Capital, LLC, 510 Madison Avenue, 7th Floor, New York, NY, 10022.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zeecd9a0fe921424485dd1dd2251203d6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(2)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="text-align: left; line-height: 1.25;">
                        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Represents (i) 852,273 ordinary shares issuable upon exercise of previously issued warrants, (ii) 1,500,000 ordinary shares issuable upon exercise of
                            warrants issued in our April 2020 Private Placement, (iii) 2,500,000 ordinary shares issuable upon exercise of warrants issued in our First May 2020 Private Placement, and (iv) 2,500,000 ordinary shares issuable upon exercise of
                            warrants issued in our Second May 2020 Private Placement.</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="text-align: left; line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 27pt; vertical-align: top; align: right;">(3)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>
                      <div style="line-height: 1.25;">
                        <div style="text-align: left; line-height: 1.25;">
                          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Represents (i) 1,500,000 ordinary shares issuable upon exercise of warrants issued in our April 2020 Private Placement, (ii) 2,500,000 ordinary shares
                              issuable upon exercise of warrants issued in our First May 2020 Private Placement, and (iii) 2,500,000 ordinary shares issuable upon exercise of warrants issued in our Second May 2020 Private Placement.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="text-align: left; line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z98651fe143d04dcfbe6706927cda922a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(4)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">Represents 852,273 ordinary shares issuable upon exercise of previously issued warrants.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z57d6eca1172a42b3bf8d743bba01b705" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(5)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Sabby Management, LLC is the investment manager of Sabby Volatility Warrant Master Fund, Ltd., or Sabby VWMF, and shares voting and investment power with respect to these shares in this capacity. As manager of Sabby Management, LLC,
                    Hal Mintz also shares voting and investment power on behalf of Sabby VWMF. Each of Sabby Management, LLC and Hal Mintz disclaims beneficial ownership over the securities listed except to the extent of their pecuniary interest therein.
                    The address of principal business office of Sabby VWMF is 10 Mountainview Road, Suite 205, Upper Saddle River, New Jersey 07458.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z5ed29e3c9cf14c6bb0322893fe99b411" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(6)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">Represents 1,000,000 ordinary shares issuable upon exercise of warrants issued in our April 2020 Private Placement.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="za98996f7dd3743f7a47de765ea0b04ef" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(7)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Hudson Bay Capital Management LP, the investment manager of Hudson Bay Master Fund Ltd., has voting and investment power over these securities. Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the general
                    partner of Hudson Bay Capital Management LP. Each of Hudson Bay Master Fund Ltd. and Mr. Gerber disclaims beneficial ownership over these securities.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zb605c7b0e1fe4457a8401854c490ec82" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(8)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="text-align: left; line-height: 1.25;">
                        <div style="text-align: justify; line-height: 1.25;">Represents (i) 484,496 ordinary shares issuable upon exercise of warrants issued in our February 2019 private placement and (ii) 833,334 ordinary shares issuable upon exercise of
                          warrants issued in our April 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="text-align: left; line-height: 1.25;">
        <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; line-height: 1.25;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z1242c73e5aa140edb8f9076154ac4214" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(9)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="text-align: left; line-height: 1.25;">
                        <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">Represents 833,334 ordinary shares issuable upon exercise of warrants issued in our April 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="text-align: left; line-height: 1.25;">
        <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; line-height: 1.25;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z3abd3a6264c44cfca1e5db3704c0c3ab" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(10)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents 484,496 ordinary shares issuable upon exercise of warrants issued in our February 2019 private placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="za1a0319d3c33438cb1af5901de868364" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(11)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Michael Bigger has the power to vote or dispose of the shares owned by Bigger Capital Fund, LP. The investor&#8217;s address is 175 W Carver, Huntington, NY, 11743. Michael Bigger disclaims beneficial ownership over these securities.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zd0184a573e644c69b32765e31ff729c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(12)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents (i) 416,667 ordinary shares issuable upon exercise of warrants issued in our April 2020 Private Placement, (ii) 416,667 ordinary shares issuable upon exercise of warrants issued in our First
                      May 2020 Private Placement, and (iii) 833,333 ordinary shares issuable upon exercise of warrants issued in our Second May 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z73896d2f7e434472b38012065fcd99b7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(13)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Michael Bigger has the power to vote or dispose of the shares owned by District 2 Capital Fund LP. The investor&#8217;s address is 175 W Carver, Huntington, New York 11743. Michael Bigger disclaims beneficial ownership over these
                    securities.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z918f9d26b8db4c9382586d4dd556f9ae" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(14)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents (i) 416,667 ordinary shares issuable upon exercise of warrants issued in our April 2020 Private Placement and (ii) 416,667 ordinary shares issuable upon exercise of warrants issued in our First
                      May 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z9ead2e515bc1402785a34a84910334fa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(15)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Mitchell P. Kopin, or Mr. Kopin, and Daniel B. Asher, or Mr. Asher, each of whom are managers of Intracoastal Capital, LLC, or Intracoastal, have shared voting control and investment discretion over the securities reported herein
                    that are held by Intracoastal. As a result, each of Mr. Kopin and Mr. Asher may be deemed to have beneficial ownership (as determined under Section 13(d) of Exchange Act) of the securities reported herein that are held by Intracoastal.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z339635d6992548a09e3a78b171e8cc13" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(16)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">Represents (i) 725,860 ordinary shares issuable upon exercise of previously issued warrants, (ii) 833,334 ordinary shares issuable upon exercise of warrants issued in connection with our April 2020
                        Private Placement, and (iii) 1,250,000 ordinary shares issuable upon exercise of warrants issued in our First May 2020 Private Placement.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zd910f06edb4a4149b2fdcb7bcf643d8c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(17)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25;">Represents (i) 833,334 ordinary shares issuable upon exercise of warrants issued in connection with our April 2020 Private Placement, and (ii) 1,250,000 ordinary shares issuable upon exercise of
                          warrants issued in our First May 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7c06e4d2cf8f424b9a5ca38cd08442a8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(18)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents 725,860 ordinary shares issuable upon exercise of previously issued warrants.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z18860d694e7e4983ad01258a63e193c6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(19)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Steve Segal has the power to vote or dispose of the shares owned by KBB Asset Management, LLC. The investor&#8217;s address is 29 Maple Street, Essex Junction, Vermont 05452. Steve Segal disclaims beneficial ownership over these
                    securities.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zb9393a97ab3b432aa1d0f5f6049c49e4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(20)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents 833,334 ordinary shares issuable upon exercise of warrants issued in connection with our April 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="za1c3a1e15d224ace8a45ec37c6c1e997" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(21)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Anson Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of Anson Investments Master Fund LP, or Anson, hold voting and dispositive power over the Common Shares held by Anson. Bruce Winson is the managing member
                    of Anson Management GP LLC, which is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. Mr. Winson, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership of these
                    Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson is 190 Elgin Ave; George Town, Grand Cayman.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z41a933bf54a44da2a2b53af39abeef85" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(22)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents (i) 484,196 ordinary shares issuable upon exercise of warrants issued in connection with our February 2019 private placement, (ii) 833,333 ordinary shares issuable upon exercise of warrants
                      issued in connection with our April 2020 Private Placement, (iii) 1,666,667 ordinary shares issuable upon exercise of warrants issued in connection with our First May 2020 Private Placement, and (iv) 1,666,667 ordinary shares issuable
                      upon exercise of warrants issued in our Second May 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zca2bb58173214ac085a324b871de748a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(23)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Represents (i) 833,333 ordinary shares issuable upon exercise of warrants issued in connection with our April 2020 Private Placement, (ii) 1,666,667
                          ordinary shares issuable upon exercise of warrants issued in connection with our First May 2020 Private Placement, and (iii) 1,666,667 ordinary shares issuable upon exercise of warrants issued in our Second May 2020 Private
                          Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z0d3db96f41a948ba84dc9f38a1991b99" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(24)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents 484,196 ordinary shares issuable upon exercise of warrants issued in connection with our February 2019 private placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7c69308b654c4854a35bd0ad87666387" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(25)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Heights Capital Management, Inc., the authorized agent of CVI Investments, Inc., or CVI, has discretionary authority to vote and dispose of the shares held by CVI and may be deemed to be the beneficial owner of these shares.&#160; Martin
                    Kobinger, in his capacity as Investment Manager of Heights Capital Management, Inc., may also be deemed to have investment discretion and voting power over the shares held by CVI.&#160; Mr. Kobinger disclaims any such beneficial ownership of
                    the shares.&#160; CVI Investments, Inc. is affiliated with one or more FINRA members, none of whom are currently expected to participate in the sale pursuant to this prospectus contained in the registration statement of common shares
                    purchased by CVI.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z48f68fe854514a618fbfedcbbec6e2cb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(26)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">Represents (i) 27,363 ordinary shares, (ii) 136,364 ordinary shares issuable upon exercise of previously issued warrants and (iii) 1,250,000 ordinary shares issuable upon exercise of warrants issued in
                        connection with our First May 2020 Private Placement.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7bb9736a7fa84d7385d109c026c61057" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(27)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents 1,250,000 ordinary shares issuable upon exercise of warrants issued in connection with our First May 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7b50d3041ac8403f813a304f375da786" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(28)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">
                        <div style="line-height: 1.25;">Represents (i) 27,363 ordinary shares and (ii) 136,364 ordinary shares issuable upon exercise of previously issued warrants.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"></div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zbf198d1fb54a43e2b5d8eb58ae28b885" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(29)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Referenced person is affiliated with H.C. Wainwright, a registered broker dealer. H.C. Wainwright is a registered broker-dealer and acted as the placement
                        agent in the April 2020 Private Placement, the First May 2020 Private Placement, and the Second May 2020 Private Placement. The address of H.C. Wainwright &amp; Co., LLC, 430 Park Avenue, New York, NY 10022.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z9d828fad4c834e509a9683d96d0f5ff6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(30)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                          <div style="line-height: 1.25;">
                            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Represents (i) 137,331 ordinary shares issuable upon exercise of previously issued placement agent warrants, (ii) 299,250 ordinary shares issuable
                              upon exercise of placement agent warrants issued in connection with our April 2020 financing, (iii) 336,656 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020
                              Private Placement, and (iv) 224,438 ordinary shares issuable upon exercise of placement agent warrants issued in our Second May 2020 Private Placement.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z4c65e19476d543649a5ddc4b141a05bd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(31)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Represents (i) 299,250 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (ii)
                          336,656 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020 Private Placement, and (iii) 224,438 ordinary shares issuable upon exercise of placement agent warrants issued
                          in connection with our Second May 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;"><br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zc8368e23dc9b42a8bdb33277816e8422" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(32)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">
                          <div style="line-height: 1.25;">
                            <div style="line-height: 1.25;">Represents 137,331 ordinary shares issuable upon exercise of previously issued placement agent warrants.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; line-height: 1.25;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z3c91ee7750c94a668504ab2289920c12" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(33)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Represents (i) 68,840 ordinary shares issuable upon exercise of previously issued placement agent warrants, (ii) 147,000 ordinary shares issuable upon
                            exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (iii) 165,375 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020
                            Private Placement, and (iv) 110,250 ordinary shares issuable upon exercise of placement agent warrants issued in our Second May 2020 Private Placement.</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zc44f2fb041244b529535a1b508e1783f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(34)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Represents (i) 147,000 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (ii)
                          165,375 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020 Private Placement, and (iii) 110,250 ordinary shares issuable upon exercise of placement agent warrants issued
                          in our Second May 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zfa43b3fce82d47978de4d5268dd346b6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(35)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">
                          <div style="line-height: 1.25;">Represents 68,840 ordinary shares issuable upon exercise of previously issued placement agent warrants.</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; line-height: 1.25;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z51616d115ad84f91a17c882835a0b03b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(36)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Represents (i) 15,750 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (ii)
                          17,719 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020 Private Placement, and (iii) 11,812 ordinary shares issuable upon exercise of placement agent warrants issued
                          in our Second May 2020 Private Placement.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zd73eb3f1888f49638a23f29a22108943" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(37)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Represents (i) 2,129 ordinary shares issuable upon exercise of previously issued placement agent warrants, (ii) 4,667 ordinary shares issuable upon
                            exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (iii) 5,250 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our First May 2020 Private
                            Placement, and (iv) 3,500 ordinary shares issuable upon exercise of placement agent warrants issued in our Second May 2020 Private Placement.</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z8ec339bc630e4e51a1cf047c538a3b1e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(38)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">Represents (i) 4,667 ordinary shares issuable upon exercise of placement agent warrants issued in connection with our April 2020 Private Placement, (ii) 5,250 ordinary shares issuable upon exercise of
                      placement agent warrants issued in connection with our First May 2020 Private Placement, and (iii) 3,500 ordinary shares issuable upon exercise of placement agent warrants issued in our Second May 2020 Private Placement.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zfc8552446d484635bfdbdabb5e242bcf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 27pt; vertical-align: top; align: right;">(39)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25;">
                          <div style="line-height: 1.25;">
                            <div style="line-height: 1.25;">Represents 2,129 ordinary shares issuable upon exercise of previously issued placement agent warrants.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25;"><br>
      </div>
    </div>
    <div style="line-height: 1.25;"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="DESCRIPTIONOFSHARECAPITAL"><!--Anchor--></a>DESCRIPTION OF SHARE CAPITAL</div>
    <br>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following description of our share capital summarizes certain provisions of our amended articles of association. Such summaries do not purport to be complete and are subject
      to, and are qualified in their entirety by reference to, all of the provisions of our amended articles of association, copies of which have been filed as exhibits to the registration statement of which this prospectus forms a part.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Ordinary Shares</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of May 20, 2020, our authorized share capital consists of 90,000,000 ordinary shares, par value NIS 2.40 per share, of which 30,171,012 are outstanding.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Memorandum and Articles of Association</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Registration Number and Purposes of the Company</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our registration number with the Israeli Registrar of Companies is 51-425981-1. Our purpose as set forth in our amended articles of association is to engage in any lawful activity.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Voting Rights and Conversion</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All ordinary shares have identical voting and other rights in all respects.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Transfer of Shares</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our fully paid ordinary shares are issued in registered form and may be freely transferred under our amended articles of association, unless the transfer is restricted or
      prohibited by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by our amended articles
      of association or the laws of the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel, according to applicable Israeli law&#8217;s requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Board of Directors may, to the extent it deems necessary in its discretion, close the register of shareholders of registration of transfers of shares for a period determined by
      the Board of Directors, and no registrations of transfers of shares shall be made by us during any such period during which the register of shareholders is so closed.&#160; We shall notify shareholders with respect to such suspension of registration in
      such manner as shall be determined by our Board of Directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Election of Directors</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under our amended articles of association, our board of directors must consist of not less than four but no more than eleven directors, including (if any) external directors
      (within the meaning of the Israeli Companies Law).&#160; Pursuant to our amended articles of association, each of our directors will be appointed by a simple majority vote of holders of our voting shares, participating and voting at an annual general
      meeting of our shareholders (subject to the special approval requirements under the Israeli Companies Law for the election of external directors, if any). Our ordinary shares do not have cumulative voting rights for the election of directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each director (other than external directors, if any) will hold office until the next annual general meeting following the annual general meeting at which they were elected and
      until his or her successor is elected and qualified, or until the occurrence of certain events, in accordance with the Israeli Companies Law and our amended articles of association, including his or her earlier resignation, death or removal by a vote
      of the majority of the voting power of our shareholders at a general meeting of until his or her office expires by operation of law. In addition, our amended articles of association allow our board of directors to appoint directors (other than
      external directors) to fill vacancies on the board of directors to serve for a term of office equal to the remaining period of the term of office of the directors(s) whose office(s) have been vacated.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Dividend and Liquidation Rights</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. Under the Israeli Companies Law, dividend distributions
      are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. Our amended articles of association do not require shareholder approval of a
      dividend distribution and provide that dividend distributions may be determined by our board of directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Israeli Companies Law, we may declare and pay dividends only if, upon the determination of our board of directors, there is no reasonable concern that the
      distribution will prevent us from being able to meet the terms of our existing and foreseeable obligations as they become due. Under the Israeli Companies Law, the distribution amount is further limited to the greater of retained earnings or earnings
      generated over the two most recent years legally available for distribution according to our then last reviewed or audited financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the
      date of the financial statements is not more than six months prior to the date of distribution. In the event that we do not have retained earnings or earnings generated over the two most recent years legally available for distribution, we must seek
      the approval of the court in order to distribute a dividend. The court may approve our request if it is convinced that there is no reasonable concern that the payment of a dividend will prevent us from satisfying our existing and foreseeable
      obligations as they become due.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to the nominal
      value of their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in
      the future.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Exchange Controls</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments
      to non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Shareholder Meetings</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the
      previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our amended articles of association as special general meetings. Our board of directors may call special general meetings whenever
      it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Israeli Companies Law provides that our board of directors is required to convene a special general meeting upon the written request of (i) any
      two of our directors or one-quarter of the serving members of our board of directors; or (ii) one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding shares and 1% of our outstanding voting power or (b) 5% or more
      of our outstanding voting power.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Furthermore, the Israeli Companies Law requires that resolutions regarding the following matters be approved by our shareholders at a general meeting:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55494a16e3be472bbdb81f205775942a">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">amendments to our articles of association;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc41581433079442dbcd91f33a3efb15e">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">appointment, terms of service and termination of service of our auditors;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91faddaf47364816a80be3755ce189ac">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">appointment of external directors;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zad58795b11424f4ab2e1afe71599e364">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">approval of certain related party transactions;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdb0c821640b44073b74bb034eaf212b9">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">increases or reductions of our authorized share capital;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3db20a7888ee47d79d36af066be07f59">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">mergers; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda72bcee83f34222a94d8f95961964b1">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25;">the exercise of our board of director&#8217;s powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is essential for our proper management.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to the provisions of the Israeli Companies Law and regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the
      shareholders of record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and 40 days prior to the date of the meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law requires that a notice of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if
      the agenda of the meeting includes, among other things, the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, an approval of a merger or the approval of the compensation policy,
      notice must be provided at least 35 days prior to the meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, our shareholders are not permitted to take action via written consent in lieu of a meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Voting rights</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Quorum Requirements</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to our amended articles of association, holders of our ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the
      shareholders at a general meeting. The quorum required for general meetings of our shareholders is at least two shareholders present in person, by proxy or written ballot, who hold or represent between them at least 25% of the total outstanding
      voting rights (or if a higher percentage is required by law, such higher percentage), within half an hour of the time fixed for the commencement of the meeting. A meeting adjourned for lack of a quorum is adjourned either to the same day in the
      following week at the same time and place or to such day, time and place as specified in the notice of the meeting or to such day, time and place as the chairman of the general meeting shall determine. At the reconvened meeting, at least two
      shareholders present in person or by proxy shall constitute a lawful quorum, unless the meeting of shareholders was convened at the demand of shareholders, in which case, the quorum shall be the presence of one or more shareholders holding at least
      5% of our issued share capital and at least one percent of the voting power of our shares, or one or more shareholders with at least 5% of the voting power of our shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Vote Requirements</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended articles of association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Israeli Companies Law or by
      our amended articles of association. Under the Israeli Companies Law, certain actions require a special majority, including: (i) approval of an extraordinary transaction with a controlling shareholder or in which the controlling shareholder has a
      personal interest and the terms of employment or other engagement of the controlling shareholder or a relative of the controlling shareholder (even if not extraordinary), requiring the approval described in Item 6C to the 2019 Annual Report
      &#8220;Directors, Senior Management and Employees &#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8212; Disclosure of Personal Interests of Controlling Shareholders and Approval of Certain Transactions&#8221;; (ii) approval of a compensation
      policy, requiring the approval described in Item 6C to the 2019 Annual Report &#8220;Directors, Senior Management and Employees&#8212; Board Practices&#8212; Compensation Committee and Compensation Policy&#8221;; and (iii) approval of executive officer compensation
      inconsistent with our office holder compensation policy or the compensation of our chief executive officer (subject to limited exceptions), requiring the approval described in Item 6C to the 2019 Annual Report &#8220;Directors, Senior Management and
      Employees&#8212; Board Practices&#8212; Approval of Related Party Transactions under Israeli Law&#8212; Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions.&#8221;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, under the Israeli Companies Law the appointment of external directors requires the approval of a majority vote of the shares present and voting on the matter, provided
      that either: (i) such majority includes a majority of the shares held by all shareholders who are non-controlling shareholders and shareholders who do not have a personal interest in the election of the external director (other than a personal
      interest not deriving from a relationship with a controlling shareholder) that are voted at the meeting, excluding abstentions; or (ii) the total number of shares held by shareholders who are non-controlling shareholders and shareholders who do not
      have a personal interest in the election of the external director (other than a personal interest not derived from a relationship with a controlling shareholder) voted against the election of the external director does not exceed 2% of the aggregate
      voting rights in the company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Furthermore, under the Israeli Companies Law the authorization of the chairman of the board to assume the role or responsibilities of the chief executive officer, or the
      authorization of the chief executive officer or his or her relative thereof to assume the role or responsibilities of the chairman of the board, for periods of no longer than three years each, is subject to receipt of the approval of a majority of
      the shares voting on the matter, provided that either (i) included in such majority are at least two-thirds of the shares of shareholders who are non-controlling shareholders and shareholders who do not have a personal interest in the resolution that
      are voted at the meeting on the matter (excluding any abstentions); or (ii) the total number of shares of shareholders specified in clause (i) who voted against the resolution does not 2% of the voting rights in the company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, of the company
      pursuant to Section 350 of the Israeli Companies Law, which requires the approval of holders of 75% of the voting rights represented at the meeting and voting on the resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Access to Corporate Records</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, shareholders are provided access to: minutes of the general meetings of our shareholders; our shareholders register and principal shareholders
      register, articles of association and financial statements; and any document that we are required by law to file publicly with the Israeli Companies Registrar or the Israel Securities Authority. In addition, shareholders may request to be provided
      with any document in the company&#8217;s possession related to an action or transaction requiring shareholder approval under the related party transaction provisions of the Israeli Companies Law. We may deny this request if we believe it has not been made
      in good faith or if such denial is necessary to protect our interest or protect a trade secret or patent.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Modification of Class Rights</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law and our amended articles of association, the rights attached to any class of shares, such as voting, liquidation and dividend rights, may be
      modified or cancelled by adoption of a resolution by the holders of a majority of all shares as one class, without any required separate resolution of any class of shares, or otherwise in accordance with the rights attached to such class of shares,
      as set forth in our amended articles of association.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Acquisitions under Israeli Law</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Full Tender Offer</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A person wishing to acquire shares of an Israeli public company, and who would as a result hold over 90% of the target company&#8217;s voting rights or issued and outstanding share
      capital, is required by the Israeli Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the company. A person wishing to acquire shares of a Israeli public company,
      and who would as a result hold over 90% of the target company&#8217;s voting rights or issued and outstanding share capital of a certain class of shares of the company, is required to make a tender offer to all of the shareholders who hold shares of the
      relevant class for the purchase of all of the issued and outstanding shares of that class. If the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable class, and
      more than half of the shareholders who do not have a personal interest in the offer accept the offer, all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. However, a tender offer will also
      be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon a successful completion of such a full tender offer, any shareholder that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may,
      within six months from the date of acceptance of the tender offer, petition an Israeli court to determine whether the tender offer was for less than fair value and that the fair value should be paid as determined by the court. However, under certain
      conditions, the offeror may include in the terms of the tender offer that an offeree who accepted the offer will not be entitled to petition the Israeli court as described above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If (a) the shareholders who did not respond or accept the tender offer hold at least 5% of the issued and outstanding share capital of the company, or of the applicable class, or
      the shareholders who accept the offer constitute less than a majority of the offerees that do not have a personal interest in the acceptance of the tender offer, or (b) the shareholders who did not accept the tender offer hold 2% or more of the
      issued and outstanding share capital of the company (or of the applicable class), the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company&#8217;s issued and outstanding share capital or of the
      applicable class from shareholders who accepted the tender offer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Special Tender Offer</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the
      purchaser would become a holder of 25% or more of the voting rights in the company, if there is no other shareholder that holds 25% or more of the voting rights in the company, subject to exceptions. Similarly, the Israeli Companies Law provides that
      an acquisition of shares in an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other
      shareholder of the company who holds more than 45% of the voting rights in the company, subject to certain exceptions. No tender offer is required if the acquisition of shares: (i) occurs in the context of a private placement, that was approved by
      the company&#8217;s shareholders and whose purpose is to give the acquirer at least 25% of the voting rights in the company if there is no person who holds 25% or more of the voting rights in the company, or as a private placement whose purpose is to give
      the acquirer 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in the company; (ii) was from a holder of 25% or more of the voting rights in the company following which the purchaser will hold 25% or
      more of the voting rights in the company; or (iii) was from a holder of more than 45% of the voting rights in the company following which the purchaser will hold more than 45% of the voting rights in the company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A special tender offer must be extended to all shareholders of a company (but the offeror is not required to purchase shares representing more than 5% of the voting power attached
      to the company&#8217;s outstanding shares, regardless of how many shares are tendered by shareholders). A special tender offer may be consummated only if (i) at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by
      the offeror; and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling shareholders, holders of 25% or more of the voting rights in the company or
      any person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person&#8217;s relatives and entities under their control). If a special tender offer is accepted, then the purchaser or any person
      or entity controlling it, at the time of the offer, and any person or entity under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company and may
      not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Merger</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless certain requirements described under the Israeli Companies Law are
      met, by a majority vote of each party&#8217;s shares, and, in the case of the target company, a majority vote of each class of its shares, voted on the proposed merger at a shareholders meeting. The board of directors of a merging company may not approve
      the merger if it determines that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging entities.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For purposes of the shareholder vote of a merging company whose shares are held by the other merging company or a person or entity holding 25% or more of any of the means of
      control of the other merging entity, unless a court rules otherwise, the merger will not be deemed approved if a majority of the votes of shares voting on the matter at the shareholders meeting (excluding abstentions) that are held by parties other
      than the other party to the merger, or by any other person or entity who holds 25% or more of the voting rights or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives or
      corporations controlled by any of them, vote against the merger. If, however, the merger involves a merger with a company&#8217;s own controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is
      instead subject to the same Special Majority approval that governs all extraordinary transactions with controlling shareholders (as described in Item 6C to the 2019 Annual Report &#8220;Directors, Senior Management and Employees&#8212;Board Practices&#8212; Approval
      of Related Party Transactions under Israeli Law &#8212; Disclosure of Personal Interests of Controlling Shareholders and Approval of Certain Transactions&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the votes of certain
      shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the valuation of the
      merging companies and the consideration offered to the shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a
      result of the merger, the surviving company will be unable to satisfy the obligations of the merging entities, and may further give instructions to secure the rights of creditors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, a merger may not be consummated unless at least 50 days have passed from the date on which a proposal for approval of the merger was filed by each party with the
      Israeli Registrar of Companies and at least 30 days have passed from the date on which the merger was approved by the shareholders of each party.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Anti-Takeover Measures under Israeli Law</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law allow us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred
      rights with respect to voting, distributions or other matters and shares having preemptive rights. No preferred shares are currently authorized under our amended articles of association. In the future, if we do authorize, create and issue a specific
      class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the
      market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our amended articles of association, which requires the prior approval of the holders of a majority of the voting
      power attached to our issued and outstanding shares at a general meeting. The convening of the meeting, the shareholders entitled to participate and the majority vote required to be obtained at such a meeting will be subject to the requirements set
      forth in the Israeli Companies Law and our amended articles of association as described above in &#8220;&#8212; Voting Rights.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Borrowing Powers</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Israeli Companies Law and our amended articles of association, our board of directors may exercise all powers and take all actions that are not required under law
      or under our amended articles of association to be exercised or taken by our shareholders, including the power to borrow money for company purposes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Changes in Capital</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended articles of association enable us to increase or reduce our share capital. Any such changes are subject to the provisions of the Israeli Companies Law and must be
      approved by a resolution duly passed by our shareholders at a general meeting by voting on such change in the capital. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence
      of sufficient retained earnings or profits, require the approval of both our board of directors and an Israeli court.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Description of the Warrants</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">
      <div style="line-height: 1.25; font-style: italic;">April 2020 Warrants</div>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The following is a brief summary of the investor warrants and placement agent warrants issued in connection with our April 2020 Private Placement and is subject in all respects to the provisions
          contained in the investor warrants, in the form filed as an exhibit to our Current Report on Form 6-K dated April 22, 2020 and the placement agent warrants, in the form filed as an exhibit to the registration statement, of which this prospectus
          forms a part. Unless otherwise stated, references to warrants in this section include the investor warrants and placement agent warrants.</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercisability</font>. Holders may exercise warrants at any time after April 22, 2020 until close of business on October 22, 2025, except that the
      placement agent warrants are exercisable until close of business on April 20, 2025. The warrants are exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full
      for the number of shares of ordinary shares purchased upon such exercise (except in the case of a cashless exercise in limited circumstances discussed below).</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Cashless Exercise</font>. If at the time of exercise of the warrants there is no effective registration statement registering the ordinary shares
      underlying the warrants, the holder may, at its option, exercise its warrants on a cashless basis. When exercised on a cashless basis, a portion of the warrant is cancelled in payment of the purchase price payable in respect of the number of our
      ordinary shares purchasable upon such exercise.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercise Price</font>. The exercise price of ordinary shares purchasable upon exercise of the investor warrants is $0.80 per share, and the exercise price of
        ordinary shares purchasable upon exercise of the placement agent warrants is $0.75. The exercise price and the number of shares issuable upon exercise of the warrants is subject to appropriate adjustment in the event of recapitalization events,
        stock dividends, stock splits, stock combinations, reclassifications or similar events affecting our ordinary shares, and also upon any distributions of assets, including cash, stock or other property to our shareholders.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Transferability</font>. Subject to certain transfer restrictions, the warrants may be transferred at the option of the holder upon surrender of the warrants with the
        appropriate instruments of transfer. In addition, the holder (or permitted assignees under FINRA Rule 5110(g)(1)) of the placement agent warrants may not sell, transfer, assign, pledge, or hypothecate the warrants or the securities underlying these
        warrants, nor may they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date or
        commencement of sales of the public offering of the ordinary shares issuable upon exercise of the warrants, subject to limited exceptions.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Purchase Rights, Fundamental Transactions and Change of Control</font>. If we sell or grant any rights to purchase shares, warrants or securities or other
            property to our shareholders on a pro rata basis, we will provide the holders of warrants with the right to acquire, upon the same terms, the securities subject to such purchase rights as though the warrant had been exercised immediately prior
            to the declaration of such rights. If we consummate any fundamental transaction, as described in the warrants and generally including any consolidation or merger into another corporation, the consummation of a transaction whereby another entity
            acquires more than 50% of our outstanding ordinary shares, the sale of all or substantially all of our assets, any tender offer or exchange offer or another transaction in which our ordinary shares are converted into or exchanged for other
            securities or other consideration, the holder of warrants will thereafter receive upon exercise of the warrants the securities or other consideration to which a holder of the number of ordinary shares then deliverable upon the exercise or
            conversion of such warrants would have been entitled upon such consolidation, merger or other transaction. In addition, in the event of a fundamental transaction which is approved by our board of directors, the holders of the warrants have the
            right to require us or a successor entity to redeem the warrants for cash in the amount of the Black-Scholes value of the unexercised portion of the warrants as of the date of the consummation of the fundamental transaction; provided, however,
            in the event of a fundamental transaction which is not within the our control (including not approved by our board of directors), we will only be required to pay the same type of consideration, at the Black-Scholes value of the unexercised
            portion of the warrant, that is being offered and paid to the holders of our shares in connection with the Fundamental Transaction.</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exchange Listing</font>. We do not plan on making an application to list the warrants on the Nasdaq Capital Market, any national securities
      exchange or other nationally recognized trading system. Our ordinary shares underlying the warrants will be listed on the Nasdaq Capital Market and our ordinary shares are traded on the Nasdaq Capital Market.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Rights as Shareholder</font>. Except as otherwise provided in the warrants (such as the rights described above of a warrant holder upon our sale
      or grant of any rights to purchase shares, warrants or securities or other property to our shareholders on a pro rata basis) or by virtue of such holder&#8217;s ownership of our ordinary shares, the holders of the warrants do not have the rights or
      privileges of holders of our ordinary shares, including any voting rights, until they exercise their warrants.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
    <br>
    <div style="line-height: 1.25; font-style: italic;">First May 2020 Warrants</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The following is a brief summary of the investor warrants and placement agent warrants issued in connection with our First May 2020 financing and is subject in all respects to the provisions
        contained in the investor warrants, in the form filed as an exhibit to our Current Report on Form 6-K dated May 4, 2020 and the placement agent warrants, in the form filed as an exhibit to the registration statement, of which this prospectus forms
        a part. Unless otherwise stated, references to warrants in this section include the investor warrants and placement agent warrants.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercisability</font>. Holders may exercise warrants at any time after May 4, 2020 until close of business on November 4, 2025, except that the placement agent
        warrants are exercisable until close of business on April 30, 2025. The warrants are exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number
        of shares of ordinary shares purchased upon such exercise (except in the case of a cashless exercise in limited circumstances discussed below).</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Cashless Exercise</font>. If at the time of exercise of the warrants there is no effective registration statement registering the ordinary shares
      underlying the warrants, the holder may, at its option, exercise its warrants on a cashless basis. When exercised on a cashless basis, a portion of the warrant is cancelled in payment of the purchase price payable in respect of the number of our
      ordinary shares purchasable upon such exercise.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercise Price</font>. The exercise price of ordinary shares purchasable upon exercise of the investor warrants is $0.80 per share, and the exercise price of
        ordinary shares purchasable upon exercise of the placement agent warrants is $0.75. The exercise price and the number of shares issuable upon exercise of the warrants is subject to appropriate adjustment in the event of recapitalization events,
        stock dividends, stock splits, stock combinations, reclassifications or similar events affecting our ordinary shares, and also upon any distributions of assets, including cash, stock or other property to our shareholders.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Transferability</font>. Subject to certain transfer restrictions, the warrants may be transferred at the option of the holder upon surrender of
      the warrants with the appropriate instruments of transfer. In addition, the holder (or permitted assignees under FINRA Rule 5110(g)(1)) of the placement agent warrants may not sell, transfer, assign, pledge, or hypothecate the warrants or the
      securities underlying these warrants, nor may they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days
      from the effective date or commencement of sales of the public offering of the ordinary shares issuable upon exercise of the warrants, subject to limited exceptions.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Purchase Rights, Fundamental Transactions and Change of Control</font>. If we sell or grant any rights to purchase shares, warrants or securities or other
            property to our shareholders on a pro rata basis, we will provide the holders of warrants with the right to acquire, upon the same terms, the securities subject to such purchase rights as though the warrant had been exercised immediately prior
            to the declaration of such rights. If we consummate any fundamental transaction, as described in the warrants and generally including any consolidation or merger into another corporation, the consummation of a transaction whereby another entity
            acquires more than 50% of our outstanding ordinary shares, the sale of all or substantially all of our assets, any tender offer or exchange offer or another transaction in which our ordinary shares are converted into or exchanged for other
            securities or other consideration, the holder of warrants will thereafter receive upon exercise of the warrants the securities or other consideration to which a holder of the number of ordinary shares then deliverable upon the exercise or
            conversion of such warrants would have been entitled upon such consolidation, merger or other transaction. In addition, in the event of a fundamental transaction which is approved by our board of directors, the holders of the warrants have the
            right to require us or a successor entity to redeem the warrants for cash in the amount of the Black-Scholes value of the unexercised portion of the warrants as of the date of the consummation of the fundamental transaction; provided, however,
            in the event of a fundamental transaction which is not within the our control (including not approved by our board of directors), we will only be required to pay the same type of consideration, at the Black-Scholes value of the unexercised
            portion of the warrant, that is being offered and paid to the holders of our shares in connection with the Fundamental Transaction.</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exchange Listing</font>. We do not plan on making an application to list the warrants on the Nasdaq Capital Market, any national securities
      exchange or other nationally recognized trading system. Our ordinary shares underlying the warrants will be listed on the Nasdaq Capital Market and our ordinary shares are traded on the Nasdaq Capital Market.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Rights as Shareholder</font>. Except as otherwise provided in the warrants (such as the rights described above of a warrant holder upon our sale
      or grant of any rights to purchase shares, warrants or securities or other property to our shareholders on a pro rata basis) or by virtue of such holder&#8217;s ownership of our ordinary shares, the holders of the warrants do not have the rights or
      privileges of holders of our ordinary shares, including any voting rights, until they exercise their warrants.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <br>
    <div style="line-height: 1.25;"><font style="font-style: italic;">Second May 2020</font>&#160;<font style="font-style: italic;">Warrants</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The following is a brief summary of the investor warrants and placement agent warrants issued in connection with our Second May 2020 financing and is subject in all respects to the provisions
        contained in the investor warrants, in the form filed as an exhibit to our Current Report on Form 6-K dated May 12, 2020 and the placement agent warrants, in the form filed as an exhibit to the registration statement, of which this prospectus forms
        a part. Unless otherwise stated, references to warrants in this section include the investor warrants and placement agent warrants.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercisability</font>. Holders may exercise warrants at any time after May 13, 2020 until close of business on November 13, 2025, except that the placement agent
        warrants are exercisable until close of business on May&#160; 8, 2025. The warrants are exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of
        shares of ordinary shares purchased upon such exercise (except in the case of a cashless exercise in limited circumstances discussed below).</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Cashless Exercise</font>. If at the time of exercise of the warrants there is no effective registration statement registering the ordinary shares
      underlying the warrants, the holder may, at its option, exercise its warrants on a cashless basis. When exercised on a cashless basis, a portion of the warrant is cancelled in payment of the purchase price payable in respect of the number of our
      ordinary shares purchasable upon such exercise.</div>
    <div style="line-height: 1.25;">&#160; </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exercise Price</font>.&#160; The exercise price of ordinary shares purchasable upon exercise of the investor warrants is $0.80 per share, and the exercise price of
        ordinary shares purchasable upon exercise of the placement agent warrants is $0.75. The exercise price and the number of shares issuable upon exercise of the warrants is subject to appropriate adjustment in the event of recapitalization events,
        stock dividends, stock splits, stock combinations, reclassifications or similar events affecting our ordinary shares, and also upon any distributions of assets, including cash, stock or other property to our shareholders.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Transferability</font>. Subject to certain transfer restrictions, the warrants may be transferred at the option of the holder upon surrender of
      the warrants with the appropriate instruments of transfer. In addition, the holder (or permitted assignees under FINRA Rule 5110(g)(1)) of the placement agent warrants may not sell, transfer, assign, pledge, or hypothecate the warrants or the
      securities underlying these warrants, nor may they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days
      from the effective date or commencement of sales of the public offering of the ordinary shares issuable upon exercise of the warrants, subject to limited exceptions.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Purchase Rights, Fundamental Transactions and Change of Control</font>. If we sell or grant any rights to purchase shares, warrants or securities or other
            property to our shareholders on a pro rata basis, we will provide the holders of warrants with the right to acquire, upon the same terms, the securities subject to such purchase rights as though the warrant had been exercised immediately prior
            to the declaration of such rights. If we consummate any fundamental transaction, as described in the warrants and generally including any consolidation or merger into another corporation, the consummation of a transaction whereby another entity
            acquires more than 50% of our outstanding ordinary shares, the sale of all or substantially all of our assets, any tender offer or exchange offer or another transaction in which our ordinary shares are converted into or exchanged for other
            securities or other consideration, the holder of warrants will thereafter receive upon exercise of the warrants the securities or other consideration to which a holder of the number of ordinary shares then deliverable upon the exercise or
            conversion of such warrants would have been entitled upon such consolidation, merger or other transaction. In addition, in the event of a fundamental transaction which is approved by our board of directors, the holders of the warrants have the
            right to require us or a successor entity to redeem the warrants for cash in the amount of the Black-Scholes value of the unexercised portion of the warrants as of the date of the consummation of the fundamental transaction; provided, however,
            in the event of a fundamental transaction which is not within the our control (including not approved by our board of directors), we will only be required to pay the same type of consideration, at the Black-Scholes value of the unexercised
            portion of the warrant, that is being offered and paid to the holders of our shares in connection with the Fundamental Transaction..</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Exchange Listing</font>. We do not plan on making an application to list the warrants on the Nasdaq Capital Market, any national securities
      exchange or other nationally recognized trading system. Our ordinary shares underlying the warrants will be listed on the Nasdaq Capital Market and our ordinary shares are traded on the Nasdaq Capital Market.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Rights as Shareholder</font>. Except as otherwise provided in the warrants (such as the rights described above of a warrant holder upon our sale
      or grant of any rights to purchase shares, warrants or securities or other property to our shareholders on a pro rata basis) or by virtue of such holder&#8217;s ownership of our ordinary shares, the holders of the warrants do not have the rights or
      privileges of holders of our ordinary shares, including any voting rights, until they exercise their warrants.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PLANOFDISTRIBUTION"><!--Anchor--></a>PLAN OF DISTRIBUTION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">We are registering the ordinary shares issuable upon exercise of the warrants and placement agent warrants issued in our April 2020 Private Placement, our First May&#160; 2020 Private Placement and our
        Second May&#160; 2020 Private Placement to permit the resale of these ordinary shares by the holders of these warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling shareholders
        of the ordinary shares other than proceeds from the cash exercise of the warrants and placement agent warrants, if and when exercised. We will bear all fees and expenses incident to our obligation to register the ordinary shares.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The selling shareholders may sell all or a portion of the ordinary shares beneficially owned by them and offered hereby from time to time directly or through one or more
      underwriters, broker-dealers or agents. If the ordinary shares are sold through underwriters or broker-dealers, the selling shareholders will be responsible for underwriting discounts or commissions or agent&#8217;s commissions. The ordinary shares may be
      sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses
      or block transactions,</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc8b4892a0f0146afa829859c028d12a0">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0657fe4cb9fa48a39a55d912d483ea85">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">in the over-the-counter market;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z739ea26b4e2647e59179e01e09b13e8f">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">in transactions otherwise than on these exchanges or systems or in the over-the-counter market;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za188d28c774541b08400f91e0fb2d553">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">through the writing of options, whether such options are listed on an options exchange or otherwise;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z31b771ef707e4cc4be9ee0d61fc95f75">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z312598a00a8245b48385202bb6f6550a">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4168f6f343824163846e61a741438acf">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1a42e2dadd09448181b7c604e66bb2f0">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">an exchange distribution in accordance with the rules of the applicable exchange;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z75783eb46edc4e938c439b6ef18b4337">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">privately negotiated transactions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zed0b78842e0240aaa4a0879e7149b9b3">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">short sales;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zac5f75d98668408498024e7c2142d206">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">sales pursuant to Rule 144;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze916a911369b4b35bdadf655547fafaa">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">broker-dealers may agree with the selling security holders to sell a specified number of such shares at a stipulated price per share;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd957c96da70a4e41984daa1702604395">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">a combination of any such methods of sale; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z25d1a53dc510412f9e49e6360b30cbf3">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">any other method permitted pursuant to applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the selling shareholders effect such transactions by selling ordinary shares to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents
      may receive commissions in the form of discounts, concessions or commissions from the selling shareholders or commissions from purchasers of the ordinary shares for whom they may act as agent or to whom they may sell as principal (which discounts,
      concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of ordinary shares or otherwise, the selling shareholders may
      enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the ordinary shares in the course of hedging in positions they assume. The selling shareholders may also sell ordinary shares short and deliver ordinary
      shares covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling shareholders may also loan or pledge ordinary shares to broker-dealers that in turn may sell such shares.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The selling shareholders may pledge or grant a security interest in some or all of the warrants, placement agent warrants or ordinary shares owned by them and, if they default in
      the performance of their secured obligations, the pledgees or secured parties may offer and sell the ordinary shares from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision
      of the Securities Act of 1933, as amended, amending, if necessary, the list of selling shareholders to include the pledgee, transferee or other successors in interest as selling shareholders under this prospectus. The selling shareholders also may
      transfer and donate the ordinary shares in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The selling shareholders and any broker-dealer participating in the distribution of the ordinary shares may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, and any
          commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular offering of the ordinary shares is made, a prospectus
          supplement, if required, will be distributed which will set forth the aggregate amount of ordinary shares being offered and the terms of the offering, including the name or names of any broker-dealers or agents, any discounts, commissions and
          other terms constituting compensation from the selling shareholders and any discounts, commissions or concessions allowed or reallowed or paid to broker-dealers.</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the securities laws of some states ordinary shares may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states ordinary
      shares may not be sold unless such ordinary shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There can be no assurance that any selling shareholder will sell any or all of the ordinary shares registered pursuant to the registration statement, of which this prospectus forms
      a part.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The selling shareholders and any other person participating in such distribution will be subject to applicable provisions of the Exchange Act, and the rules and regulations
      thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the ordinary shares by the selling shareholders and any other participating person. Regulation M may also
      restrict the ability of any person engaged in the distribution of the ordinary shares to engage in market-making activities with respect to the ordinary shares. All of the foregoing may affect the marketability of the ordinary shares and the ability
      of any person or entity to engage in market-making activities with respect to the ordinary shares.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">We will pay all expenses of the registration of the ordinary shares, estimated to be $40,000 in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of
        compliance with state securities or &#8220;blue sky&#8221; laws; provided, however, that each selling shareholder will pay all underwriting discounts and selling commissions, if any,&#160;and any related legal expenses incurred by it.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Once sold under the registration statement, of which this prospectus forms a part, the ordinary shares will be freely tradable in the hands of persons other than our affiliates.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">23</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="LEGALMATTERS"><!--Anchor--></a>LEGAL MATTERS</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">McDermott Will &amp; Emery LLP, New York, New York, has passed upon certain legal matters regarding the securities offered hereby under U.S. law, and Fischer Behar Chen Well Orion
      &amp; Co., Tel Aviv, Israel, has passed upon certain legal matters regarding the securities offered hereby under Israeli law. If the securities are distributed in an underwritten offering, certain legal matters will be passed upon for the
      underwriters by counsel identified in the applicable prospectus supplement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXPERTS</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The consolidated financial statements of Check-Cap Ltd. and its subsidiaries as of December 31, 2019 and 2018 and for each of the three years in the period ended December 31, 2019
      incorporated by reference in this prospectus have been audited by Brightman Almagor Zohar &amp; Co., a firm in the Deloitte Global Network, an independent registered accounting firm, as set forth in their report thereon, included therein, and
      incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WHERE YOU CAN FIND MORE INFORMATION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have filed with the SEC a registration statement on Form F-1, including amendments and relevant exhibits and schedules, under the Securities Act covering the ordinary shares to
      be sold in this offering. This prospectus, which constitutes a part of the registration statement, summarizes material provisions of contracts and other documents that we refer to in the prospectus. Since this prospectus does not contain all of the
      information contained in the registration statement, you should read the registration statement and its exhibits and schedules for further information with respect to us and our ordinary shares. You may review and copy the registration statement,
      reports and other information we file at the SEC&#8217;s public reference room at 100 F Street, N.E., Washington, D.C. 20549. You may also request copies of these documents upon payment of a duplicating fee by writing to the SEC. For further information on
      the public reference facility, please call the SEC at 1-800-SEC-0330. Our SEC filings, including the registration statement, are also available to you on the SEC&#8217;s Web site at http://www.sec.gov.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may read and copy the registration statement, including the related exhibits and schedules, and any document we file with the SEC without charge at the SEC&#8217;s public reference
      room at 100 F Street, N.E., Room 1580, Washington, DC 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington, DC 20549. Please call the
      SEC at 1-800-SEC-0330 for further information on the public reference room. The SEC also maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are
      also available to the public through the SEC&#8217;s website at <u>http://www.sec.gov</u>.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are subject to the information reporting requirements of the Exchange Act that are applicable to foreign private issuers, and under those requirements are filing reports with
      the SEC. Those other reports or other information may be inspected without charge at the locations described above. As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy
      statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file
      annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as United States companies whose securities are registered under the Exchange Act. However, we will file with the SEC, within 120 days after the
      end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and will submit to the SEC, on Form 6-K, unaudited
      quarterly financial information.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We maintain a corporate website at https://www.check-cap.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.
      We have included our website address in this prospectus solely as an inactive textual reference. We post on our website any materials required to be so posted on such website under applicable corporate or securities laws and regulations, including,
      posting any XBRL interactive financial data required to be filed with the SEC and any notices of general meetings of our shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold; text-align: center;"><a name="INCORPORATIONOFCERTAININF"><!--Anchor--></a>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160; <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are allowed to incorporate by reference the information we file with the SEC, which means that we can disclose important information to you by referring to those documents. The
      information incorporated by reference is considered to be part of this prospectus. We incorporate by reference in this prospectus the documents listed below:</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcb26128b37184dc291040719d8273761">

        <tr>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Our Annual Report on Form 20-F for the year ended December 31, 2019 filed with the SEC on March 6, 2020;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1f710fe760e94210a86b1fba107108d3">

        <tr>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Our Form 6-K filed with the SEC on March 6, 2020, April 6, 2020, April 20, 2020, April 22, 2020, April 30, 2020, May 4, 2020 and May 12, 2020 (to the extent expressly incorporated by
              reference into our effective registration statements filed by us under the Securities Act); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb6544a2b77844f67aeb275fad993fadf">

        <tr>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">(3)</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The description of our ordinary shares contained in our Registration Statement on Form F-1, as amended, under the Securities Act, as originally filed with the SEC
                  on December 23, 2014 (Registration No. 333- 201250) under the heading &#8220;Description of Securities&#8221; and as incorporated into our Registration Statement on Form 8-A12B, filed with the SEC February 11, 2015.</div>
              </div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information relating to us contained in this prospectus does not purport to be comprehensive and should be read together with the information contained in the documents
      incorporated or deemed to be incorporated by reference in this prospectus.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As you read the above documents, you may find inconsistencies in information from one document to another. If you find inconsistencies between the documents and this prospectus,
      you should rely on the statements made in the most recent document. All information appearing in this prospectus is qualified in its entirety by the information and financial statements, including the notes thereto, contained in the documents
      incorporated by reference herein.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Potential investors, including any beneficial owner, may obtain a copy of any of the documents summarized herein (subject to certain restrictions because of the confidential nature
      of the subject matter) or any of our SEC filings incorporated by reference herein without charge by written or oral request directed to Mira Rosenzweig, Chief Financial Officer; at Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya,
      3009000, Israel; Our telephone number is +972-4-8303400.&#160;</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You also may access the incorporated reports and other documents referenced above on our website at <font style="font-style: italic;">www.</font>&#160;<font style="font-style: italic;">check-cap.com</font>.
      The information contained on, or that can be accessed through, our website is not part of this prospectus.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should rely only on the information contained or incorporated by reference in this prospectus or a prospectus supplement. We have not authorized any other person to provide you
      with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should
      assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus, or such earlier date, that is indicated in this prospectus. Our business, financial condition, results of operations and
      prospects may have changed since that date.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ENFORCEABILITYOFCIVILLIAB"><!--Anchor--></a>ENFORCEABILITY OF CIVIL LIABILITIES</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are incorporated under the laws of the State of Israel. All of our current executive officers, the Israeli experts and the majority of our directors reside outside the United
      States, and substantially all of our assets and a substantial portion of the assets of these persons are located outside the United States. Therefore, service of process upon us and upon our directors and officers and the Israeli experts named in
      this prospectus, substantially all of whom reside outside the United States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets, and a substantial portion of those of our officers and directors
      who reside outside the United States and the Israeli experts named herein, are located outside the United States, any judgment obtained in the United States against us or any of these persons may not be collectible within the United States.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have appointed Puglisi &amp; Associates as our agent to receive service of process in any action against us in any United States federal or state court arising out of this
      offering or any purchase or sale of securities in connection with this offering. The address of Puglisi &amp; Associates is 850 Library Avenue, Suite 204, Newark, Delaware 19711.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have been informed by our legal counsel in Israel, Fischer Behar Chen Well Orion &amp; Co., that there is doubt as to the enforceability of civil liabilities under U.S.
      securities laws pursuant to original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws on the grounds that Israel is not the most appropriate forum to bring such a claim. In
      addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact by expert
      witnesses, which can be a time-consuming and costly process. Certain matters of procedure may also be governed by Israeli law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to certain time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter, including a judgment based upon the civil liability
      provisions of the Securities Act and the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that, among other things:&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9cbd9bffd23147daa5d7b64d909a4713">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">the judgment was rendered by a court which was, according to the laws of the state of the court, competent to render the judgment;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z315936a1713d4fcba0d802db05ee42c7">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">the judgment may no longer be appealed;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z77c6dae39fbf4fa2981bab044ad750de">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel and the substance of the judgment is not contrary to public
              policy; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zad7da93e7a9e411889b334fa4cad6020">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">the judgment is executory in the state in which it was given.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Even if such conditions are met, an Israeli court may not declare a foreign civil judgment enforceable if:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf568f3e2bcab478293748c1aea39c573">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the judgment was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9acd58af280c488eac4e4ce8fa19843c">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the judgment was obtained by fraud;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli court;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the judgment was rendered by a court not competent to render it according to the laws of private international law as they apply in Israel;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">the judgment is contradictory to another judgment that was given in the same matter between the same parties and that is still valid; or</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">&#160;</td>
          <td style="width: 88.46%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#9679;</div>
          </td>
          <td style="width: 88.46%; vertical-align: top;">
            <div style="line-height: 1.25;">at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Foreign judgments enforced by Israeli courts generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. The
      usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to render a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the
      judgment, but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the
      annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><img width="250" height="133" src="image0.jpg"></div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">, 2020</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%1%II - %%-->
  <div>&#160;
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PART II</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Item 6. Indemnification of Directors, Officers and Employees</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder
      in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care, but only if a provision authorizing such exculpation is included in its articles of association. Our amended
      articles of association include such a provision, to the fullest extent permitted by law. The company may not exculpate in advance a director from liability arising out of a prohibited dividend or other distribution to shareholders.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law and the Israeli Securities Law, 5728-1968, or the Israeli Securities Law, a company may indemnify an office holder in respect of the following
      liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of any such event or following an event, provided its articles of association include a provision authorizing
      such indemnification:</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court.
      However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s
      activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and
      amount or criteria;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her
      by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability was imposed upon him or her
      as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (2) in connection
      with a monetary sanction;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the
      company, on its behalf, or by a third party, or in connection with criminal proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal intent; and</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such
      office holder, or certain compensation payments made to an injured party imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">II - 1</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law and the Israeli Securities Law, a company may insure an office holder against the following liabilities incurred for acts performed by him or her as
      an office holder if and to the extent provided in the company&#8217;s articles of association:</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm
      the company;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a breach of the duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a financial liability imposed on the office holder in favor of a third party; and</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such
      office holder or certain compensation payments to an injured party imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Securities Law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, a company may not indemnify, exculpate or enter into an insurance contract for office holder liability, for any of the following:</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted
      in good faith and had a reasonable basis to believe that the act would not prejudice the company;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;an act or omission committed with intent to derive illegal personal benefit; or</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a fine, monetary sanction or forfeit levied against the office holder.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with
          respect to the chief executive officer and a director or (under certain circumstances), also by the shareholders. See Item 6C to the 2019 Annual Report &#8220;Directors, Senior Management and Employees &#8212;Board Practices&#8212;Approval of Related Party
          Transactions under Israeli Law.&#8221; However, the insurance of office holders shall not require shareholder approval and may be approved only by the compensation committee, if the engagement terms are determined in the company&#8217;s compensation policy
          and that policy was approved by the shareholders by a special majority (as described in Item 6C to the 2019 Annual Report &#8220;Directors, Senior Management and Employees &#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8221;),
          provided that the policy is on market terms and is not likely to materially impact the company&#8217;s profitability, assets or obligations.&#160; </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended articles of association permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted under the Israeli Companies Law and the Israeli
      Securities Law. We have obtained directors&#8217; and officers&#8217; liability insurance for the benefit of our office holders and intend to continue to maintain such coverage and pay all premiums thereunder to the fullest extent permitted by the Israeli
      Companies Law.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have entered into indemnification and exculpation agreements with each of our current officers and directors exculpating them from a breach of their duty of care to us to the
      fullest extent permitted by the Israeli Companies Law and undertaking to indemnify them to the fullest extent permitted by the Israeli Companies Law and the Israeli Securities Law, to the extent that these liabilities are not covered by insurance.
      This indemnification is limited to events determined as foreseeable by our board of directors based on our activities, as set forth in the indemnification agreements. Under such indemnification agreements, the maximum aggregate amount of
      indemnification that we may pay to any and all of our currently serving or future officers and directors together may not exceed the higher of $5 million and 25% of our shareholders equity according to our most recent financial statements at the time
      of payment. In the opinion of the SEC, however, indemnification of directors and office holders for liabilities arising under the Securities Act of 1933, as amended, is against public policy and therefore unenforceable.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">II - 2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Item 7. Recent Sales of Unregistered Securities</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Set forth below are the sales of all unregistered securities of ours sold by us within the past three years (i.e., since May 1, 2017, up to the date of this registration statement)
      which were not registered under the Securities Act:</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On June 2, 2017, we consummated a registered direct offering of 112,460 ordinary shares at a price of $24.00 per share and a simultaneous private placement of one-year warrants to
      purchase an aggregate of up to 112,460 ordinary shares. The warrants have an exercise price of $25.50 per share and are immediately exercisable. We received gross proceeds from the June 2017 registered direct offering of approximately $2.69 million.
      On June 2, 2018, all of the warrants expired without being exercised.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">On November 22, 2017, we consummated a registered direct offering of 189,387 ordinary shares at a price of $13.20 per share and a simultaneous private placement of five-year warrants to purchase an
        aggregate of up to 142,042 ordinary shares. The warrants have an exercise price of $15.00 per share and are immediately exercisable. We received approximately $2.5 million gross proceeds from the November 2017 registered direct offering. During the
        year ended December 31, 2018, 56,812 warrants were cashless exercised into 13,574 ordinary shares.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On February 6, 2019, we consummated a registered direct offering of 1,881,500 units at a purchase price of $2.58 per unit and 1,024,876 pre-funded units, at a purchase price of
      $2.57 per pre-funded unit. Each unit consisted of one ordinary share and one Series D Warrant to purchase 0.5 ordinary share. Each pre-funded unit consisted of one pre-funded warrant to purchase one ordinary share and one Series D Warrant to purchase
      0.5 ordinary share. The exercise price of each pre-funded warrant included in the pre-funded unit was $0.01 per share. The Series D warrants have an exercise price of $2.58 per ordinary share, are immediately exercisable and will expire five years
      from the date of issuance. We received gross proceeds of approximately of $7.5 million from the offering.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On February 4, 2020, we consummated a private placement of 2,720,178 ordinary shares at a purchase price of $1.75 per share.&#160; We received gross proceeds of approximately $4.76
      million from the private placement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On April 22, 2020, we consummated a registered direct offering of 6,666,669 ordinary shares at a price of $0.60 per share and a simultaneous private placement of five and a
      half-year warrants to purchase an aggregate of up to 6,666,669 ordinary shares. The warrants have an exercise price of $0.80 per share and are immediately exercisable. We received gross proceeds from the April 22, 2020 registered direct offering of
      approximately $4.0 million.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 4, 2020, we consummated a registered direct offering of 7,500,001 ordinary shares at a price of $0.60 per share and a simultaneous private placement of five and a half-year
      warrants to purchase an aggregate of up to 7,500,001 ordinary shares. The warrants have an exercise price of $0.80 per share and are immediately exercisable. We received gross proceeds from the May 4, 2020 registered direct offering of approximately
      $4.5 million.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 13, 2020, we consummated a registered direct offering of 5,000,000 ordinary shares at a price of $0.60 per share and a simultaneous private placement of five and a half-year
      warrants to purchase an aggregate of up to 5,000,000 ordinary shares. The warrants have an exercise price of $0.80 per share and are immediately exercisable. We received gross proceeds from the May 13, 2020 registered direct offering of $3.0 million.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The privately placed securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act and Rule 506 of
      Regulation D promulgated thereunder since, among other things, the transactions did not involve a public offering and the securities were acquired for investment purposes only and not with a view to or for sale in connection with any distribution
      thereof.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">II - 3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%4%II -%%-->
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Item 8. Exhibits and Financial Statement Schedules</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3af5d423d93441b48b70298b4ff2e9bc">

        <tr>
          <td style="width: 3.83%; vertical-align: top;">
            <div style="line-height: 1.25;">(a)</div>
          </td>
          <td style="width: 96.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Exhibits</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb6657744d4dc4a6b9a36f6cc55d15c8b">

          <tr>
            <td style="width: 9%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Exhibit No.</div>
            </td>
            <td style="width: 1%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320000745/exhibit_1-1.htm">3.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320000745/exhibit_1-1.htm">Amended and Restated Articles of Association of Check-Cap Ltd. (1)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #FFFFFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-14.htm">4.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-14.htm">Form of Registrant&#8217;s Ordinary Share Certificate (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">4.2</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">Form of Long Term Incentive Warrant Certificate (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #FFFFFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">4.3</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">Form of Warrant Agreement dated as of February 24, 2015 between Check-Cap Ltd. and American Stock Transfer &amp; Trust
                  Company LLC, as Warrant Agent (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315002104/exhibit_4-1.htm">4.4</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315002104/exhibit_4-1.htm">Amendment No.1 dated as of June 24, 2015, to Warrant Agreement dated as of February 24, 2015 between Check-Cap Ltd.
                  and American Stock Transfer &amp; Trust Company LLC, as Warrant Agent (3)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #FFFFFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_1-1.htm">4.5</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_1-1.htm">Form of 2014 Underwriter Warrants (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_4-2.htm">4.6</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_4-2.htm">Form of June 2017 Warrants (4)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #FFFFFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_4-2.htm">4.7</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_4-2.htm">Form of June 2017 Placement Agent Warrants (4)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-1.htm">4.8</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-1.htm">Form of November 2017 Warrants (5)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #FFFFFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">4.9</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #FFFFFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">Form of November 2017 Placement Agent Warrants (5)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">4.10</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">Form of Ordinary Shares Warrant Certificate issued pursuant to a certain Credit Line Agreement dated as of August 20,
                  2014 (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-14.htm">4.11</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-14.htm">Form of Series C Warrant (6)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-15.htm">4.12</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-15.htm">Form of Warrant Agent Agreement between Check-Cap Ltd. and American Stock Transfer &amp; Trust Company LLC, as
                  Warrant Agent (6)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-1.htm">4.13</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-1.htm">Form of February 2019 Series D Warrant (7)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">5.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;"><br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="exhibit_5-1.htm">Opinion of Fischer Behar Chen Well Orion &amp; Co., Israeli counsel to the Registrant*</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-3.htm">10.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-3.htm">Form of the February 2019 Placement Agent Warrant (8)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">10.2</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">Form of Warrant issued by Check-Cap Ltd. on April 22, 2020 (9)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-2.htm">10.3</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-2.htm">Form of Warrant issued by Check-Cap Ltd. on May 4, 2020 (10)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-2.htm">10.4</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-2.htm">Form of Warrant issued by Check-Cap Ltd. on May 13, 2020 (11)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_10-5.htm">10.5</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);"> <br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="exhibit_10-5.htm">Form of Placement Agent Warrant issued by Check-Cap Ltd. on April 22, 2020*</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_10-6.htm">10.6</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;"> <br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="exhibit_10-6.htm">Form of Placement Agent Warrant issued by Check-Cap Ltd. on May 4, 2020*</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_10-7.htm">10.7</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);"> <br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="exhibit_10-7.htm">Form of Placement Agent Warrant issued by Check-Cap Ltd. on May 13, 2020*</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-15.htm">10.8</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
            <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-15.htm">Forms of Ordinary Shares Warrant Certificate issued to the Pontifax entities (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891316006206/exhibit_10-2.htm">10.9</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891316006206/exhibit_10-2.htm">Placement Agent Agreement dated August 5, 2016 by and between Check-Cap Ltd. and Chardan Capital Markets LLC (12)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_10-1.htm">10.10</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_10-1.htm">Securities Purchase Agreement dated as of May 30, 2017 by and among Check-Cap Ltd. and the Purchasers named therein
                  (13)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_10-1.htm">10.11</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891317001696/exhibit_10-1.htm">Securities Purchase Agreement dated as of November 20, 2017 by and among Check-Cap Ltd. and the Purchasers named
                  therein (14)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001462/exhibit_1-1.htm">10.12</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891318001462/exhibit_1-1.htm">Underwriting Agreement, dated as of May 4, 2018, by and between Check-Cap Ltd. and H.C. Wainwright &amp; Co., LLC (15)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">10.13</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">Form of Securities Purchase Agreement dated as of February 4, 2019 by and between Check-Cap Ltd. and the Purchasers
                  named therein (16)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">10.14</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">Form of Securities Purchase Agreement dated as of December 19, 2019 by and between Check-Cap Ltd. and the Purchasers
                  named therein (17)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhibit_10-1.htm">10.15</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhibit_10-1.htm">Form of Securities Purchase Agreement dated as of April 20, 2020 by and between Check-Cap Ltd. and the Purchasers
                  signatory thereto (2)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-1.htm">10.16</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-1.htm">Form of Securities Purchase Agreement dated as of April 30, 2020 by and between Check-Cap Ltd. and the Purchasers
                  signatory thereto (3)</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-1.htm">10.17</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-1.htm">Form of Securities Purchase Agreement dated as of May 8, 2020 by and between Check-Cap Ltd. and the Purchasers
                  signatory thereto (4)</a></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">23.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="http://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">Consent of Brightman Almagor Zohar &amp; Co.*</a></div>
            </td>
          </tr>
          <tr>
            <td style="background-color: #FFFFFF; vertical-align: top; width: 9%;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">23.2</a></div>
            </td>
            <td style="background-color: #FFFFFF; vertical-align: top; width: 1%;"><br>
            </td>
            <td style="background-color: #FFFFFF; vertical-align: top; width: 90%;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">Consent of Fischer Behar Chen Well Orion &amp; Co. (included in
                  Exhibit 5.1)*</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="#ATTORNEY">24.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;"><a href="#ATTORNEY">Power of Attorney (included in signature page)</a></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> </div>
    <div style="text-align: justify; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> </div>
    <div style="text-align: justify; line-height: 1.25;"> </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z830df9f799b04e5c96a6d9311e169670">

        <tr>
          <td style="width: 3.83%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">*</div>
          </td>
          <td style="width: 96.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Filed herewith.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcb87ed35c2774288b6ae7d678b490ef8">

        <tr>
          <td style="width: 3.89%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 96.11%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">Incorporated herein by reference to the Annual Report on Form 20-F filed with the SEC on March 6, 2020.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za45915a531ee4656ac71cf6e8140d71d">

        <tr>
          <td style="width: 3.83%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 96.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">Incorporated by reference to the Registration Statement on Form F-1 of the Registrant (File No. 333-201250).</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z93fdd2b8111b4fae9b85f7de383ce23f">

        <tr>
          <td style="width: 3.83%; vertical-align: top;">
            <div style="line-height: 1.25;">(3)</div>
          </td>
          <td style="width: 96.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on June 24, 2015.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfe04070e416d4e4880b6882d4441be3c">

        <tr>
          <td style="width: 3.83%; vertical-align: top;">
            <div style="line-height: 1.25;">(4)</div>
          </td>
          <td style="width: 96.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">
              <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on June 2, 2017.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">II -4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfe04070e416d4e4880b6882d4441be3c">

          <tr>
            <td style="width: 3.83%; vertical-align: top;">
              <div style="line-height: 1.25;">(5)</div>
            </td>
            <td style="width: 96.17%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="margin-right: 0.1pt; line-height: 1.25;">
                  <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on November 22, 2017.</div>
                </div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;<br>
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 3.83%; vertical-align: top;">
                  <div style="line-height: 1.25;">(6)</div>
                </td>
                <td style="width: 96.17%; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;">
                    <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                      <div style="line-height: 1.25;">Incorporated by reference to the Registration Statement on Form F-1/A by the Registrant with the Securities and Exchange Commission on April 25, 2018.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;
            <div style="line-height: 1.25;">
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 3.83%; vertical-align: top;">
                      <div style="line-height: 1.25;">(7)</div>
                    </td>
                    <td style="width: 96.17%; vertical-align: top;">
                      <div style="text-align: justify; line-height: 1.25;">
                        <div>
                          <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on February 6, 2019.</div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height: 1.25;">&#160;
                <div style="line-height: 1.25;">
                  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                      <tr>
                        <td style="width: 3.83%; vertical-align: top;">
                          <div style="line-height: 1.25;">(8)</div>
                        </td>
                        <td style="width: 96.17%; vertical-align: top;">
                          <div style="text-align: justify; line-height: 1.25;">
                            <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                              <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on February 6, 2019.</div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height: 1.25;">&#160;
                    <div style="line-height: 1.25;">
                      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                          <tr>
                            <td style="width: 3.83%; vertical-align: top;">
                              <div style="line-height: 1.25;">(9)</div>
                            </td>
                            <td style="width: 96.17%; vertical-align: top;">
                              <div style="text-align: justify; line-height: 1.25;">
                                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Incorporated herein by reference to the Current Report on Form 6-K filed with the SEC on April 22, 2020.</div>
                                </div>
                              </div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height: 1.25;">&#160;
                        <div style="line-height: 1.25;">
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                              <tr>
                                <td style="width: 3.83%; vertical-align: top;">
                                  <div style="line-height: 1.25;">(10)</div>
                                </td>
                                <td style="width: 96.17%; vertical-align: top;">
                                  <div style="text-align: justify; line-height: 1.25;">
                                    <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                                      <div style="line-height: 1.25;">Incorporated herein by reference to the Current Report on Form 6-K filed with the SEC on May 4, 2020.</div>
                                    </div>
                                  </div>
                                </td>
                              </tr>

                          </table>
                          <div style="line-height: 1.25;">&#160;
                            <div style="line-height: 1.25;">
                              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                                  <tr>
                                    <td style="width: 3.83%; vertical-align: top;">
                                      <div style="line-height: 1.25;">(11)</div>
                                    </td>
                                    <td style="width: 96.17%; vertical-align: top;">
                                      <div style="text-align: justify; line-height: 1.25;">
                                        <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                                          <div style="line-height: 1.25;">Incorporated herein by reference to the Current Report on Form 6-K filed with the SEC on May 12, 2020.</div>
                                        </div>
                                      </div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height: 1.25;">&#160;
                                <div style="line-height: 1.25;">
                                  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                                      <tr>
                                        <td style="width: 3.83%; vertical-align: top;">
                                          <div style="line-height: 1.25;">(12)</div>
                                        </td>
                                        <td style="width: 96.17%; vertical-align: top;">
                                          <div style="text-align: justify; line-height: 1.25;">
                                            <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                                              <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on August 12, 2016.</div>
                                            </div>
                                          </div>
                                        </td>
                                      </tr>

                                  </table>
                                  <div style="line-height: 1.25;">&#160;
                                    <div style="line-height: 1.25;">
                                      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                                          <tr>
                                            <td style="width: 3.83%; vertical-align: top;">
                                              <div style="line-height: 1.25;">(13)</div>
                                            </td>
                                            <td style="width: 96.17%; vertical-align: top;">
                                              <div style="text-align: justify; line-height: 1.25;">
                                                <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                                                  <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on June 2, 2017.</div>
                                                </div>
                                              </div>
                                            </td>
                                          </tr>

                                      </table>
                                      <div style="line-height: 1.25;">&#160;
                                        <div style="line-height: 1.25;">
                                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                                              <tr>
                                                <td style="width: 3.83%; vertical-align: top;">
                                                  <div style="line-height: 1.25;">(14)</div>
                                                </td>
                                                <td style="width: 96.17%; vertical-align: top;">
                                                  <div style="text-align: justify; line-height: 1.25;">
                                                    <div style="text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; line-height: 1.25;">
                                                      <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on November 22, 2017.</div>
                                                    </div>
                                                  </div>
                                                </td>
                                              </tr>

                                          </table>
                                          <div style="line-height: 1.25;">&#160;
                                            <div style="line-height: 1.25;">
                                              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                                                  <tr>
                                                    <td style="width: 3.83%; vertical-align: top;">
                                                      <div style="line-height: 1.25;">(15)</div>
                                                    </td>
                                                    <td style="width: 96.17%; vertical-align: top;">
                                                      <div style="text-align: justify; line-height: 1.25;">
                                                        <div style="line-height: 1.25;">
                                                          <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on May 4, 2018.</div>
                                                        </div>
                                                      </div>
                                                    </td>
                                                  </tr>

                                              </table>
                                              <div style="line-height: 1.25;">&#160;</div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 3.83%; vertical-align: top;">
                <div style="line-height: 1.25;">(16)</div>
              </td>
              <td style="width: 96.17%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on February 6, 2019.</div>
                  </div>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 3.83%; vertical-align: top;">
                  <div style="line-height: 1.25;">(17)</div>
                </td>
                <td style="width: 96.17%; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;">
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25;">Incorporated by reference to the Annual Report on Form 20-F filed by the Registrant with the Securities and Exchange Commission on March 6, 2020.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The agreements included as exhibits to this registration statement contain representations and warranties by each of the parties to the applicable agreement. These representations
      and warranties were made solely for the benefit of the other parties to the applicable agreement and (i) were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those
      statements prove to be inaccurate; (ii) may have been qualified in such agreement by disclosures that were made to the other party in connection with the negotiation of the applicable agreement; (iii) may apply contract standards of &#8220;materiality&#8221;
      that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Registrant acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, the registrant is responsible for considering whether additional specific
      disclosures of material information regarding material contractual provisions are required to make the statements in this registration statement not misleading.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z09360a8ade0b4dedb1a4862215e9036b">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(b)</div>
          </td>
          <td style="width: 92.24%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Financial Statement Schedules</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All schedules have been omitted because either they are not required, are not applicable or the information is otherwise set forth in the consolidated financial statements and
      related notes thereto.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">II -5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Item 9. Undertakings</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z01455172d23c4939bde59d9b634523e3">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(a)</div>
          </td>
          <td style="width: 92.24%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The undersigned Registrant hereby undertakes:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1dbbed1d122641bfb3b3c7ec8fc7779f">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5bfc6b064cf64e0bb31b1925f5bce78a">

        <tr>
          <td style="width: 15.38%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">i.</div>
          </td>
          <td style="width: 76.92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zac7de525d35b49c8b710c2f8ffb0d8bc">

        <tr>
          <td style="width: 15.38%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">ii.</div>
          </td>
          <td style="width: 76.92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or
              in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
              offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
              aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z53b881df7bf147da89739bd43e3607c0">

        <tr>
          <td style="width: 15.38%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">iii.</div>
          </td>
          <td style="width: 76.92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the
              registration statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6c5430aea6bd481cb4ccc0edb9ea328c">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">That for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration
              statement relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6bd27ca450234ffab390bc39a16427ec">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(3)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcd93daac03cc4830bbf6bd8da7ef2a22">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(4)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a
              continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial
              statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with
              respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Rule 3-19 of this chapter if such financial statements and
              information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7ad882466506475ebebd457ef0c1d898">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(5)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">That for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance
              upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared
              effective.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z36fc19ec899646c6849058daf868d432">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(6)</div>
          </td>
          <td style="width: 84.62%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration
              statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd525c4baecf9443eb29284df073151bd">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="line-height: 1.25;">(b)</div>
          </td>
          <td style="width: 92.24%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the
              provisions described in Item 6 hereof, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a
              claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or
              proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
              to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">II -6</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on
      Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Isfiya, State of Israel on this 20<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of May 2020.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z96a3a9daee344f36aaa6aabe6a96a6ce">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="2" style="vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="2" style="vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">/s/ Alex Ovadia</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">Name:&#160;</div>
          </td>
          <td style="width: 35%; vertical-align: top;">
            <div style="line-height: 1.25;">Alex Ovadia</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 35%; vertical-align: top;">
            <div style="line-height: 1.25; font-style: italic;">Chief Executive Officer</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">POWER OF <a name="ATTORNEY"><!--Anchor--></a>ATTORNEY</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">KNOW ALL MEN BY THESE PRESENTED, that each director and officer of Check-Cap Ltd. whose signature appears below hereby appoints Alex Ovadia and Mira Rosenzweig, and each of them
      severally, acting alone and without the other, his/her true and lawful attorney-in-fact with full power of substitution or re-substitution, for such person and in such person&#8217;s name, place and stead, in any and all capacities, to sign on such
      person&#8217;s behalf, individually and in each capacity stated below, any and all amendments, including post-effective -amendments to this Registration Statement, and to sign any and all additional registration statements relating to the same offering of
      securities of the Registration Statement that are filed pursuant to Rule 462(b) of the Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission,
      granting unto said attorneys-in-fact, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in
      person, hereby ratifying and confirming all that said attorneys-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcf1ca6c231fa48779f15922d8ee7ff1c">

        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">Name</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25;">Title</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">Date</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Alex Ovadia</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Chief Executive Officer and Director</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Alex Ovadia</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">(principal executive officer)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Mira Rosenzweig</div>
          </td>
          <td style="width: 1%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Operating and Financial Officer</div>
          </td>
          <td style="width: 1%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Mira Rosenzweig</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">(principal financial officer and principal accounting officer)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Steven Hanley</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Chairman of the Board</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Steven Hanley</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Clara Ezed</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Director</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Clara Ezed</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Mary Jo Gorman</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Director</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Mary Jo Gorman</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ XiangQian (XQ) Lin</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Director</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">XiangQian (XQ) Lin</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Yuval Yanai</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">Director</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Yuval Yanai</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">II -7</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160; <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Check-Cap Ltd., has signed this registration
      statement on May 20, 2020.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze9e1a2a9930b4f5f84d763d77462a628">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="2" style="vertical-align: top;">
            <div style="line-height: 1.25;">Puglisi &amp; Associates</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 30%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">/s/ Donald J. Puglisi</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">Name:&#160;</div>
          </td>
          <td style="width: 30%; vertical-align: top;">
            <div style="line-height: 1.25;">Donald J. Puglisi</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 30%; vertical-align: top;">
            <div style="line-height: 1.25;">Authorized Representative</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font id="DSPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">II -8</font> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit_5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 5.1</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div id="DSPFPageHeader">
        <div style="text-align: center; line-height: 1.25;"><img src="image00002.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" id="z652eb8c1850f4725a0950c8ad20ece2e" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 85%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 15%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25;">Tel. 972-3-69441111</div>
              </td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 15%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">Fax. 972-3-6091116</div>
              </td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25;">fbc@fbclawyers.com</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;">May 20, 2020</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">To:</div>
      <div style="line-height: 1.25;">Check-Cap Ltd.</div>
      <div style="line-height: 1.25;">Check-Cap Building</div>
      <div style="line-height: 1.25;">29 Abba Hushi Avenue</div>
      <div style="line-height: 1.25;">P.O. Box 1271</div>
      <div style="line-height: 1.25;">Isfiya, 3009000, Israel</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Re: <u>Check-Cap Ltd.</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Ladies and Gentlemen:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have acted as Israeli counsel to Check-Cap Ltd., a company organized under the laws of the State of Israel (the
        &#8220;<font style="font-weight: bold;">Company</font>&#8221;), in connection with the Registration Statement on Form F-1 (the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;) being filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;)
        pursuant to the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Securities Act</font>&#8221;), which registers the resale, from time to time, by certain selling
        shareholders named in the Registration Statement of up to an aggregate of 20,508,337 ordinary shares, par value NIS 2.40 per share, of the Company (the &#8220;<font style="font-weight: bold;">Warrant
          Shares</font>&#8221;), which are issuable upon exercise of certain warrants that were issued to the selling shareholders by the Company in certain private placements as described in the Registration Statement (the &#8220;<font style="font-weight: bold;">Warrants</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection herewith, we have examined the originals, or photocopies or copies, certified or otherwise identified
        to our satisfaction, of: (i) the form of the Registration Statement, to which this opinion is attached as an exhibit; (ii) a copy of the articles of association of the Company, as currently in effect (the &#8220;<font style="font-weight: bold;">Articles</font>&#8221;); (iii) resolutions of committees of the board of directors of the Company and of the board of directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) that have heretofore been approved and which relate to the offering and sale of the Warrants and the Warrant Shares; and (iv) such other corporate records, agreements, documents and
        other instruments, and such certificates or comparable documents of public officials and of officers and representatives of the Company as we have deemed relevant and necessary as a basis for the opinions hereafter set forth.&#160; We have also made
        inquiries of such officers and representatives as we have deemed relevant and necessary as a basis for the opinions hereafter set forth.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons,
        the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as reproduced or certified copies and the authenticity of the originals of such latter documents.&#160; We have assumed
        the same to have been properly given and to be accurate.&#160; We have also assumed the truth of all facts communicated to us by the Company and that all consents and minutes of meetings of committees of the Board, the Board and the shareholders of the
        Company that have been provided to us are true and accurate and have been properly prepared in accordance with the Articles and all applicable laws.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <img src="image00003.jpg"></div>
      <div style="text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Based upon and subject to the foregoing, we are of the opinion that the Warrant Shares, when issued, delivered and
        paid for in accordance with the terms of the applicable Warrants upon due exercise thereof, will be validly issued, fully paid and non-assessable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Members of our firm are admitted to the Bar in the State of Israel, and we do not express any opinion as to the
        laws of any other jurisdiction.&#160; This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to
        this firm under the caption &#8220;Legal Matters&#8221; and &#8220;Enforceability of Civil Liabilities&#8221; in the prospectus forming part of the Registration Statement.&#160; In giving this consent, we do not thereby admit that we are within the category of persons whose
        consent is required under Section 7 of the Securities Act, the rules&#160;and regulations of the SEC promulgated thereunder or Item 509 of the SEC&#8217;s Regulation S-K promulgated under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts,
        circumstances, events or developments that may be brought to our attention after the date hereof that may alter, affect or modify the opinions expressed herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3c7c98c2753e44f7a9c26a1d9d04c516" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Very truly yours,</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Fischer Behar Chen Well Orion &amp; Co.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Fischer Behar Chen Well Orion &amp; Co.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; text-align: center;">&#160;2
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>exhibit_10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 10.5</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
        RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
        PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#160; THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF
        THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;CHECK-CAP LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zdfdbac7c06a74cf8a060d8534558c453" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 41.76%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Warrant Shares: _______</div>
            </td>
            <td style="width: 58.24%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">Initial Exercise Date: April 22, 2020</div>
              <div style="text-align: center; line-height: 1.25;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.76%; vertical-align: top;">&#160;</td>
            <td style="width: 58.24%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">Issue Date: April 22, 2020</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled,
        upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on April 20,
        2025 (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Check-Cap Ltd., an Israeli company (the &#8220;<u>Company</u>&#8221;), up to ______&#160; Ordinary Shares, NIS 2.40 par value (the &#8220;<u>Ordinary Share(s)</u>&#8221;) (as subject to
        adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).&#160; This Warrant is being issued pursuant to that certain engagement
        letter, dated as of March 18, 2020, by and between the Company and H.C. Wainwright &amp; Co., LLC.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 1</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase
        Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated April 20, 2020, among the Company and the purchasers signatory thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 2</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
        or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or <font style="font-style: italic;">.pdf</font> copy via e-mail attachment) of the Notice of Exercise in the
        form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of
        exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise
        procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.<font style="font-weight: bold;">&#160; </font>No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of
        guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the
        Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is
        delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
        hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any
        objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
          paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Exercise Price</u>.&#160; The exercise price per Ordinary Share under this Warrant shall be <font style="font-weight: bold;">$0.75</font>, subject
        to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Cashless Exercise</u>. If at the time of exercise hereof, there is no effective registration statement registering, or no current prospectus
        available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant
        Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zcec388e160d8440cb5bf8f9be30d3c35" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 75pt;"><br>
                </td>
                <td style="width: 28.8pt; vertical-align: top; align: right;">(A) =</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a
                    Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities
                    laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Ordinary Share on the principal Trading
                    Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2)
                    hours thereafter&#160; (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zeed2c7a056004b53b3d76022070844c8" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="width: 75pt;">&#160;</td>
              <td style="vertical-align: top; width: 28.8pt;">
                <div style="text-align: justify; line-height: 1.25;">(B) =</div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; line-height: 1.25;">the Exercise Price of this Warrant, as adjusted hereunder; and</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 75pt;">&#160;</td>
                <td style="vertical-align: top; width: 28.8pt;">
                  <div style="text-align: justify; line-height: 1.25;">(X) = </div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
                    than a cashless exercise.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"><font style="background-color: #FFFFFF;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with
          Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised</font>, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant<font style="background-color: #FFFFFF;">.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or
        quoted on a Trading Market, the bid price of the Ordinary Share for the time in question (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
        Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or OTCQX as
        applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Purchasers of a majority
        in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or quoted
        on a Trading Market, the daily volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a
        Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or
        OTCQX as applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its
        functions of reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Holders of a
        majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Mechanics of Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
        Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such
        system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
        manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
        entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) the earlier of (A) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (B)
        one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;<u>Warrant
          Share Delivery Date</u>&#8221;).&#160;&#160; Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
        irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of
        Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
        Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Ordinary Share on the date of the applicable Notice of Exercise),
        $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
        such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.&#160; As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement
        period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Ordinary Share as in effect on the date of delivery of the Notice of Exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
        and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new
        Warrant shall in all other respects be identical with this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
        2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other rights available to the
        Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
        date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
        the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the
        Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
        giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise
        shall be deemed rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases Ordinary Share
        having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
        sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of
        such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the
        Company&#8217;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
        Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
        fraction multiplied by the Exercise Price or round up to the next whole share.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
        incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the
        Holder; <u>provided</u>, <u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
        duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent fees required for same-day
        processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
        Warrant, pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Holder&#8217;s Exercise Limitations</u>.&#160; &#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
        exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
        and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For
        purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable upon exercise of this Warrant with respect to which
        such determination is being made, but shall exclude the number of Ordinary Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
        Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Ordinary Share Equivalents) subject to a limitation on conversion or
        exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be
        calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with
        Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
        Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
        of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
        Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a determination as to any group status as
        contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this Section 2(e), in determining the number of outstanding Ordinary Shares, a Holder
        may rely on the number of outstanding Ordinary Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
        written notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the
        number of Ordinary Shares then outstanding.&#160; In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its
        Affiliates or Attribution Parties since the date as of which such number of outstanding Ordinary Shares were reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% of the number of the Ordinary Shares outstanding immediately after
        giving effect to the issuance of Ordinary Shares issuable upon exercise of this Warrant.&#160; The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the
        Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise of this Warrant held by the Holder and the provisions of this
        Section 2(e) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and
        implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
        contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 3</u>.&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Certain Adjustments</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Share Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a
        distribution or distributions on its Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this
        Warrant), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of the
        Ordinary Shares any capital share of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding immediately
        before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
        aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or
        distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Reserved</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Subsequent Rights Offerings</u>.&#160; In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
        sells any Ordinary Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Ordinary Shares (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
        upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any
        limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
        date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the
        Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent) and
        such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than
        cash) or other distribution of its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
        by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Company shall
        reserve and put aside the maximum Distribution amount the Holder would have been entitled to receive if the Holder had held the number Ordinary Shares acquirable upon complete exercise of such Warrant immediately before the date on which a record
        is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the participation in such Distribution. Upon exercise of a Warrant, in whole or in part, the Company
        shall, contemporaneously with the delivery of the Ordinary Shares, distribute to the Holder a pro rata portion of such Distribution based on the portion of the Warrant that has been exercised (<u>provided</u>, <u>however</u>, to the extent that
        the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
        ownership of any Ordinary Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
        Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
        related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
        conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
        completed pursuant to which holders of the Ordinary Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares, (iv)
        the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively
        converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
        limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Ordinary Shares (not including any
        Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;Fundamental
        Transaction&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
        Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation or of the Company, if it is the surviving
        corporation, and any additional consideration (the &#8220;Alternate Consideration&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable immediately prior to such
        Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
        Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
        reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Ordinary Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
        be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
        Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
        applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the
        consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the
        Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Ordinary Shares of the
        Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Ordinary Shares are given the choice to receive from among alternative forms of
        consideration in connection with the Fundamental Transaction; provided, further, that if holders of Ordinary Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Ordinary Shares will be
        deemed to have received securities of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &#8220;Black Scholes Value&#8221; means the value of this Warrant based on the Black Scholes
        Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg, L.P. (&#8220;Bloomberg&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
        to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day
        volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per
        share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x)
        the last VWAP immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to the time between the
        date of the public announcement of the applicable Fundamental Transaction and the Termination Date.&#160; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five (5) Trading Days of the Holder&#8217;s
        election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;Successor Entity&#8221;) to assume in writing all of
        the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
        delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
        to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to
        any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the
        Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
        immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
        substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
        shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
        be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Notice to Holder</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall
        promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such
        adjustment.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
        Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or
        purchase any capital shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company is a
        party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the
        voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall
        appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
        distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
        or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares of record shall be
        entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect
        therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
        regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K.&#160; The Holder shall remain entitled to exercise this Warrant during the period commencing on the
        date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 4</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <u>Transfer of Warrant</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Transferability</u>.&#160; Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
        shall be sold, transferred, assigned, pledged or hypothecated , or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the securities by any person for a period
        of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z4a0667ae669d42fea7fc063075b9225e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">i.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>by operation of law or by reason of reorganization of the Company;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z66e3cb438fc74f15bb4d63c5393d8832" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">ii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>to any FINRA member firm participating in the offering and the officers and partners thereof, if all securities so transferred remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zb2485d5616c94fab988b6f6125bd39ee" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>if the aggregate amount of the securities of the Company held by the placement agent or related persons do not exceed 1% of the securities being offered;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z9f98e3ab250f475cb1a016e664b1d0f0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iv.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund, and participating members in the aggregate do not
                    own more than 10% of the equity in the fund; or</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z257f70adc9cd4ebcb6c868e177a97e54" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">v.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the foregoing restriction and subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1
        of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
        agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon
        such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of
        assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to
        physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date on which the Holder delivers an
        assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
        together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be involved in such
        division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
        the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant
          Register</u>&#8221;), in the name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
        Holder, and for all other purposes, absent actual notice to the contrary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
        this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
        restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of
        Section&#160; 4.1(a) of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon
        any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any
        applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 5</u>.&#160;&#160;&#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Miscellaneous</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>No Rights as Shareholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends
        or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160; Without limiting the rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise,&#8221;
        and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle a Warrant exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably
        satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
        the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and
        dated as of such cancellation, in lieu of such Warrant or share certificate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or
        granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Authorized Shares</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin: 0px 0px 0px 72pt; line-height: 1.25; text-align: justify; text-indent: 36pt;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient
        number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
        charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
        provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise
        of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
        and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles of
        association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
        but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160; Without
        limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
        be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations,
        exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
        the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in
        accordance with the provisions of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the
        Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
        a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of
        this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of
        appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">h)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be
        delivered to the address for the Holder that appears in the Company&#8217;s Warrant Register.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">i)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
        purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Ordinary Share or as a shareholder of the Company, whether such liability is
        asserted by the Company or by creditors of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be
        entitled to specific performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to
        waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
        the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
        Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">l)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the
        Holder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under
        applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
        or the remaining provisions of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">n)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part
        of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">********************</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">(Signature Page Follows)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z77d3040612f145a785686f6cb17a7924" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">By:__________________________________________</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Name:</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Title:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CHECK-CAP LTD.</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
        tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
        respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accredited Investor. The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Name of Investing Entity: ________________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>: _________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Name of Authorized Signatory: ___________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Title of Authorized Signatory: ____________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Date: ________________________________________________________________________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT B</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">ASSIGNMENT FORM</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;">&#160;(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z85df7de3c9f348f0832361f670ae7bb5" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Address:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Phone Number:</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Email Address:</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Dated: _______________ __, ______</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Signature:</font>&#160; ___________________________<br>
              </div>
              <div style="text-align: justify; line-height: 1.25;"> <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Address:</font>&#160;&#160;&#160; ___________________________&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>4
<FILENAME>exhibit_10-6.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 10.6</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
        RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
        PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#160; THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF
        THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: right; text-indent: 396pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT A</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;CHECK-CAP LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zb659fe7308234663a7b2a50b6c2fd670" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Warrant Shares: _______</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">Initial Exercise Date: May 4, 2020</div>
              <div style="text-align: center; line-height: 1.25;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">Issue Date: May 4, 2020</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled,
        upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on April 30,
        2025 (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Check-Cap Ltd., an Israeli company (the &#8220;<u>Company</u>&#8221;), up to ______&#160; Ordinary Shares, NIS 2.40 par value (the &#8220;<u>Ordinary Share(s)</u>&#8221;) (as subject to
        adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).&#160; This Warrant is being issued pursuant to that certain engagement
        letter, dated as of March 18, 2020, by and between the Company and H.C. Wainwright &amp; Co., LLC.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 1</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase
        Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated April 30, 2020, among the Company and the purchasers signatory thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 2</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
        or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or <font style="font-style: italic;">.pdf</font> copy via e-mail attachment) of the Notice of Exercise in the
        form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of
        exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise
        procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.<font style="font-weight: bold;">&#160; </font>No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of
        guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the
        Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is
        delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
        hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any
        objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
          paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>.&#160; The exercise price per Ordinary Share under this Warrant shall be <font style="font-weight: bold;">$0.75</font>, subject
        to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>. If at the time of exercise hereof, there is no effective registration statement registering, or no current prospectus
        available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant
        Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7ca51ee6a4cc4f0aafb0d400ebf8d543" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 75pt;"><br>
                </td>
                <td style="width: 28.8pt; vertical-align: top; align: right;">(A) =</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a
                    Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities
                    laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Ordinary Share on the principal Trading
                    Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2)
                    hours thereafter&#160; (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 75pt;">&#160;</td>
                  <td style="vertical-align: top; width: 28.8pt;">
                    <div style="text-align: justify; line-height: 1.25;">(B) = </div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: justify; line-height: 1.25;">the Exercise Price of this Warrant, as adjusted hereunder; and</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 75pt;">&#160;</td>
                  <td style="vertical-align: top; width: 28.8pt;">
                    <div style="text-align: justify; line-height: 1.25;">(X) = </div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: justify; line-height: 1.25;">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
                      than a cashless exercise.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160; </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"><font style="background-color: #FFFFFF;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with
          Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised</font>, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant<font style="background-color: #FFFFFF;">.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or
        quoted on a Trading Market, the bid price of the Ordinary Share for the time in question (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
        Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or OTCQX as
        applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Purchasers of a majority
        in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or quoted
        on a Trading Market, the daily volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a
        Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or
        OTCQX as applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its
        functions of reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Holders of a
        majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
        Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such
        system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
        manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
        entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) the earlier of (A) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (B)
        one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;<u>Warrant
          Share Delivery Date</u>&#8221;).&#160;&#160; Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
        irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of
        Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
        Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Ordinary Share on the date of the applicable Notice of Exercise),
        $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
        such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.&#160; As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement
        period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Ordinary Share as in effect on the date of delivery of the Notice of Exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
        and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new
        Warrant shall in all other respects be identical with this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
        2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other rights available to the
        Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
        date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
        the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the
        Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
        giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise
        shall be deemed rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases Ordinary Share
        having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
        sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of
        such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the
        Company&#8217;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
        Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
        fraction multiplied by the Exercise Price or round up to the next whole share.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
        incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the
        Holder; <u>provided</u>, <u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
        duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent fees required for same-day
        processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
        Warrant, pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>.&#160; &#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
        exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
        and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For
        purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable upon exercise of this Warrant with respect to which
        such determination is being made, but shall exclude the number of Ordinary Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
        Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Ordinary Share Equivalents) subject to a limitation on conversion or
        exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be
        calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with
        Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
        Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
        of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
        Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a determination as to any group status as
        contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this Section 2(e), in determining the number of outstanding Ordinary Shares, a Holder
        may rely on the number of outstanding Ordinary Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
        written notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the
        number of Ordinary Shares then outstanding.&#160; In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its
        Affiliates or Attribution Parties since the date as of which such number of outstanding Ordinary Shares were reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% of the number of the Ordinary Shares outstanding immediately after
        giving effect to the issuance of Ordinary Shares issuable upon exercise of this Warrant.&#160; The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the
        Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise of this Warrant held by the Holder and the provisions of this
        Section 2(e) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and
        implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
        contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 3</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Certain Adjustments</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Share Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a
        distribution or distributions on its Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this
        Warrant), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of the
        Ordinary Shares any capital share of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding immediately
        before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
        aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or
        distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reserved</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>.&#160; In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
        sells any Ordinary Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Ordinary Shares (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
        upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any
        limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
        date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the
        Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent) and
        such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than
        cash) or other distribution of its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
        by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Company shall
        reserve and put aside the maximum Distribution amount the Holder would have been entitled to receive if the Holder had held the number Ordinary Shares acquirable upon complete exercise of such Warrant immediately before the date on which a record
        is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the participation in such Distribution. Upon exercise of a Warrant, in whole or in part, the Company
        shall, contemporaneously with the delivery of the Ordinary Shares, distribute to the Holder a pro rata portion of such Distribution based on the portion of the Warrant that has been exercised (<u>provided</u>, <u>however</u>, to the extent that
        the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
        ownership of any Ordinary Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
        Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
        transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
        conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
        completed pursuant to which holders of the Ordinary Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares, (iv)
        the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively
        converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
        limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Ordinary Shares (not including any
        Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;Fundamental
        Transaction&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
        Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation or of the Company, if it is the surviving
        corporation, and any additional consideration (the &#8220;Alternate Consideration&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable immediately prior to such
        Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
        Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
        reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Ordinary Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
        be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
        Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
        applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the
        consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the
        Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Ordinary Shares of the
        Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Ordinary Shares are given the choice to receive from among alternative forms of
        consideration in connection with the Fundamental Transaction; provided, further, that if holders of Ordinary Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Ordinary Shares will be
        deemed to have received securities of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &#8220;Black Scholes Value&#8221; means the value of this Warrant based on the Black Scholes
        Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg, L.P. (&#8220;Bloomberg&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
        to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day
        volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per
        share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x)
        the last VWAP immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to the time between the
        date of the public announcement of the applicable Fundamental Transaction and the Termination Date.&#160; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five (5) Trading Days of the Holder&#8217;s
        election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;Successor Entity&#8221;) to assume in writing all of
        the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
        delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
        to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to
        any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the
        Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
        immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
        substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
        shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
        be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Holder</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall
        promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such
        adjustment.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
        Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or
        purchase any capital shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company is a
        party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the
        voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall
        appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
        distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
        or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares of record shall be
        entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect
        therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
        regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K.&#160; The Holder shall remain entitled to exercise this Warrant during the period commencing on the
        date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 4</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Transfer of Warrant</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>.&#160; Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall
        be sold, transferred, assigned, pledged or hypothecated , or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180
        days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z47cb7bba5ebe4858ab9c327ec389780e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">i.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>by operation of law or by reason of reorganization of the Company;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zd821d9aa80b245a39a7dc1bf80e2282d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">ii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>to any FINRA member firm participating in the offering and the officers and partners thereof, if all securities so transferred remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="zf75fdce22737417bb82c230352377406" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>if the aggregate amount of the securities of the Company held by the placement agent or related persons do not exceed 1% of the securities being offered;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z649facb26a7c40acb072c9af4cbac4f8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iv.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund, and participating members in the aggregate do not
                    own more than 10% of the equity in the fund; or</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" id="z7f785f76f042475ca7a4a8127e4442bc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">v.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the foregoing restriction and subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1
        of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
        agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon
        such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of
        assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to
        physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date on which the Holder delivers an
        assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
        together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be involved in such
        division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
        the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant
          Register</u>&#8221;), in the name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
        Holder, and for all other purposes, absent actual notice to the contrary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
        this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
        restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of
        Section&#160; 4.1(a) of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
        exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
        state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 5</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Miscellaneous</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Shareholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or
        other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160; Without limiting the rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise,&#8221; and
        to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle a Warrant exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably
        satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
        the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and
        dated as of such cancellation, in lieu of such Warrant or share certificate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or
        granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin: 0px 0px 0px 72pt; line-height: 1.25; text-align: justify; text-indent: 36pt;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient
        number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
        charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
        provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise
        of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
        and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles of
        association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
        but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160; Without
        limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
        be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations,
        exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
        the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in
        accordance with the provisions of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the
        Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
        operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
        provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees,
        including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be
        delivered to the address for the Holder that appears in the Company&#8217;s Warrant Register.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">i)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
        Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Ordinary Share or as a shareholder of the Company, whether such liability is asserted
        by the Company or by creditors of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be
        entitled to specific performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to
        waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
        the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
        Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">l)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the
        Holder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under
        applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
        or the remaining provisions of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
        this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">********************</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">(Signature Page Follows)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcd9a80ccf8534c7e9d1298b87a2a07cf" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">By:__________________________________________</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Name:</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Title:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CHECK-CAP LTD.</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
        tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
        respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accredited Investor. The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Name of Investing Entity: ________________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>: _________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Name of Authorized Signatory: ___________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Title of Authorized Signatory: ____________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Date: ________________________________________________________________________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT B</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">ASSIGNMENT FORM</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;">&#160;(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z48e99b7a8f81401eb4d353e6e7a319cd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Address:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Phone Number:</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Email Address:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Dated: _______________ __, ______</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Signature:</font> ______________________________________</div>
              <div style="text-align: justify; line-height: 1.25;"> <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Address:</font>&#160; ______________________________________</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br>
        </div>
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>5
<FILENAME>exhibit_10-7.htm
<DESCRIPTION>EXHIBIT 10.7
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 10.7</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
        RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
        PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#160; THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF
        THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: right; text-indent: 396pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT A</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;CHECK-CAP LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za8c896eb3ea44e0c9ba07eca95348c19">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">Warrant Shares: _______</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Initial Exercise Date: May 13, 2020</div>
              <div style="line-height: 1.25;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Issue Date: May 13, 2020</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled,
        upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on May 8,
        2025 (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Check-Cap Ltd., an Israeli company (the &#8220;<u>Company</u>&#8221;), up to ______&#160; Ordinary Shares, NIS 2.40 par value (the &#8220;<u>Ordinary Share(s)</u>&#8221;) (as subject to
        adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).&#160; This Warrant is being issued pursuant to that certain engagement
        letter, dated as of March 18, 2020, by and between the Company and H.C. Wainwright &amp; Co., LLC.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 1</u>.&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase
        Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated May 8, 2020, among the Company and the purchasers signatory thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 2</u>.&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
        or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or <font style="font-style: italic;">.pdf</font> copy via e-mail attachment) of the Notice of Exercise in the
        form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of
        exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise
        procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.<font style="font-weight: bold;">&#160; </font>No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of
        guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the
        Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is
        delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
        hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any
        objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
          paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>.&#160; The exercise price per Ordinary Share under this Warrant shall be <font style="font-weight: bold;">$0.75</font>, subject
        to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>. If at the time of exercise hereof, there is no effective registration statement registering, or no current prospectus
        available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant
        Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb822f2bb062d47ff985bc857f59873ff">

              <tr>
                <td style="width: 75pt;"><br>
                </td>
                <td style="width: 28.8pt; vertical-align: top; align: right;">(A) =</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a
                    Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities
                    laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Ordinary Share on the principal Trading
                    Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2)
                    hours thereafter&#160; (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 75pt;">&#160;</td>
                  <td style="vertical-align: top; width: 28.8pt;">
                    <div style="text-align: justify; line-height: 1.25;">(B) = </div>
                  </td>
                  <td style="vertical-align: top; width: auto;">
                    <div style="text-align: justify; line-height: 1.25;">
                      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">the Exercise Price of this Warrant, as adjusted hereunder; and</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: -31.5pt; margin-left: 103.5pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 75pt;">&#160;</td>
                  <td style="vertical-align: top; width: 28.8pt;">
                    <div style="text-align: justify; line-height: 1.25;">(X) = </div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: justify; line-height: 1.25;">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
                      than a cashless exercise.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <br>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"><font style="background-color: #FFFFFF;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with
          Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised</font>, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant<font style="background-color: #FFFFFF;">.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or
        quoted on a Trading Market, the bid price of the Ordinary Share for the time in question (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
        Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or OTCQX as
        applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Purchasers of a majority
        in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Share is then listed or quoted
        on a Trading Market, the daily volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg L.P. (based on a
        Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or
        OTCQX as applicable, (c) if the Ordinary Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its
        functions of reporting prices), the most recent bid price per the Ordinary Share so reported, or (d)&#160;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the Holders of a
        majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
        Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such
        system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
        manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
        entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) the earlier of (A) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (B)
        one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;<u>Warrant
          Share Delivery Date</u>&#8221;).&#160;&#160; Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
        irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of
        Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
        Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Ordinary Share on the date of the applicable Notice of Exercise),
        $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
        such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.&#160; As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement
        period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Ordinary Share as in effect on the date of delivery of the Notice of Exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
        and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new
        Warrant shall in all other respects be identical with this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
        2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other rights available to the
        Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
        date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
        the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the
        Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
        giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise
        shall be deemed rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases Ordinary Share
        having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
        sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of
        such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the
        Company&#8217;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
        Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
        fraction multiplied by the Exercise Price or round up to the next whole share.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
        incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the
        Holder; <u>provided</u>, <u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
        duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent fees required for same-day
        processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
        Warrant, pursuant to the terms hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>.&#160; &#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
        exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
        and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For
        purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable upon exercise of this Warrant with respect to which
        such determination is being made, but shall exclude the number of Ordinary Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
        Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Ordinary Share Equivalents) subject to a limitation on conversion or
        exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be
        calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with
        Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
        Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
        of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
        Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a determination as to any group status as
        contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this Section 2(e), in determining the number of outstanding Ordinary Shares, a Holder
        may rely on the number of outstanding Ordinary Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
        written notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the
        number of Ordinary Shares then outstanding.&#160; In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its
        Affiliates or Attribution Parties since the date as of which such number of outstanding Ordinary Shares were reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% of the number of the Ordinary Shares outstanding immediately after
        giving effect to the issuance of Ordinary Shares issuable upon exercise of this Warrant.&#160; The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the
        Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise of this Warrant held by the Holder and the provisions of this
        Section 2(e) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and
        implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
        contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 3</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Certain Adjustments</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Share Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a
        distribution or distributions on its Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this
        Warrant), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of the
        Ordinary Shares any capital share of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding immediately
        before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
        aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or
        distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reserved</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>.&#160; In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
        sells any Ordinary Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Ordinary Shares (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
        upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any
        limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
        date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the
        Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent) and
        such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than
        cash) or other distribution of its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
        by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Company shall
        reserve and put aside the maximum Distribution amount the Holder would have been entitled to receive if the Holder had held the number Ordinary Shares acquirable upon complete exercise of such Warrant immediately before the date on which a record
        is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the participation in such Distribution. Upon exercise of a Warrant, in whole or in part, the Company
        shall, contemporaneously with the delivery of the Ordinary Shares, distribute to the Holder a pro rata portion of such Distribution based on the portion of the Warrant that has been exercised (<u>provided</u>, <u>however</u>, to the extent that
        the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
        ownership of any Ordinary Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
        Holder exceeding the Beneficial Ownership Limitation).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
        transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
        conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
        completed pursuant to which holders of the Ordinary Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares, (iv)
        the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively
        converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
        limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Ordinary Shares (not including any
        Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;Fundamental
        Transaction&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
        Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation or of the Company, if it is the surviving
        corporation, and any additional consideration (the &#8220;Alternate Consideration&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable immediately prior to such
        Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
        Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
        reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Ordinary Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
        be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
        Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
        applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the
        consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the
        Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Ordinary Shares of the
        Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Ordinary Shares are given the choice to receive from among alternative forms of
        consideration in connection with the Fundamental Transaction; provided, further, that if holders of Ordinary Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Ordinary Shares will be
        deemed to have received securities of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &#8220;Black Scholes Value&#8221; means the value of this Warrant based on the Black Scholes
        Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg, L.P. (&#8220;Bloomberg&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
        to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day
        volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per
        share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x)
        the last VWAP immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to the time between the
        date of the public announcement of the applicable Fundamental Transaction and the Termination Date.&#160; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five (5) Trading Days of the Holder&#8217;s
        election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;Successor Entity&#8221;) to assume in writing all of
        the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
        delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
        to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to
        any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the
        Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
        immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
        substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
        shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
        For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Holder</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall
        promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such
        adjustment.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
        Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or
        purchase any capital shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company is a
        party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the
        voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall
        appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
        distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
        or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares of record shall be
        entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect
        therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
        regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K.&#160; The Holder shall remain entitled to exercise this Warrant during the period commencing on the
        date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 4</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Transfer of Warrant</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>.&#160; Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall
        be sold, transferred, assigned, pledged or hypothecated , or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180
        days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z32b78c78c3564810952f4505ee3a9f28">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">i.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>by operation of law or by reason of reorganization of the Company;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a85bc58015f47009873e50198f9ba79">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">ii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>to any FINRA member firm participating in the offering and the officers and partners thereof, if all securities so transferred remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7541ed12a86456c892787890bfc2967">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iii.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>if the aggregate amount of the securities of the Company held by the placement agent or related persons do not exceed 1% of the securities being offered;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24a15dcc3b5244ce96add29585fdaf1e">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">iv.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund, and participating members in the aggregate do not
                    own more than 10% of the equity in the fund; or</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11101e787aec4988b978eae3f83fee69">

              <tr>
                <td style="width: 72pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">v.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the foregoing restriction and subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1
        of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
        agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon
        such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of
        assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to
        physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date on which the Holder delivers an
        assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
        together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be involved in such
        division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
        the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant
          Register</u>&#8221;), in the name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
        Holder, and for all other purposes, absent actual notice to the contrary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
        this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
        restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of
        Section&#160; 4.1(a) of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
        exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
        state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><u>Section 5</u>.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Miscellaneous</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Shareholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or
        other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160; Without limiting the rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise,&#8221; and
        to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle a Warrant exercise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably
        satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
        the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and
        dated as of such cancellation, in lieu of such Warrant or share certificate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or
        granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin: 0px 0px 0px 72pt; line-height: 1.25; text-align: justify; text-indent: 36pt;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient
        number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
        charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
        provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise
        of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
        and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles of
        association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
        but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160; Without
        limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
        be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations,
        exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
        the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in
        accordance with the provisions of the Purchase Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder
        does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
        operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
        provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees,
        including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be
        delivered to the address for the Holder that appears in the Company&#8217;s Warrant Register.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
        Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Ordinary Share or as a shareholder of the Company, whether such liability is asserted
        by the Company or by creditors of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
        to specific performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive
        and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
        the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
        Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under
        applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
        or the remaining provisions of this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
        this Warrant.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">********************</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">(Signature Page Follows)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc8e999dc10a44ae78a66793dc08f5b39">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">By:__________________________________________</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Name:</div>
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Title:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CHECK-CAP LTD.</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
        tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
        respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">_______________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accredited Investor. The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Name of Investing Entity: ________________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>: _________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Name of Authorized Signatory: ___________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Title of Authorized Signatory: ____________________________________________________________________</div>
      <div style="text-align: justify; line-height: 1.25;">Date: ________________________________________________________________________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT B</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">ASSIGNMENT FORM</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25; font-style: italic;">&#160;(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 10.5pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z4cd4869c3c6b4980861228ab84bc655c">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Address:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">______________________________________</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Phone Number:</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Email Address:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Please Print)</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">______________________________________</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Dated: _______________ __, ______</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;"> <br>
                </font></div>
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Signature:</font> ______________________________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;"> <br>
                </font></div>
              <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">Holder&#8217;s Address:</font>&#160;&#160; ______________________________________&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
  <br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 23.1</font></u><br>
      <div><br>
      </div>
      <div style="text-align: left;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">We consent to the incorporation by reference in this Registration Statement on Form F-1 of our report dated March 6, 2020, relating to
          the financial statements of Check-Cap Ltd. appearing in the annual filing on Form 20-F for the year ended December 31, 2019.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">We also consent to the reference to our Firm under the heading &#8220;Experts&#8221; in such Prospectus.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">/s/ Brightman Almagor Zohar &amp; Co.</div>
        <div style="line-height: 1.25; font-weight: bold;">Brightman Almagor Zohar &amp; Co.</div>
        <div style="line-height: 1.25; font-weight: bold;">Certified Public Accountants</div>
        <div style="line-height: 1.25; font-weight: bold;">A Firm in the Deloitte Global Network</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Tel Aviv, Israel</div>
        <div style="line-height: 1.25;">May 20, 2020</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!W@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&: "BFLP4=:C
M:X5>XIV FHJLUT@'WA4+7Z#C(I\K)YD7LU&\@ K+EU15XW"J,NJC/WQ51@V)
MR1M-/CDFH7NL=ZYZ76 /XA5:36!C[XK>-(FYTC7I ZBH6OSV(KDY-8).W?\
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MYS18"6BHMWO3E;G%%@'T4F136.#G-(!]%1;N<YJ3(H 6BDR*,B@!:*3(HS0
MM%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.41W/]O.1_K#^=)_;C_\]#^=</\ :VQC-1F\?G+?3FERB1WBZ\X.?,/YT?\
M"0.#Q(?SK@?MS 8W<_6FB\;/#<TK%)'H/]N-U\P_G3#KCLV#(?SKA?MK9X8X
MI&O'Z@G%4D!W8UZ0<"0_G4B:X[=7K@%OF'5OIS4BWS]F.:JPT=VVNR#HYJ$Z
M]*#]\UQ37S@?>.?K41OG(^]^M*6@SO4UY_\ GH<?6E?Q#)C_ %AXKSQK]^@8
MX^M"WTC<%C[5SO<NQWX\0R'^,U=M=9=F'SGGWKSE)W9QR<UT&EK(TB]>M9R"
MQZEIMZSHOS'FN]T*8% -U>9Z1$WEKP<5Z+H$!"#CBLNI6QVL!S&*EJ*W&(A4
MM2R@HHHI %%%% !1110 4444 %%%% !3"^#0S57:3FFD!*T@SC-0._/6F-(I
M/%02/ZTT!,TW&<\U']IYZU5D?\ZC&#SWH'8TDGX/- N,'KQ6>C<X[4KM@8'2
MDQ&EY_&<TSSR>2:I))\O)I?,^7WI 7!/CYB:<+C/0UGLP*8[TU'P>*5M -/S
M_>D-QCJ:I[UQG-,W GG\*2 T1,"N<U(DHQUK(\PAL9J:.3\Z: TP_!YI5? ]
MJJHXQ[=Z:\R@<'BA@75E!/6I <]*RTDSU-7K=\KS0@)Z*3<,XHW"F M%(#D4
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I"0!4;S*@R:H3WZKGFKC!LERL374^Q237/WFJ^6&YJ/4
M=8 4Y(_.N+U76/E;!YK>,+(S;N:%]K^TL,_K7):AKQ);!/7UKG]2UMR[ &N9
MN]6D;)!XS6BB0=!>:T22,_K6%<ZB6)Y_6L26^E=B<\57:>1CUJTAHO3SEB3W
MJB^[J*<"W?K3\;AQ6L42V5"K'Z4Y1@5(1SCM3UBS@U:B',(JMW%*P(^M6-G3
M-(\?YU<8HCF*ZCFG;<]*DV>E&"#QTJG$5QJ@C@BGJ3WI<'&:3G-2D*XN-W%)
MLVU(%P/>GA1CFK2)YB$)E?:D48X[5(3C@=*8,Y]JM(=QH3G)I=HW9I1GG- !
MQSUIM V. S2E.:4>U.J&B6R/;@\TFT=ZD;&*CR2:GE'>X8'3O3U5@.* .YZT
M_#'[II6%<B*\\TF1T%/;KSTI%4$Y[46'<-@(S3=OYU(,@T%>_>G85Q@I>O2F
MC.ZI ,46"XTC'!Z4S'/\JE;&.:C#9./RHL%Q3R/>@+CFG!>YIU*P7(\"EXQ[
M4$8/'2E R/:GRCN-"=Z._O3\'%-(/7O1RB;$ YXZTNP4Q<[JF'%*P7(SQP>E
M&/\ ZU2, :9TX/X46"XAY^M&W IRCG)ZT')Z4<H7&$>E '&33BI XH49'M3Y
M1W$ Y_E0>?K4FW-(4(Z]:?+H*Y%CFGA0:, \=Z=PO%/E"XA]#TIFT%N:G*?+
MFH>,G]*.4+CB/EXIH&.E/7..:7%+E"Y&1S[4O'X4K#'3I2@ BGRZA<,<9%,;
M)/3FI .PIK(RG)-'*"8@XZ=:7:>PXI!@].M24<H7(]O..U !STZ4XY!I,D'G
MO2Y0N-));IS3L8YIV!G-(3GI1RA<;].E*!Q@=*:3Z4Y/TJN4!=M,8\<]:E-1
M,..:7**X)C'O2 9-.3'XT\ "A1U'<9_*@)S3\#&*;NP<&CE"XC@?C28*C/>G
M8XSWI#G%#B)LBQFEP<4\C% &?I1RBYA>-HS33@CGK3CBFD>O6CD"XT=:<5R.
M*4#MWI<$=*?*',-P<8/2FD8J0_I2 9I<H7$VEA[T;<#WI^"!2<D4<HKD>*,'
M&:?3E&?I1RE)C0F11M_.I#P,4PG'7K3Y1W&@$&G8]/QI <].M*/44<H7#&..
MU&W-(V2,]J%<]*7**X%6)Z4I3 IZYQS2,2>!1RCN,(!Z4O&/:DIP&?I1RBN,
MQ@TN,CGK3CCI33D4<H[@%(.:<!NZ"D#%ACO3U^4<=Z7*%QI./I3&I7!Q[4WD
MCFERC0 $TX@8HP5-*>1[U7*%QI [4[&>.U-IX'.1TIN F+M&*8<=^M2FHB.>
M:7**XF,CWI=N!_.@?K3LYXHY0N-'IVIK=*D( %1]:.4$0]^>M2Q@YSWH*C-2
MQX_&FHCN.QQ4;ID5,.M# &CE!,KXVBI1)QS3'Z569RK8J&BEJ3L^XXINP]OQ
MJ-,LU6HAQS18;9%L^6G;<"IR@(XZ4A'%%A*1$,8YHXQGO2$8-)28Q2 1Q4?E
M_-[5(.M2JH)SVJ"D577 IB-SS5F2/@U6",'K.3T-$S0MXO,/2NBT;2]\H.*J
M:+8&<#UKT'P_I*AQN%<LBS5T#21YB\<?2O0[#3MFWC@52T32T0@XXKK8H54"
ML92L5%#HEVH!BI***Q- HHHH **** "BBB@ HHHH *8[8XI^:JRO\W%  [U5
ME(*T/)43$L,CI32*1"RMG/:C+=QSVI^[C!I!D?>_"F# 9ZG[U.P1SZ]:0 L<
M?Q5)C P:5R2/C'M2*F3[4C'TZ4^//X4#']L#K3"C#D_>J8#%,DW>O-(1 I.3
MQ4@"[*;'U.:=QM/'% #&SCCI2_7KVIQ*[*C;.10 ]<;N>M#*1T[TY5[GK3J3
M A&0,'I0V<#'2GO]RHU;L:: 7G<N12.</FG]"-WX4/AC@=: &CGI3MN..U-
M(.!4VW*YJ0(B.,'IVJ,*0#G\*F;&.:;]?PIK8!J @<_>J>.2HN^/XJ0MM/'7
MO0@+Z3 <&IEGY]JS-V?F[4Z.<A^>E,#8#@TZJ<;U/O\ EZT 2T4U6R*=0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ5Z3I=BL<0.VN>;2&6+& (!@8K2'2F(@4<"GUSR=S1(****DH**** "BBB@
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M3)-VW5GL?2GH.V3BF@-=),C@U/&>.:S86 [U<C>@"S142-\_)J0'- "T444
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M&<G I59@"1TI@.;).#QBFDG(XH9B1DTASD9% !GY\X_"G_KFF9._WI5)R:
M_*N!3TQLYIO;VI&S@8Z4 2Y"\T%B1NQ^%0DMD9J3<<8_BI6 ;^N:#\JX'>FC
M=DTJYP<]*: 0D[<8_&D&0:<W08Z4ASD9%,"7<=N<4Y6P.14)D8'!% =FZ"I8
M$X<8Q3'&1UQ3%./I2.Q(]J$ C-NXIA( I-Q'6A5).>]4P!5QSZT[GK3BO'%*
M@)&.U( 'S+@C'O0BD'/I3MI/':G)GH: )XIB2.,5>67(K*+[>G6I(YSTI :H
M8,.*6JT#87FK .13 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JM//LR,U.S #DUSVJ7R(6&^KA&[)DR'4]4*\*PXKA]:UT
MJK L.M2:QJJ@GYZ\\UW5!(Y^:NJ,49-C=8U@N&^88Q7#ZC=EVZYR:L7M[O)&
MZL>1MS=<UM$E" %C4BQ$_=IL2Y/M5R*,#O6\4*3&Q(4&34JG)]J1Q@T@X.15
MI&+9,03@$TUE(.,TIQC(--^]WK1(@A9"QX-,V'\*LE:"H--(JY JD'VJ6G!
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M'ER+Q7-.9:->SL=B+FM5%VKBDCCVBI*XI2N:I!1114#"BBB@ HHHH ****
M]*J2R8!YJP[  UFSMR1FDQD;LS]QFH.1F@\'K2Y##Z4,0G.W/:@@[>M'&.M*
M$R.M(",QGO4L8(&,T;?>C;[_ (T(I:#AD-_.G'Y^E,3!;KTJ;8,9S5@V1A2.
M#TIC!MPYJ<XV]>:A)"G&>M(D0C)P>M(H.<9IVWCK^-/V!AUJ1"*AZ@\4N*<%
MXSFEVY'% )$>T]_PIO?'\7K4V .]-=1Z_C30R)<Y/-#?=XZ4@&<\T?P]:O0
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MT.!GGC&WOZ5C*0SKM%T@-$K!*]-\.Z:J1J=E4?#6EAK:/=&.GI7?6%D(%'R
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M@8J2J5NYP#5P'(I7 6BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
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M,9ILC#(Q^--*<;ATJ1I$JXSUQ4@=3WJH Y/M3@I_&I;*<466<#H:C?)'7K3
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M'ZU4>2@"5IP>!4$DE5VDYS0LF[DC\* %W;B0?PI" JX[TT]<T[=E>1^- !N
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M%<)X9L-B*-O/':O3M+@V0+@=JXZCT*BC215 X I](HP*6N1FZ"BBB@ HHHH
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MB/\ >(/>O2]'C/E)]*R;).HM2?)'I2W>3"?IQ2P*0@]*+L?N3]*RZCU.!\1
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M.<\_A2GY33&!R.::W /FW^]/))&!^-."$C&>:9Y;*>M,!.WMWIK9Q[4IR>E
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MS.N;C"<'M7C7B9&\QSSU->V:S$-A'M7E7B&T#2-D=ZZ:>J,V>572'S"35%\
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MC.I!_P"(#%>=C7LG:)3CZT_^V2/^6A_.M8Q)/0/[0&,[OPH_M''._P#"O/\
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M4I.!1QBE*@"D3L0N/>EC'O2,!GK3D4=C0F6MBP@/K3)$SSFGKS2.!ZT7)=R
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ME==INC,J@X&<4<QFV<Z-,=5R4JK<V3!>%KOWTIMGW16+?V)C!XHYB5N><:A
M5# BLRW.)?H:Z768=H?CBN;@P9>?6I<]#1([/17.5(':O1M"<Y4X[UYSHBD%
M?I7I>@IG:>^:RD[E,[[2CA1]*V2,BLC3%*@5L'IQTKEGN4C!UB/*'Z5Y-XE
MW/\ 6O7=9P(CGTKR#Q.<,Y]S5Q!'$RS^5+5^PU)0PYK"O9/G-5K6YVRC!X[U
M;>A?0]Q\+WX?RQGTYKTRUE4Q"O#_  K?!1'SQQ7JVG7X>(9-9M7$;DCYZ57"
M$N:(W,AS5A%(.>]+8#+OK0LG S7GOB&Q(\SCUKU";[I&*X[7+3S5<#O6U-W,
M6>):O9L'/RURUW&5)..E>GZSIS G([5Y_K$+1,1CO74EV$C$0D-TJ[&XQ5%2
M=_2IU.VM8BDM"^CCI1(?:H8V'X5(S@CFM>AC8KR'VJ-2=V<5*^2:%'-"8T2=
MJB+8.*D+!1Q5=VR>*M,=@+$FIUZ9J '/6IX^G-#8N@=#G%(3FI",U&5(/%9-
MD .N*>>G2F@8IY)P*!,C'KW]*,X.<4_;WIK=,]ZHM";L"A6!%0LW:I(^OM3*
M2%<<57(JU(05P:JD\U#=S1(BR0W2M+3%+2\#-4@FXY[UN:+;D/D=ZYZCL6CT
M#PG:%Y5&/2O6=+L2I7BO/_!UL2ZX'I7K=C;E$4FN.I(T1?MX]B#Z5/2+P*6N
M-N[-4%%%%(84444 %%%% "$X%4YGZ^E6)#@>U4Y6#*<TK@9\I#,31&WM4<F1
M)4D9/7O5(98ZXP*1O3]:<C8!]Z20@I3 :AYQBI >:8IP.:"V/K0*X]FYS3&?
M'3FDW\8[TS./QZT"N+YOM2.Q(Z8IC8[4N[(Q2&0,QW5(.><4K)S[TH4XP1S0
M *<9XI>HQ^M. QP/QH*GIVH)%0\XQ4A;)XIG"BA"<\T$EE6!'(J)A\QQ2;_F
MXZT!B,T!88YXQBHCGTJ1SGITIF[/!JGL4,W<4Y&QU%,8<YIZ\CGK2L,?G@G'
M6DW';TI5SR.W>G 9X'2CJ,12<4H)]*4 @X[49(Z_A2)L1Y.[I^%*"<]*=C/^
M]3 VT\U20QS/QBE4\<TUE[CI2CE<'I18!"V3Q2^_Z4!<=?PIN6W>])C'=/?-
M(O(Q^M+]/QHXQQTI &!T[>M(_L*7M[4C9R*: C)P.1SZ4P9STJ<H&.?XJ:%-
M "@X7&*"?EQBC'>DH: 0G I 3C-*4.1FEVG..] "J2!TI1G:1^M"YSC%.*G&
M!WHLK@-^;;@"EP67IBG+\O!'%/((&:-@*W3K32W/%2');WI@7!-(!X/R=*,G
M:.*5>GM2\8YZ46 0ECC I>^?TIXSCI3=I^]WI )TY SFFKR",?C3A[?C3O+.
M..E  G!QC\:E8Y'2FKM3J:4MGFDP&'('3FH03DU.Q)&>]1[2.?7K20")RIS0
M>F/UH/W?EZ4#E>>E%F H(/X4W<=W3\*54.<TX]<CK3T 3IR!G--#=J=]/QI-
M@+<4 +CY<9I<?=I",<'I2-G(_2FA#VX.?TIO3GK[4>_\5'?CK0,&.!P,U'@X
MS4AZ<=*;SL]J (CDG/I3XV.<XIJYR<T]<[N* +]OP0:T!T%9T)"D'O6BIRHH
M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ()\[3Z5PWB2
M3_1Y ?2NWN#A#7 >)6_<R<]JZ:)C*[/%?$'^NESZFN,?[U==X@?]])]:Y$\M
M7? R8BDAJL 9&:KC[U61P,ULC)CE!(YII!#4]>><TAZUM$AL._O2]J0CCK0#
MFK,V!.*4<TAI:74 Q2'D4#(ZT5+ ;C'2G+AEHQ1D 5DRT !!]J:^>].W<9IF
M23S4EH3&X8'6F[2IXZT_D'BEZT6+)(I65QSQ76:#<GS%&>]<66Q)P:W=&F99
M5PW>ID4CVO1;DD+SVKK[61FP,\UY?H-X^0-W:O0M*<NR_-7/-E'1Q94?6K '
M%11KD#VJ;H*Y)/491NH Y-85]IP92<5TS<U2N%!4C%:PD58\SU;2E?=@<UQM
MYI.'.!^E>NW]HK;OEKGI](60GY:OF'8\LN-/(;@<5 -/)/0UZ/-H2[_N5#_8
M"@YV5/.%C@%TT[AD?I6K:Z6>#C]*ZL:$NX?*:T[?1U4 ;:GG)N8NF:4/3O79
M:;I"$#CM3[#3 I^[7565JL:#Y>U/GL29*Z4HZBL[4[01P-FNODC !.*P-8VK
M PZU<9C/%O%$8"R#OS7G+_+/QZUZ3XL?B48]:\U?+S'ZUKS:E):&_IC993VQ
M7I?ADCY,^M>::4IW+7I?AD8*'WI2'8]8T@?NQGTK:'W?>L32#A!]*VATKDGN
M(S]2_P!7QZ5YQX@ZMZ9KT;4CF,X]*\UU]L.WUK2DB&SSW6#PP[8KC;I,R?C7
M8ZN<ECBN2N2 U=21%RLJ#=@4\ K31]:>6&*UC$0UJ;3&<DTJ^N:30VB6)<M6
MWIZX<>M9%OC=CUK;T_ 8#]:RE$1V6B9$R?6O4=%<[$^E>7:-_KD^M>G:.WR)
M]*RDM"DSKE<X]J@N\^6:FB^9<U#>#$9YKG6Y:V.+UT9C8&O-=94&-Q[5Z1K[
M8C:O,]9?]V_/:MT):'GNHIF9OK3M/&, U'J$A\UOK3].;IFFS5'?>'_X:]1\
M-\R*.]>4^'GY%>I^&G&\>O%0T2SOX3A14DC96JT4N5 ITCDBN=K4+G+:]\S'
MTKS7786+G]*]5U*#?DFN,U330['Y>M:1$>3:M;,4/'-<Z]HWH<UZO>:&K(<K
MFL@^'US_ *NMHZ%7//5LVST-7$MR !BNV'AP*?N&IE\/+U*&M$Q'&)9,0"1^
ME$EH1V.:[Q-  'W32MH",/N4[@>?+9MGI2FT..*[E]"7;@+C%4)M-$>?EH8C
MA;E-AZ52W$-FNBU2U <D"N=E7:Y%0P1IZ==D3#UKO=!OF^T(,]Z\Q@?:XQQ[
MUU^@7+"X3YN]0]QV/>-%N"T:8/&*ZU#E!CI7FNC7A"1_-VKOK&XWPKDU,E?4
MFQHB/(J&9<+[U.GW>O6HY$)XK-/4+&1/ 7!K!N]*$I8D5V'E \8J"6W7^[6B
MF"9Y-J^D!'.!Q7*7FEG<3C]*]?U73UD8G;^%<Y<Z.KY&RGS >:?V6<YQ^E)_
M91!R!7H"Z& <%32G1 QQM(JE(#AX],SC _2M6STG&,CCZ5TZ:(%(^6M2VTM1
MCY:.81E6&C# ./TKK=.TI=H!'.*ELK)5XVUT%I;!5'%)S)9@W-@$!X[5S&K6
MJ8/%=_J,8V'Z5Q.L$!&IJ>@)'EGB*)5\STYKBXQBX_&NU\1?-YASZ\5QR8\_
M\:3D6D=KH0R%'?%>E:&A54QUS7G&@* %^E>F:'\P4>]2V#9W>F@%!]*U"<#V
MK.TY?D&/2KTK;5S6,M64C$UD@H?I7D7BG[S_ %KU36)L(?I7D_B9LE_K6L=A
MGG6H'#-BLF.4B3BM74!N=N:Q&.V3BG?0I,[_ ,-WK*8\GCBO4]'U E%R:\/T
MBZ*%3G%>BZ%J1.!N[T"T/8=-F\Q!ZXK6 P,UR^@W.Z-1GJ*Z82 KBLYK45R"
M8;NE8U[;!@Q(K;<CTJM)&)%Z5<'8S9YOKUB "<=J\IU^U.]L^M>\:W:*5/RY
MXKRGQ)8C>Q [UUQ=S.YYA(AC?BF9+?A6M>6NUSQ69(FPULM!IH<CG\*GSFJR
MGOC\*E7KUJU(4D3[<KSUI ,4>U%49B-@U7<8;BIZB=>].]BB,9W597I[U74X
M-6D^[0V)CAD"D-+32.:AD@/O<]*<P[]J;D TX\]Z:(8"FR#C(IY&!UJ-CD8J
MBT5FQFIDQBHFZ]*>GK0S1(E91MYJK( &]ZLR'"57ZGFL[E(FMT) ]:ZK0[<L
MRX_&L.Q@#@5VV@VF2O'2L*NQ:/0_!UN Z_A7J-NF$%<)X5M@""/:N^B&%KSZ
MK-H(DHHHKG- HHHH **** "BBD8X%)[ 07#86LYW/?I5VX.5S6<_&3G-+0"O
M)R]/7(%-QZTY>E6@N3 Y''XT9X]J:#Q2D\9_2J%<#T]J;D]#UIV>/6FG@XZY
M[TA,.>G>D//X=:7V_6D/7 H0A!C\*>%S3=O>IHT-.PP5.YI^SG/>G[*?LXQW
MI%="#9SD4=#[5*1BHV'>@DBDQ3-_'-/8CTJ)ABBPD*I);WJ<XV<?C4,:&I0W
M!!'2G8=B/^5,8=^U2,,C(X]JCYH 2E!H(VU*D8=:07$7)Z?C4R  TU5VFI<#
MK0-,8W7BHN_/X5*2":CQ@\\T[#$[X_BI"N[\.M+WQW]:6JL(3C'M1Q^%/5-X
MW=O2ATV#=Z]J0#,'(S^%(V0WO2]/QHX)V_K2&AJY/3\:>-NRF <GFCMFE8 ;
MIQTI0?7KVHZ#/KVHQCWS0 ['YT]5XIFX;=O?UIRMV-,!I&/I28'7M4G6DV\^
MU'0 "^M-Q^\I]+QBD,C_ (OEI_.:9C+<<5,H&W-,0;1U-!'8T[(QGU[4X*.N
M:3 BV+GI\U1R1C/'XU.Q!./UIC,.E+8"(C;]*%7<?:E(RV>U!^4\4 .QQ@4A
M# 8SS2YXXH'3DY]Z=@&;2.GXU*K8X/2F,">AI:0"-&2<_P -,R5X)Z]*>SD#
M%0L#D<]:0$N&V^].525I@;!VDT_=@4@(V&WZ4G;/\-#9<9H!PO(H >#Q2$?G
M06Z4C')Q^M(!.O3\:>%(Z4S],4[)ZT#0X@$<TUL# []J4OQFHSG(/K3$)\V\
M<\T[OQUIN#N'-+GM3N OTZ=Z1LXXZ4O7GI[4>_Z4 ,*G'7K2 ,G4\T\@Y'--
M<<]<T 3PL68 5K1_=%9-LPW@8K6C.5H ?1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%(3Q0!5NON&O/O$C 0RX/8UW=X^ ?6O/O$7,4N.N#77
M21C+<\4UXGS9?J:Y5<'@UTWB D7$@]ZY=<Y]J[8F+) ,-4W!7.:A7DX/X5.%
MXQWK=&3'H!C@TH'K0J[12'YCQTK6)#%(&.M)P!0>..U-!R>?PJR1U+Q2<9H^
M7/'6E<5@;VI >?:@C'2E^7'M47*!C3#R,]Z>V,<_A3.OUK)LI+49DTZE*\>]
M(.M)%(<HSQ39/2I <'VJ-]I/-4D4F[E5R0^<UJ:7.5E7GO6;(!GWJU9D @CK
MFLIHVZ'INBSKE<-7I&AS L@W5XGIE[Y;KAOUKO\ 1M8VR)\_ZURS%U/8[=EV
M#FI2P%<EIVL"0<O^M;MK-YW).:YVC1(N$\5 5)SQ5K;E>.M.*<4*5AV,F6T$
MG!'%53IXS]VNA,0V<"F&/VHY[E)& =)5N2@S]*C.DKC&P?E73;?E]Z0*OXU-
MPL<L-*4'(05/#IPW#*<5T'E#/ X[TX1J.W%*Y%BC!9(G\(J_'$%7I4@04[M0
MV38I71"H?I7(ZPP\IB#74WY!0^N*XG69E6)QFMH;"/*_%+AO,';FO/<#SS]:
M[GQ&^3(.W-<,G^O;/KQ6RW+3.DTA 2N>M>E>&X^5X[UYOHX_>*3Z5Z;X=ZIC
MKFKEL#9Z7I*X0?2MD#BLO24)C'TK8Q@8[5QS>H&+J;$*<^E>;:^=SL3US7I^
MI1@H<^G%><:_#EV..<UO2MN92N>;ZKQNQZ5R-Y]XUVFLIL5O7%</=M\Y^M=:
M1"5RJ"<XIW/K0N#]*DV@=?PK:*N4QF!BD#8.*<1@TW !SWHE$+DT+8;ZUO:=
MAF'-<W$P\RNAT[&1CI64D2=UHN#*@]Z]*T<95#7FVA+^]3/K7J6C(-B9]*YY
MVZ EJ=-"/EJ.['[HU:C4;<=ZBO !"?I7&G[QLM#S[Q&<0M7E^KM^[?)KU'Q,
M@,+>E>8:RG[EL]*ZHZH5]3SZ^(\UOK2V!(/%-OU_>MGUJ2Q' (ZTRTSM-!)!
M&.]>G>&6;SE%>9Z#&V5/YUZIX8BRZG%9R(9W, .*G.-M$2$)STH(QUK!NX(I
M2Q>9VK/N=,1QG;UK="KCCK2>6&SQ30'(OI"'C8,57.AINSY8_*NS^S(1TI5M
MAW'%:<R*B<BNB1D?ZL?E2_V(@_Y9C\JZ_P A1VH:$'MS34T!QW]DJ#P@I/['
M0\;.*ZWR%SP/K4AMDV<"G[1($C@KG2513\E<W?:>#N.W%>I7=L/*;<.,5Q>J
M1$,V!6D9)@T>4ZM:A788KBK^,),<>M>CZXJB1C_%7GFIX\]L>O--HE&;O^:N
M@T:=EG3)[U@,@QQ5ZPE99%R> :AHNY[)HMUNC0EN<5Z)I5R7C7!KP[3=4**H
MW\CWKT30-6;RA\_/UI,5CU6V8&,9-6/EZ=JYC3M1WC!;Z\UO6\H<]>*PE'J!
M8*>@J-X]PY%6<@"F'WJ$Q6,:ZMLGA<U1^P!FY0?E71LH(SWJ'RP6Z?6M.89A
M_P!E*>-@QZTXZ0F/N"NA1!C&.*5DX]J7.(YP:8N/N#-/CL ASMYK9((:GA=W
MUJN8G8H06H7D+6C'& M*BXZ5(0 *S<@L8VK-B,@>E>?ZU(2K9KOM78"-L^E>
M<ZY)D-S6B=D"/.-><%G&>>:Y9%'G?C70:XWSN>]<W"Q,W'K5I:C.WT$G*CMB
MO3M!&0H]Z\RT+JN.F*]/T#HOIFAH3/0--Y3GTJQ<#@XJ#3ON<^E6I1G(%8?:
M+6QR.M?=/TKRSQ%DAQ[UZSK4)(/':O,?$$(P_'&:V6P[GF5^GS-6+(OS<UTF
MHH%<Y'%<[=_?!'K3L!-;W#1$8-=CX>OFW#+=ZX+?S[UN:-<LD@P>],IGT'X9
MNPP12W:NWC8; 0:\B\,WP"H=W;UKT.QO=Z ;N*35S(W<AA[TTH1S38%W?-5P
M 'K6;=A6.?U2 LA..U><Z]8AM_R]Z]9NH]P/%<?K%DK(V%XS712D9R/$M6L]
MI;Y:Y:Y0Y.1TKU+6]/P&^7C'I7 ZE;[6Z=ZZMR$S"4D'I4P&.:5DVMSUH!ST
MH29;=Q=QQBG9.VDV]Z<.G/2MT9B 9ZTF/6@\4]5W]>M)O49$$&>*GC Z4TKM
M.!2_=%3<3%?"]*CSGDT[AA2$#-!(G4Y-2$#'%-XS[TAX/'XU0K7 MDXIII2!
MG/:@#UZ4RD-(!- '.:<% Z_A2G 'O1<I,B=N.*A4Y.*F88R1448&^L^I:.BT
M> D#BO2O#ED&0%E^E<1H"CRUXXKU?PY:[HE)'TK&HU8N)U.@0>61Q77H/EK&
MTR#9C(K:'2O-JO4Z(K06BBBL2PHHHH **** $I&Z4M,E.%J+@4K@X&*HMCUJ
MS<-\I/>J0()IH!>,X[4[;MZ=*>J*PI=NWKTK1"$QN7GCTJ-LK3RW/TZ4'YQS
MUJ@ #Y<CDT+DC%*..%ZU( ,4K!<CQCCMZT 9_#I4FSY?:EV<C]*=A"*A)R14
MP&T9%.YV^](3QQUHL,>N,4''6H-^!47G<XSQ0%RP?FZ_A44F1S31*2>OTI2[
M'CO1;4+#,=QUI=E$8;=Q5C9D9'3O0T-HB"[5]J8>3D]NE32$;>?N]JKGW_"D
M'00D[J6C^='TZT[$W% &*DB7/TIH QQ4T0PN.U%@)0HQ4; @YJ7[HS^5,)R/
M>I"^I 1\Y-)@ '-(^0U,>0$<50[AM^;VIZ@-U[=*C!.WGI3^.,_A1<"PB=Z)
M%S0KY7'>EYZ=^] %4K@TFWYO:K#*&''XU&0H7!Z4@(PO6DV\>].^O3M1]?O=
MJ=F,;M^7WH&>E/P<9[]Z3CM^-*S"X>W;UIQ"G'-,/3C[M(N._P"%" L;3BE*
M\<=:C61C\N>>U.)P/]JD)L0XQ21@[L?PTNW<*=&".G2GK85Q=HR:8V5J5L5"
MY)&#UI#3'J0PX/-/Z=*@B(4^_>I@P(..G>G8=QCCCKQ474\GI4O!'^S3?+'X
M=J";CP!M]Z0H,9[U(B@#GK2LN>G6E8JY7Q@\=Z=MXQ4C)QQ2;3CVH :!Q4;\
M'/>I2N!4;KN'O18!F<\]Z0KDC% !!XZTX=?E_&DP&E/FQVI[ 8'-*02WM3#P
M?F_"D X,=O3FF'U[TOUZ]J!U]^])L!!2XYQVH_W?QH S_NT[:"#K2%B.M*>.
MOX4;-PYJ2D&<C-&?UHY P.M)_DT"N-88Y%*OS<&G<?\  >]-Q@Y[4P%[TOOW
M]*/KUIOS;SZTP'?UZTQ@ >#2KG)_6CY=WM0 ^W ,@S6Q&0% K(@V^;6M&H(!
MI@2T444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ICG I]-?I36X&9
M>D;#ZUYYXB?]U)CTKO\ 46^0@5YUX@_U4F?0UUTS&1XWKYW3R?6N9S@5TFMD
MF:3CN:YICQ77 S8Y>6!%6@>,=ZJH>15D'/%;IF,A^2>*3/I3QA13.3SBM8LS
M8HY.3TH;%&>*/3BK)$'!YHZGBE.3Q2 XX- #B>*9[]J=D^E-ZG-0QH=D>E+C
MO48)!Z4]7)XQ6;*0'KQ33BGYJ-B?2D4@W8&3TI"0>W6DR=N<4N[CI5HI#&48
MP>M.C.WI3]I8=*:1L'-1):%\VA8@N]C5TFFZGC:=U<>7]JMVUP5P.E<DHC/7
M=&U=6P-_>O1M%O5=5!8=*\"TC4/+<9/>O1M'UQ%5?G[5@XE7/7XY%*#D5)N4
M]Q7&VGB&.2-4W5J1:FK<YK-PU*3.@!QSVI68 5EQ:@K'K5@W:$<&I]F[EW1,
M[XXI%.:J-< G I5G"U?([";1H*1BFEQ5<W"A<YJO)=KUS4J#(;-#S0*:TR@8
MS6-+J:IWJA<:VB#&ZFJ9*D6]4O%7(![5PFNWJ%#@U;U77HR"-W:N)U75DD5O
MFK6,&AG,:[,'9\>]<DI'G?C6SJET&+$'-8D)/FD]<FM8Q91T^D@Y6O3O#'WD
M'?->9:4IRIKT7P_.(]@]ZN46T*YZ]I;+Y8^E:F0:YC2KY2@YQQ6XEXI&,\UQ
M5(.XTR+4"-IX[5P&NJ/FX[UV^H7*A#]*X#7;M2&^M;T8LSD[GGGB# 5@/2O/
M;T_O>/6N\UN4/NQZ5PMX,R9QT-=T4)6(HL$]*MA1CI56$_,.*O*PQTK2.A,F
M5Y%QQ5=U/2K<G)R*KN?:FP3(HL!Q70Z6WSCTKG%.)170Z8XW#'6L9(NQZ'H+
M#SD'O7K.BA1$F?2O(-$EV2H<=Z]0TB[&Q/I7).+8([50 HJO>$>74*WB[<9J
MK>W8V5S1INY3D<KXC*^4WI7F&M+^Z;CM7HFO7 *FO.-8G'EOQVKJC%V)OJ>>
MZCQ(V?6GZ<-R@"FZ@<RM@=34FFMM &*;1::.]\/ $*/2O4_#*A9%/:O*O#\H
M!6O4/#LZEUP?PK*42&ST",97-#!<\U62Z"I44EV,UCR-L:+; 8XIZE0M9GV]
M<=:07ZYZT^1A<U1CKVI>!S6='?KG%2_;%]:7(QJ1<X'6FYJH;Q<=:B:_4<9H
M4&%RZ@&XU*H'7M6<EZF<DXJPMVI7.:)18U(9?C]TWTKA=5(4N*Z^_O%$38YX
MKA=6N@2^.:WI18FSS_7L>:U>>ZFP,S #H:[O6ILR-7"7^6G;CO6_)H2F9VTD
MY[5*A*'-2;#CI^%1E67M46+YB[!?[& S7<Z#JV(U&[FO-,E6Z5T&E7GEH 32
MY2DCVW1-61@/FZ5V6G:BI<<UXKHVL+$RY-=QI>MQEU.ZI< >YZB+A64'-3;U
M(KEK?68RHYS6A'J2$<'-8NF1<U]PQ2*1FL];Q&'6G+=KGK2Y&*YI[A2,PQ55
M;D$TYI1C.:GD8-@[ &A7&,53DN,$U$+U5X)J^1B-@2+CK4<DH SGBL6;5HT/
MWJIW&NQE<[J2IZA<?K-VFQAGM7FVNSC#8/>MK5]:0EL-VK@M7U16R <Y-:J(
MDSF-8FRSKGFL*V!,WXU>U&8,S5GVI/FYQWJU$H[W001M/M7I^@.,+]:\MT27
M[A([5Z1H4P^4^]4XZ >DZ<X"C/I6F0"*Y[3[I0HYK3^W*!@FN6<'?0I,IZL$
M,9X[5Y=XC0?/@=Z]#U6^4J>>U>;^(;Q6W'WK2$&A7/.=63YFKE+P<UUFJ2;B
MQQ7+76<]*UY=!J5S/Y!K3T^;:P^M9Q7)JQ:L4;D5-BV]#TC1-2";!G'%>DZ'
MJ D5?FSS7B6GW@5E/M7H7AS4MI4D]Z.4Q;U/9M,EW+SZ5K<8KE-(U%"@ /45
MM?;D QNK&<&WH',79$#+6%?VN03CBM#[8N.M5II@Z&KI1DF3*S1Y_K]F"K8'
M:O,]8LB">.]>OZW'N#$>E>=ZQ >>.]=T497U//+B$J358+S6M?Q[6;BL?=\^
M*U2'=DZX(Q3'!%*K<YQ2L<G-781'R:D3.<4F,?C3@P7C]:FP$K+Q4!8>E/,N
M>*:3D=*0# WS>U/X-1@_-TI=V :+ *3Z4=:8'SQ^M.Y.*JP6' 9/M3RORT@Z
M=*4$T"&[?6F$'-/8X'%1EQC%9N1:0U^G%0H#OZ4]F+' %68H2S#BLG(T2.S\
M,0[XT./2O:_#%MMMER.HKRGPG:'R4X]*]K\.P;+5/I7-4F:)&W;1[.,5<IB+
M@4^N&3NS:*L%%%%24%%%% !1110 E1RD;:<S8JM*_P IJ *5RXP151<9X%3S
M98$?K40!7M5I"+$?W:9-E>:<L@VU&QW'-7$",'!Y[T\ ]J:$.:G1"!5(ELD"
MC;[T$C-*,GCI0V.M,EL?N&T&E\Q%7FJ$]XL1YK+N-9C4D;J+!<WI+A1P#55[
MM1WKG9->C QNK/EUY"<;JJP7.J:[7.=U0->INSGBN2DU]/[U57U].NZJ2'<[
MB.]7=]X5:6Y4GKS7GT>NIG.ZM*VU^,\;J3B.YWB2H5X(S4J.#R#Q7)P:RA(^
M:M*/5$('-38=S8F9>O:JQ/Z]*K"[#G.:D#;NE*PG+0E]N]'7@=:?&F>*>(SG
MI2)N@1.,U-N %*!Q5.XG$3<T!S(M^:H7G\*@DN5'&:R[C454=:S+C5D48W4K
M!<WGN5(ZBJS7*9ZBN9EUN/IOJK)KL?=Z=@NCLOM:8ZBG_:5 Y(KAQK\:\[JD
M/B*/C#5?*%SMQ=*.,\U-%<!CC/-<,OB",_+N_&KUMK:9 W?C2<1W.V1U*TQE
M##-8<6L(ZXW5<AO P!!S2Y2D7&QC%($/6G)\PS3U&!@T6!D1Y.*:>O%/D J$
MOS3L%P8\\4@8"G;2><4UD(%*PKZ">;CCO0)=W&>15*>98^"?QK/GU-8N,\#O
M4\NI/,= MPO3-*UPH'!KD6UZ//WL8IO_  D$8.2WX5IRA<Z_[4N.337N%QU%
M<@VOIG(:FMK\9XW4* 7Z'6BZ3ID9IXNTQP?K7%G78Q_%3QK\1'WJ?(4G8[6.
MY0C(Z5)YRCJ>M<=#K\>W.ZISK\>.N:AHCFU.L\]0<9IWGKG&:Y%=?CZ%JECU
MN-C]ZERE7.K#@TC'C(-8<6KHW>K*7ZOSG\*:0[F@6XII!Q@5"DN3GKFK:#(Q
MBFT,A P/>FYYR.U3LNVJ[/P>*GE&.SSN[4W/.33$;'6@N0>G6I: <3@>]*AS
MQWIF[Y<&GQM[5DQDFVF$%3GM4F[(Z4WGN*:%<9GU[TY<@4TG!Z4H>EN%Q<=^
M],/6G%^<4@^<_2D'44#<>.E/QQBE7(/2G>]%QD'3@]:5#V[TKGMBD0\XQ^-.
M^@#\>U0R##<5.QX^E0%COSBFG<!]OQ(,BMB+[HK,B^\#BM.+[M $E%%%, HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *1AE32TC<*:$!BZEE4/I7F_B%
MSY4F?2O2-2RR'TKS?Q&,129]*[*1C(\:UQV\^08[USXZ<]:Z+6E_?2$^M<YR
M:ZX&3'H"34XXYIL:X2G $K6QDV.Y;K3QG%-4$=:7FM(F; @]>]!SQ1SBCGBM
MB!V>*0KD4AR.:7..M*PTAN>QI,XY[TI'K2'GCO4V&&?2D!(&128I0#M]JEHH
M-Q/6@G(HQQFDYJ"T("<=.:8"<]*?SM]Z3:1T_&FBKD\>?3BAUW\'I21Y_"I#
MTH:T)N5"I_*E0D<]Z>PYJ-CV'6L91*O<NV]V5/%;]AK)C !)_.N/5F4G!J>*
M5]^0>*S<!WT/4M,UO<1\QZ^M=99ZUD $_K7CMA=NA&#73V>HOE<M24%N)2/5
M[?41@-GFM*._7:#FO-;?5F  W"M.+66 ^\*OD15V=ZEVI'6G"Z3/)KBEUH[>
M&%!UP@?>'YUFXBYCLY+Y0.35";45YYKDY-<8CEA^=4)M:;GYA0HH#HKW50"=
MI_6N<OM:&T\G\ZR+K56).".:P+^]=B<'BGRB+NHZOOSR<5S-YJ18'FH+RY?!
MYK(FD;/)ZU7*4I#YK@N3ZTMJIW9JJ =WO5FW+!NM4E8IR.HTY@ !78Z3/MV^
MF:X*RE*XYKH+*^9,8(Q6C5Q*1ZCIFI 8!-=#!?C@YYKRFUU1HR#N%;,&OG@;
MAGZUFX)@V=Q?7P*'GM7GVNW8WL >,U9N]:9DP&'2N3U.^+DY/>JC&QG)]C'U
M2?D^E<S<X9JUKZ;=GGBL61LM6R0)LC7*-D#FK"EC4:ID^]3J,57D)L0#MVJM
M-D'':K?:JLV<^U)H295C)\WFN@TPA6![UA[,-G/6M*Q<@]>:R9JY'>:5<XE6
MO0=*O56-<FO);"[VR#GI75V>JL%7!%'*K"YCTY-03UXJ*\U >7UKBEUHK_$,
M?6H;C6V(^\*AP2"Y>UF\RA/>N U2XW!JU[_4S(A!(S7,W\F4)!HM85SG+YOW
MI I;0@8J.Z!9R:+=L#FDT5<[+1)MI ->B>'KORY5.:\FTVX*'.:Z[2M59''(
MJ'$1Z^FH!EZU&]^O3-<0FN,%^\*8=;=N0PQ]:CE#5'6RZ@H.,\5$=2''/ZUQ
MDFL,3R14/]KON'S"JY0;._CU+WY^M6EU 'O7G\>KL>-PS4R:RX.-PIJ(DSNO
M[0'3-027P]>*XIM;?/WA4;:XQ/WACZT^5#.X_M!3MYZ=*MQ:@-G)_6O/%UDY
MY(JS'KC=-PI<B"YUU[?CRFP>U<7J-[R_H:2[U@M&0"*YR[OB^XYK2$;";,S4
MYP\C>E<O<C,I-:EY.6<\\5EN<N:N0KD04@9[U&RL>@JP.3BAQQQ65@N9S#FI
M(IFCZ=*<T?>J[$@X%%C52-NPU!MXSVKK=+U4AQS^M>=6[.'ZUMV-PZN!GFCE
M')GK-GJXXY/YUO6NJJ5'->6VE\P(&:W;;42%'S"ERZF/-<])COE*CGBK<5XA
MZGZ5Y[#K#+U88J]%K))^\*?(-L[U+P ]>:F-ZNW@UPJZT<\L,U*=;./O#\ZA
MP07.MDNU .361=Z@J X/%8,NN$@_,/SK#OM:;#?,,4U!%(VKS5@#RWZUB7>N
MX!Y/YU@76J,PR36'<W[/D T>S U[[6=Q;!.<>M<U>W^<X.:@GG=N_-9\NYNA
M^M'*'4220N31;9\S\:B .:LPKA@:M0&=?I#_ '?7%=YI%R$V\\UYI83F/'/-
M=)8ZBX(^85?(2WJ>K65Z O![5;:_7;G/%<!;ZPRIPPI\FMMLQN%+V0KG0ZAJ
M(<$$\#I7"ZU<!BQSWJ:YU1B#DBN8U*^:0D ]Z7)8ELS;Y]S''6L&X')Q6G,Y
MR<]:H.A<U+0*1GLN.G2G(34LD>/I480BIY37F+=O,4D&:[70KT_*/>N# ;>.
M>:WM*GDB*\CK5J))[)I&H;%'/:N@CU)6')KRZPU-U7[PZ5J)K#@?>&*?(&YZ
M'%J*'()Z=*E^VJ5/->>Q:NXY+"K(UIL8W#-5&FB7<Z'4;A6##VKB]4 ;/O5F
MYU<G(W#-8=U?^9GFME%$6ZG,:PH4OZ5S+M\U='JC^:S>E<[(GS&K2&D"R-Z5
M.C$_6JZ ]*L1<'FFT$B3M4+G%3\$5$Z4K"1$&]:E&3S2>5D"I40@8I6"Y&>.
M>]1,35B1/SJNP)-*P(1<YXZ5+N--7 -2!<\T!<<I..:<2,9[U'G!P:&SVK.3
M$([8%5F.34Q^;K5=_E-8MFT22%B7 Q6U9Q-(RG%8]JA,@)Z&NITV _+6<F:)
M'?\ A>V;RDP.>*]?T*-DMER.U>:>&(BD:Y]J]5TO'V9<>E<=5FB1H"BBBN8U
M"BBB@ HHHH ***0]* (9CCD5GR2-N]JMSD].]9LKMNPO;K18"0C<,5$Y(&.U
M.0DGGI22*<4TA:E9G(-/B9G[<TQA^=20J1]:M7$V68US_6IP HJ*)2/ZU(2
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M?6O.?$H'DRX]*])NERAKSKQ,O[F7CM7719C)7/"O$!_TB3'3-<Y&5_"NGU\
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M;;(>%&*C*#MTJQP1QVHXSTXJE(SN5, 'GI0@ ;)JQ)M'.*@##=R*M2*O<TH
MA />K!4$<54@D7 %6FE7;Q5ID.)6DP#[578*3[5)-)DYQ4.\>E%R5%D@P!S3
M5< ^]*#QR*0#VI7 :9 6X-(SC//2FL.>!2=^15%$BN-V.U6,#%5AC@@5:0C%
M%R),<HXXZT/C'O3<\TF>#28DBK*V#CM3%VDYIS_,<TB$ \BLI&RV'*_:F.%S
MGO4IQGI32F\X YK"0UN:NA &Z3'K7LN@VH>./ XP*\G\/0?Z5&-O.:]S\,VX
M,47R]JP;L:16IUNFVJ+$O'%;T:A4&*K6T("CBK@X%<525V=""BBBLQA1110
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M*3+6E &3\:]1\,X7;ZXKR[2L>=CWKU'PV@RF>N*!L]+TLX"M74V\Q*]:Y+3
M?E%=-!C;Q^-9228+<LRS[1UJNEP2>344PR3Z57W8.*2BK#->*;WJR,..:R86
M)-:,!K*2$0W-N&4UQ.MV8)<8XYKT)P#&:Y35H@2W'%53U$SQ[5[++MD=*X75
M+;#'CG->LZW;@%B1]*\WUA,3-D=ZZ$0<HZA1CO4EDVV88--NO]8<4RW^69?K
M4RN:)GHV@R8D3GCBO3='D+*N3QVKR?19 "F>E>F:1./+3)^E8R'8]"T\@JN3
MSBM(H,;JQ]*8.%/?%;+XV\=:S:&5M@R::5&,5(^!49P1[4V%QK8(ZTS:#3L
M=:08K-HH5%R>:E08SBF+STZU.  !^M+8LC8 CFF %CCL*EDVD>U1[@/I0Q6$
M<J.<\BFMRN[UI,*W7K2D_(!WJ0&%0!P>M")Z]*=\O'ZTX#/ ^[0!;@.2!GBM
M$=!6=;Q_,,]*T1TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]ZDQG@4F,4"N/!&S%,I:* &DY!J-3@\TI)STI>^<4P&@@$YIRL*;@]<4#.*
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M"M(H([TK9(ZT[D6&CKQUI<&F#(-/SFG<H3;V[4GECO\ A4V.*39CD_A0@1$
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MX]*5P'1*&;YN,=*M+UX%0*P/3OTJ>($-S2 L)GTJ>H%!)XJ>@ HHHH ****
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M44 %%%% !1110 51O(O,&!5ZF.N151=F)HX+Q#98A8D=J\7\6VQ 8@>M>_\
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MW<F#WKGMA+=>:W]=C*W+_6L,*<XJXH98LH3YH/IUKJ],X85S5GA6ZUOV4@#
MYJK$[GI'AYL,G/>O4M(E&P#/:O(-!N4&SYN]>E:/=I@?-VK&<;H%Y'78S5:=
M3VI8KE#@;J6XFC"YW"N9)IE-:&9=\*:X;Q&_R.<\8-=9J%[&%/S5P.OWT;*_
MS=J[J:T,FCS+7,%VSZURDZX8UTNLRJSG!SS7,R_,3S5R81'6?+_C7::(/NY]
M*XVR7]YSZUVVD 94Y[5G)E'H>@?*ZD],UZ3IKC:O/:O,]'FC0+EN]=M87T2@
M#S!6$E<#J6EQQFJ-])O7@]!48O(V& V:KW4JLOWJA1L.[,34F^4C->>>(_NO
MGTKN[Y\[JX3Q%]QS[5K% CRC5P3*?K62%P<5M:JN)&^M8V,MC-:I%LT],.U_
MQKT+0;C85Y[5YU8@A_QKM='F'RG/:M+$GK&B72[E.:[:SN2P #5Y7I-ZBE1N
M[UV=CJ2(!\U8SB.YU;RD'&:@9^>N*SAJ,3?QBDFU"$C <5BHDW+4MP%[UE7U
M^$4G=VJ&ZO8\;M_/I7-:KJ:!6^;M4"0FHZN &&^N UK4=[/\U6=2U1 &^>N.
MU"_$FY=WXU2+L9]].&<X-9SMWS23N6;K4:#/>M$%B[:1&1@:ZC2;%C(O%8ND
MVWF.*[K1+$B1>]-["L=AX>LBK1\<\5Z1:Q$1+7(Z+:X9!7<6\0$8!-8R*+$!
MVK23#=S2!0IZT,0>AK)E(JE"#]:>$(&.].V <YS2CDXJ6QB')'TJ-PW6I\#U
MJ-F'>EN)C8^F34S<KUJ( =0:4#@\TF4B&0'UJ%0VZI9.#C-(" 14W&31 Y%:
M$:9&:K11[L&M&)0!UH0#HP0*?113 **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Q];C!MS]*\A\6V@9&Q][FO:=1C$
MD!!]*\U\2V(*M@<\UT4F1)'AE[:E6;-<_,@#G'K7H>K6"JKG'-<-=Q!9&P.,
MUUIF3(K9LC!K0C( Q6;&0.15N-QCG\*UBS&19.,^]1O@\4F\?C02.W6MXO0Q
M:U(F7FFL 3BIC@TQD YJQH@"8/-3IC\:8%R>:D  I\I38_M3"@ZU+QM]Z:V,
M=*"&19'3M2G&*,+C-("">:&&X=1SUI!QTZU)@4G&>G-(0B@4O!Z4S=@\4\$
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M*%Z<T-E(@D;!YZ4)\[ 4V3YS[4^)=K#ZU(S5@ "C-74'&:K1*"H^E6U&%Q0
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M::YP,4W<U&2PHN.PF?EQBDQ[4[G;C% + 8Q291&0/2I85RXR*;SNSBK,6<C
MI 7HEP!5FHXONU)5 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF7 VUTR:7CH!5N.P [4N85C'MK(KQBM2WBV]>*N&U"?2D9!MSZ=*AR5A6'(
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M5W'GO62<9X-=%P1I:<N9,9[UZ'H5MN"GVKS[2.9>?6O5/#D 8(?:G<=C>M;
MO@8K2.CL4X%:>GV:E%(ZUO0V(*XQ6,YV%8\ZN]"=L_+6-)H$F_[M>MS:7P3@
M8JE_8RNV6'Z5"DBD>:1^'GSNVUIVFAL&' KO!HH X _*G)I6Q\@<UC)EHP;7
M2FCQQUK;MK J!Q5Z.U"L*O+$F.*FY1#%;[5%3 JO>I,#;5.5OGQ04B29@PX-
M5MG.<TX,"<9I^T'I^-#*1$R$G.:;Y>.]3,,<CI2+@]:SD L8]ZE<<=::J!>:
M4\UBP9"8^^:3';-2GI3,#;UXI$W&!>>32B/-.(7BG"@5QFW QFI8UQWZTFS^
M*GQD%L4%JY:ABW=ZNJNT8J&!?2K%-(84444P"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AG4,AS4U
M-89%-;BDM#SGQ/8*[-QQS7E6OZ:-Q..G2O=M8LA*22*\Y\0Z6!NPM=E.1SM'
MC5] 8CFLPE,\BNOUZT$4;#'/K7&RC:375%D6'AQGY:F4@\UG^9Z5:@8G%:IA
M*!="@BF2=:D'*TQN.#6J9G89QCWJ(OS3\\XJ)S[5:"Q,I!.>U.W#/-5E8U+N
MJK$VU)&8?C2K@_6H\\XI_; I6%8D!!XI#@+[4BMQ3NJY-,+# HZTG?WIY. .
M*0]<=Z!6U$X_&FG&:4GC%,H06)"1CVHXQS3 <&E#>U%Q6%8C\:3/'O3>M% 6
M'@C%*2,4T'-(#STJ;A852,\U(2-U1=^E.4YXIW*)-PZ4PL,\4A/:DS[4KC%P
M.O:E)'>CKS^E#$ =*+BL-8BG1X_&F4H..*06),@T<;:9NI<\TT.P@QWI0 I]
MZ8QP:<#ZU3V$T+D9]Z:2,\4,?2DS[4(D?QMI<@"F9YZ4;O:JZ"L*Y% QCCK3
M<\4N>*!C^W'XTQFXP*=G@4G&<XI%"*>>:D.,TP$ YQ2EAZ4!8?GG%,)YX_&C
M=29S0%AW&VC(QS29YZ4K=*$2T-8BG1D8]Z9GVI!D4T")EVEC2OM XZ5'NHW9
M-2RK#5QNIY('%)@#G%-W<<T-"%(!I.AQ1GCI2Y!QQTHL%A^5V4'&*9NYZ<49
MHL,5\8YIO!'O1NXYHSQ32$.4@#%-(&<]J=G(II//2BP@!&>>E/.!3,8YI0V>
M#18$.!#&FL0#_.DSC@4I^84 'RYSVI?KTI@XIW2BP7!B*52#]::.:.G% AX(
MIC 'D4[.:3=@]*=A@K=C2X IO4\"E#=C3&*.OO32>>*#Q0.:1(X8Q2Y%,S@]
M*4^M(8,12J0>O6F9]:3FBP6)?I321GVIPY'I3&(STIV&&>?:GY'>F9YZ4;J5
MA#C@\=Z;T-&[Y:"P..*H9(I 7BCCJ>E,W<\4N[GI28(4\4G7ZTF[UI-W'3\:
M30Q^<\4TX I0<CI0.>HJ6B'N-_E2YQ3C@#I31Q2'8>2"/>FJW- .3C%*<#M4
MBL#$=10O--SD=*,X%4@'XIX QCO4>ZGX-4AV XQBJLNT-[5;/W:I2'YNE7'<
MJ S<,X[4IQW%* ",XJ1 ",$5,T;)E9\#ZUH:7+L?\:JF/YL5+"PC/ QBN22+
M4CTG0M4,6T9XQ7IV@:GYJID\9KP'3=3:.0"O3/"^I.[1X/<<5R5(FB9[A:/N
MC!]JLUD:-,7A&?2M>N"2U-(NZ"BBBI*"BBB@ HHHH **** "BBB@ HHHH **
M** "BBD/0T 0RL"":S9G!Z]*GN)"&-4F;=S4L:(7'S?RJ:'WZT!<T\84XQ^-
M WL/W9.*B9L'"T[.3TQ3"?FZ5HB1%QGF@]:1V[@4@< 8QG-(!X( ]Z?&03[U
M!D[L8J8<CCBD!.<9IDI7\*0-Q4>XELD<4 ,ZMQ4JCYN>M,!ZX%.C;GD?C0!(
M&^; I^X5$IRW2G=:=Q6)5P>>U2@KC%5B^P4B2DDT[BU+?R_C3"J^E1JYSBAF
M-6I"(W5,\"EC1",XIC9SFG;L+D"M%+0$B01H#0Z+Z<U&&8$>]#.<XI<P6)4*
M],5.H7&15-&W''2I?,(&*ER%8?(PQ[57?WZ=J1W).:B,I;@U#>@K PYXZTG0
M\=:7GI^M&,U-QV)4Z5,,%:KA^*<LN!G]*+C29.0.AII1<].:9YOZTF\[L4[C
ML*P4=N:8(USTH9N<4*233N*VI.BIZ<59#+CI5(R;>0*43$?C0F-(G=^:16!-
M0^:.A'XTPR[3@5=QV+>Y.P^M-(1NW%5?.([4Y9#FE<3)C&A[4X(N,8YII?VZ
MT%\&BY#'A%].:>N!47F<4T.2:"2TK\\=*@OG41\^E*'YS4%[)E.1VII:CZ'%
MZY@EOK7FNO@?/]*].U<!E;CO7G/B",!'X[5O%DV/,-2(\P_6LL\'/:M34S^\
M;CH:R=WS=*W3"QLZ-_K1GUKUGPVP^0>U>3Z1]\<=Z]/\.N5*?2JN*QZEICC:
MH'7-=/;J-N:Y#1WW%<UUULV5_"N>L%B1]N/:F;(QCBB7U_2H0YSS6*6@[7+2
MHN.E(RJ#G%$;=J)",5)HD1,4["D5U'TJ&1N<^E0M+W_2GT':Y;>51VJFY#2>
M](9?;.:,9YQ4W&D(,;NE6%*XZ4V( G!%3. %X%'-T*L1,5(XZ5&, TCMCD"F
M%L5+8DBV,&/WH &*CA.3M-3-@#%0%AC@8XJ,XV^U.W9SFHMW/2DT%A>._P"%
M/R!Q4>?6C/'2D%B96[5-!$"Q-1VZYZBM&*,8X&*:&.B7'3I4M(!BEI@%%%%
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M7N.E"@8YIB$SS2@G/2E PW-.88Y%,.I%UI=QVXQ3OI^-)_*D*XG44X$X]Z"
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MYZ4U_O>]*XA<GKBF%<GCOUJ9,D<]:-NTT,$1J-O!Z4CD^G%.ESCVIAW;>>E
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M#I5Y?NU$B?E4PX%%@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
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M[77)KUSPS=>8L9SZ<5R5$:1/1T.5IU0VY!C'-35RO<V04444AA1110 4444
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M\TSISU%# LN:0<#UI .9AG'>H]I+4I7FG>WZT@$13NJ;/&*C(X!STH7YFS5
M/J/H<'O3\?,>:B9?FZT &#OQGFD"Y)I<?-C/XT!>>M# =N&VEB #%J;CO0"<
MU B4G/ J$^F>:=R/QJ-N#UIC%+>]-R?PIG4\T_C/6A")%&1S3E4DTV(_-5I
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M)_*EQD4#!%*,4"&CKS0>O'6E;&:3^=%QBBCC%)]*48VT"#'RTG?FE!]>E*U
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MQ3V7'(J(XW=*: =M&<]J4C(P?PH[?[-!.!D_A3 0+M^M!7/3K0&W?6D4-NI
M/ &VFX'X4]<$<"C9SCM0@& @GZ=*,MO'K2[0I_E1SG_:I@'TZT?3I1WXZT?3
MIWHL UNF!TH5<<G\*=QC/:CZ_A0 WYM_3FG[2!D4G.?]JEW$C H /ITI.V.U
M'TZ4=L]J8!]?PIOS;J<3@9/X4@.[ZU("DA3GO0S\^U*T>1[TC1@<T6 .ASVI
M&)[_ (4O;VH(XY_"J"XH?*X[TGTZTA^0>]*I!Z=:E@'TZ4<8]J?M&*-HVXI
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M#D[L'Z5Z_-X=#GE1^50KX64G.T9^E-#9YII^AE7!P>M>A:%I_E[1D]*TX?#
M3E5'Y5J6FE_9QTIIZDERS4(0,?C6U"^!P*H0QX R*T8AQ3N!+N^7-,+<<U%)
M(5/O4)G8G J6QDKMZ"D4Y'I30W&#2G...E0RT(QY'%*5XW8IP4L,D=*>H)ZC
MFLV,C P.>:4>E22+@<5!NVTBK#R<#%#-[5&I);VIS,2.E!0UGYZ5">3S3CD?
M-WI%))H1(TISBKUK"#VY]:CC@W<U?MTV#VJA,L1I4V,4@Z4M @HHHH ****
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MEN*>EOS4\<63C]:MI!30B.&(!>*LHGY4HCQ4E,D****!!1110 4444 %%%%
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M1Y&<?PTJD%N?PH <RACR:C8!>AI[D#D=:;\AY/6@!"!D<T8&[&>*#MW<=*7
MSG^&@!2J@<&FX&TG- V\_I1QM]Z  @8ZT[:OK33C''6@[<C'2@ P-V,TI4 =
M:3Y=WM2DJPQ^5)[@)@;2<T$# YH( 7GK2C9CFF A R.:7 W8SQ2';NXZ4?+G
MVIZ .*J!P:;@;2<T#;S^E!P%YZT@ @8ZTXH-N0:;@$<4\,@7% #H_N4II 0J
M>U,W G+?A1;0 D QG--(&.M*Y4CCK2';CCK0M@ @9'-&!N(S2';GCI2X&<]J
M '*OS<U+4(89Y[=*>9!CB@!V1TJ-DP:<A!.>](S\X[4 )D9V]J:%ZYH^7=[4
M;@>#^%*X  -O6C VT<!>>O:DXQ5Q8#MBCH>M287;C-5BXSQ3U(/7I5- 6T ]
M:>P!YJ)2H'/X4UWQQ2 9*!ZU7*<U9 5CSUHVI0!$@'3-/7J>:,#.?X:08R?T
MIB%/S#.>:=&,=3S0HYR>M+QNXZTK@/( [T<=,\5 6&<49P<C[M*XNA. ,]:D
MRO7-5?,6CS!FE<1:XZYIK!<9S4.\'IUI>,47&0R8)Z\5'@>M2.@_"D 4CFES
M#'  KUYHQ@=>:>B <FDE QQUI7*0QB!C!IRD$]:J,P!IZ,#]*"D3DX[U&?F&
M3UIYVG%!QN'K0,;&!T/6K$< !S1%&KMQUK0BA&.E%@'0H-HJ<#%(JA>E.ID-
MA1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH 0C--:-2.E/HH RKFQ4Y.VN6U/2P23LZUWC*"*R[NS+9P,U
MM"1E)'C>MZ659EV'\JX?4M-.Y@$.?I7NVHZ,9"?E_&N/U3P^<M\O;K6T9&=M
M3Q*[LF5ON'\JJB,KU4XKT;4M!903LKE;VQ:$,2O2M5(;,6I$<=^M1R[E)XJ'
M>1Q6B9G;4M-*#P*K.=QXXQ2;\\?K2%MW;&*UC(+:C&/MQ3U&!TZTJC)SC\*G
M"D=LYK920^A+#PN,5(6'3'-(C!5QC\:0MS5)F+&$@'I29&>E*3GM2#(;.*NX
MA[$8Z4S=\OO3RW'2@#'&*28B,]*7-*V>@%&?:G<5A/XNE)GFGY/]VDQC\:EL
M=A1QP:..E)[?K2@XX_6D#0WJ:>< 4 Y[4F>,XHN*PGUH/ Q1N]J5?3K33 C[
MTYL'H*5L] *7/M5)W&-7@\T<9.12\YSBG8P,@=: &<!<8HR-M+R!C%-YSTXI
MH=A W/2GY&<XI?3BDSSG% " C/2@$8Z4H//2E [8H%89VHJ3;QBFMZ>E($-&
M%YQ2%AUQ3QP>E)WZ4 P4C;THXVXQ2@X&,4<D=* 0G'I02%.<4[&?PHQW(_"@
M!!CKBF[P.,4N2#P,THZ=*8Q."*"1QQ03QTHW=.*D09&>E (STIP&3G%+MP<X
MIH0P$8Z4<8Q3B-HZ4W%4-(=GTI"0.<4HZ=.E)GGI0 H8'M3&.#TIX/M1VZ4#
M&!N<4M)SG&/QI_;&* &@C-.W<TF"#G%+GVH ,CTI,\4N>.E)VQBD TG% .1T
MI>M*.#TH&1Y(;FI<C'2DQD]*7/&*?00<8I,BDI:!AQNS1P#TH'!Z48R>E(5@
MXQ2 9.*<.G2DYII *>N*7(QTI"?:F[SUVT +QGI36.*<&)YQ01GM188@88QC
MFC(/ '2C'M2T6$+D9Z4@(W4#.<XI&)Z@4T*P[(HR.E,W'/2G<^E(8@.3TIV?
M:D)]J%8YY%%P%&,\B@$ 'B@OSP* *15@'(I&QT%.)P,"HP23BD*PHQ3LBDP<
MT&J0A*.,>]*!2=JL5AV[@8J1".N*C^\.!4B$CDBBX@<C/2FL1CI3G.><5'R
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MR1UI_P##G;03P.*A[@-W#N*:Q'I3V.#TIA!)Z540(\ \XIZ$=<4H5@?NU+C
MSC\*T 0N,=*;N!'2EY'\-)G Z4#'(1G&*E.#T%1(WM2^80>E3J K8 Z5"",G
MBIF?(SCGTJ$-@GBE<0^-^QI';GBF!L#I3E<="*+BN.X89Q4>>>G%2J20>*0@
MXSC\*E@0E@.U .1TIPZ]*<!@]*0F)'C.,5*Q!QBF=^E+0(7C/M3.%.2*>*;@
MJ<XS04AZN#VJ.9ACBE+@=!3"V>U!958C/(J6(9(..*:8RS@XJW#&<CBFD4AP
M48Z4GE^W-7$B/I4PAXZ4PN5[>/IQS6@HP*CC3;VJ6@AA1110(**** "BBB@
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M#$Y^M/!+'(Z4 2%B1BF#.#D<TG.>33</ZTK@.RVWIS3ATYIO.,9YI<X'-%P
MDAO:D&[/2FLQ/(Z4!B!S2W D4GN*')/(%-!/>@YQ@'FCJ C,2N /K3.=A]*!
MGYOUHYV'TJ@%PQ'2@AR<XHRP'6@EP<9I /RVT<<U(N=M1\XQGFERRC@_6ET
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M..:]$T34"I7YJXYLN)[AI%R75>:Z13E:X'PY=F3RR3Z5W4)RH-8,M$M%%%2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS0EJ.XU8AW% B7GBI:*=A#%C"]*?113L 4444P"BBB@ HHHH **** "BBB@
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M QM%._L=S_"*.<5C@O['<\[*#I3?W*[_ /LAMO"C- T<@Y(&?I4N>H69P/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !. R(# 2(  A$! Q$!_\0
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M]?5U_P"CY*V: $+J&52P#-T!/)I:Y_6?^1M\._2Y_P#0!704 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>5_M#:[K
M'A?PC:ZMH&ISV=RU]!:LJJC(4<G)PRGGWH ]4K!\*_\ 'UX@_P"PD_\ Z*CK
M'\3:5K5O';2Z#XCU$WD$T4TEI*L4BW, D42+]P$?*3@@]:FMTD;3_%A@N9K:
M2.^ED62$@,"(8SW!&* .PK#\3?Z_0_\ L(I_Z ]>:?#'5/$GB;X+P^)IO$=S
M'K;17$@=X8F@)C=P R;!QA0#@@]\UM>"?%L_CCP)X.U^\M1:W-U?@21KG;N4
M2J2N><';D?6@#TVBO/8?$]QXH^(^K^&-)NWL[#0X(VO[F$ RRS29VQ(2"%50
M"6.,D\#&"3LK8^(+#Q/I:VVHO>: ZR_:EN54S1OM_=X< 94G/&,YQSB@#0\(
M_P#(';_KZNO_ $?)6S7.:+?V^E^%+W4+Z3R[2UEO)YGQG:BS2%C^0-5-$\<V
M>IW^C6TEE=V@UJV>[TZ278RSQJJL<[6.UMKJ<'^8Q0!>UG_D;/#OTN?_ $ 5
MT%<_K/\ R-GAWZ7/_H KF?"'B*X^(>J:_-8WTUEH&EWC:? ;; DNI$ +R,Q!
MPF2 H&,]2>P /1J*YG1[;Q!9^*;F&]O?MN@?9%:VD>-5E6;>=RN1C=\N,' [
MYR>:Z:@ HHHH **^-?BU\;_'GA[XD>(=)TK5HHK&TNFBAC-K$VU0!QDKDUB^
M&?CA\3M?URUTR#Q#:0/<,1YDME%M0!2Q)PA/0'H* /N2BOB.\^.'CJ.:&.R\
M<:??;UD9C%I9'E[5)&0T0)SC'&<=\"L\?'7XL'3_ +<+V3[%G'VC^S8_+ZX^
M]LQUH ^[**^(='^,WQ9U&_TN!M3-M!J-Q';PW4NFQB(ES@$'9@_AZ52U#XZ_
M%;3I42^U![<R<Q^;IL:;QZC*<T ?==%?"=S\=OBQ:W"P75])#.R[UCDTV-6*
M^H!3..#^52:=\<_BG>ZY9Z5_;$4%U=3QP*)K&)=I<@*3\F<<@_2@#[HHKXPU
MCXM_$BSTV^O;#QGI6I1V$RPW:0V 1XBQ(5L/$NY<@C(SV]:R+;XW_%:6YT^.
M;4_LT5](L<,TNG1JC;B!D'9R.>U 'W-17P]K_P :?BSHFIRV=YJ++MG>&*1M
M,C59BK;<IE.?_KU5N_CI\6;.>*&\O);>:7_5QRZ9&C/] 4YH ^ZZ*^#I/C]\
M48YHXI-4"22 %%:PB!8'H0-O.:Z/6OB[\0=)N6L9?'.DS:M',L$UG#IX;RW)
MPR[_ "MA*GK@]CC- 'V=17P_XE^-'Q8\/:E=6M]J95(;B2!)VTV-$FV,5)4E
M.1QFJ<_QU^+%NUNMQ?21&X&80^FQKYH_V<ISU'2@#[LHKX1OOCQ\5K#R_MVH
M-;>8NY/.TZ--X]1E.16]HWQ4^+6KW_ARUM/$%ANUW?Y#O:Q!8]CLK;SLXQMS
MQG@B@#[0HKX@N/C1\5;?2;B^FUNV58;[^SS%]BB+M+M).!LZ# S_ +PIVF_&
M7XKW6K-IUUJRV-PMM-<[;G3HT.V.)I.A3/(0@4 ?;M%?#6M?'/XFZ4NG-)X@
MMI/MMHEVNVRB&T,6&#\O7Y:Z&V^)?Q/F:VLCXRTB/7KFW6YATMK)?,8,F]$+
M^7L#LN"%)[@<$XH ^Q**^$8?CW\494$HU4"#(S+_ &=&54$[<DA/7CZU/_PO
M'XK2W=Y#8:DUZ+5F#O!IB$  D;B-F5''<"@#[GHKX4L_CI\6+V)Y+*]DN(T!
M+/%IL;A<=<D)4-C\?_B=?7UO:6^LP-//(L48-G",LQP.=OJ: /O&BOBKQ5\7
M_B=X?AAF'BK3K^"2>:T:2WLD&R:+;YB$/&"<;UP1P<U%X>^-'Q)U6RO;^[\5
MV&FZ;9E$EN+BQ1LN^=J*J1DLQVL?0!22: /MJBOAI_CC\3YM2GM=&UM-76,;
MA+::8I#+QSM,88=<<BLUOVA_B4K$-K40(."#90\?^.T ?>]%?$6F_&#XOZG-
MID%AJ4$UQJ2N]K%]FMU:15)4GY@!U5@/7!INJ_&3XNZ7:QW-WJ=L;:23REFA
MAMIDWXSM+(" <=C0!]OT5\.M\9OC LQB:\Q(+S^SROV*'_CX_P">?W>M)#\:
M?B],\2Q7P8RW9L8\64'S3C&4'R]?F'YT ?<=%?!]C\?/BC?7T-G::M'+=32"
M*.-;*'+,3@#[OK5JU^-GQ;NEM#;WZR"[,BP8LH?WAC&7Q\O8$4 ?<U%?$5G\
M8/B_>V/VNTU.TFC\MI0D<5J92BYR?+^_Q@GI4-G\:?B]>_9/LE\)?M:226X6
MRAS*(\[]HV\D8/'7TH ^XZ*^$?\ A?/Q3_LPZA_:L?V(3?9_.^Q0X\S;NV_=
MZXYK:L?B[\4=2T.SOM,\2:?//++)'-;21VD+0[=NT_/@G=N/;M0!]J45\/3?
M&7XP0W3V\EZ!,EY_9[*+. XN/^>?"]:I1_'GXIR:FNGIJB->M-]G$(LH=QDW
M;=OW>N>* /NZBOB/3_C!\8+ZWDGAU.U2&.8V[23Q6L*^8,$H"^,D9'3U%9FH
M_'KXIZ;?36=_JB074+;)(WL805/_ 'S0!]WT5\17GQ@^+]IITE])J=H]K%M,
MKPQVLQBW' +A,E03@9(ZG%+/\7_C!#I<FH'4[22UC19)##%:RM&IP S*N64<
MCDCO0!]N45\1'XP_%_\ LMM074[22V6(3/Y45J[HAQ\S(,L!R.2..]9^F?'G
MXHZE="WM-:M/,P6_>V]O$H Z_,P _6@#[MHKX@NOC'\8+6\2UDOHVE>![I/+
MM;>19(E!+.K*"& "MG![&H8_C9\6Y!$4OU(DM7O4Q90\P)NW/]WH-C?E0!]R
MT5\06GQC^+]W<"&+4(0QM5O<R6UO&HA8@!RS   D@<GO5?6?CA\5]&EB34-4
M@C\Y/-B=;:WD21<D95E!!&01P>HH ^YZ*^!_^&B?B3_T&X?_  "A_P#B:^H/
M'OB_6M)TWPY+872QO>68EF)B5MS84YY''4UI1I.K-0CN<V+Q4,)2=:ILNQZQ
M17SO_P +)\4]?MZ8]?(3_"C_ (61XJ.<7RG'7_1TX_2NS^S:O='C_P"LN$[2
M^Y?YGT117SO_ ,+)\5'&+].>G^CIS^E!^)/BH9S?H,=?]'3_  H_LVKW0?ZR
MX3M+[E_F?1%%?/\ 8_$#Q7=W'E+J"C"L[$6JL0H&3P!S2W7CWQ; J.+[?$Z[
M]_V51@;B.>.#Q2_LZI>UT5_K%AFN;EE;T7^9[_17S]:^/_%MQ+$HO0JR-L#F
MV7;GZXJ+_A8OBWRA(;O$9X#?9EP?QQ3_ +-J]T+_ %DPMK\LON7^9]#45\[_
M /"R?%/.;]./^G=/\*/^%D>*P<&^7/I]G3_"C^S:O="_UEPO:7W+_,^B**^>
M#\1O%@17-X C'"M]F7!^AQ3E^(?B]_N71;C/%JIX]>E']FU>Z#_63"_RR^[_
M ()]"T5\\)\1_%<C[4O0S?W5MT)_E2_\+%\6[7;[7\J'#'[,N%^O'%']FU>Z
M#_67"_RR^Y?YGT-17STOQ$\7,H9;HE2< BU7!_2FR?$?Q7&Q62]56'4-;H"/
MTH_LVKW0?ZRX7?EE]W_!/H>BO"?"_P 0/$=]XCTRTNKU'@GN$CD40H,J3SSB
MO=JYJ^'E0:4CT\!F%+'1<Z2>G<****P.X**** "BBB@ HHHH **** "BBB@
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MD]]''J^FFYBL8"2'=;I8T++_ +NV0G_>KW7_ (9,TG_H:;[_ ,!4_P#BJ/\
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MNV\E91'=$2-MB7R&W2\9RHQDC SFB'7+&>:*.&1W$F L@C;9N(R%+8P&QVH
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M6'S99=R!A))YA)*OSC )R/H.G.1M*EO-(U6T?,#S73R1LPR.&#*<>F17044
M<E?>'KZ^M;H7<>F3S7DOF2K('V1D($4KW)P"3G'6EU/PU=7?DEI+.XDCM6LM
M]S&6.TA?WG^_E2?Q'(KK** .5_X1NX\WR)9;>?3A.UT1*I,DCF,J5;MMR2<]
M>WO5GP_HUUIMY<7$C0C[1L1XUDDDVHBMC#.<DY;Z8'XUT-% &%8:&]K;Z)&9
MU8Z>[LQ"XWY1UX]/O?I5"_\ #$TMW-<QFRG:22<^7=1%E59%C&1C^(&/\03T
MKK** ,34='GN=!ATQ+E<)$BF:1269TVE6QGN5YJA)8:D/$%E?SF,S2/Y3+ &
M\M$2*8KN)Y.7?V[?6NJHH Y1_#=Q#!!]D-H]YY#QS7<X?>S.27;"G!&68X/2
MKU]H]Q)I%MI=M+&MO# B^9(I+%XRACX';Y3G]*W:* .5N]!O;NSN5NXM+N9;
MR?SIDE#^6F$5%V]SPO/3KVI+[PW=3QV>Z2RNGM[5K,-=1EMRLJ?O/]_<A/T/
M4=:ZNB@#CSX0,UQ$DTWEVL:.#)#-()96:,HS$$[4)R22HR3^-7+/PTUM'J=O
M]NN)+6_;Y]S[7B01*@"$ 8/R]?3%=)10!R\?A5HK35+>.^F=+N6&1!+AA$(P
M@P,8Z[/Y>E:L^FM)J5W="0 3VBVP7'0@N<_^/?I6G10!1T^UGLM.L+6-XW\B
M)8I&8'YMJ8R/3D#\*Q[?0K^PGLKBRN+:6>.WECG,ZL!))(ZNSC'^T#QZ'KQ7
M344 8$>E26&FZ'91;IOLDR;W QP$;+8[#)J"?P[*^N27<;6JQRW4=TTNP^>I
M5%4H#TVG:/P)X-=-10!R]GX5DTVXN)=.U*Z&^R-K$)V\SRVW,V\]"3EL_7/K
M1JOAI[F'3[2U2TC@LT18KAPQFA*D<KCC/ Y/?UKJ** .>U'0IYKVYO+:>(3M
M/#/$LBG:#&I7#8YP03TZ5GWG@UKVQE\W4)X+^8L7:W;$8W2^8P"G/L,]\"NQ
MHH R];M]1N;-[;3VM0LD31NUQN)&1C(Q6?<:1J*:"=/L?[/1YK;RKB1U?YI-
M@3< /8#KZ5TE% '*KX5<S17TDT)U2&9'BDV$H(U15\HC/*\,P]&.1[[>J6#7
M\MCND"V\$XGDCQS(5!V#Z!L-_P !%7Z* .=AT*X-O(MQ/")7U);\^6IVA592
M%Y/7"]?>K.LV=Y?PW%N8+">V9DV1W&[! &23COG&/I6S10!SLWAZ23PG;Z4+
MLK<V_EO'. 1M9&# #G('&WKG%.T70!;3/-?+;,P2&*"*%3L@2+=LP3R3EV.?
MI7044 <]KN@-J&I&\46\I$*1I'-N 5E<MNRISGG%7M"T^:PANFNI(Y+BZG:X
MD\L$*I( P,\]%%:=% ',OX66Z@A@U&83PF2:XN54%?-E?[K YRNP'Y>XPI'(
MIEUX<N3X;?3+>2T$TJ+;RW+1D%HESM. ?O ?AG-=310!0-@W]O#4/,&T6QM]
MF.<[@V<_A2-8,==_M#S!M^S&WV8YSNW9S6A10!@KH3C1]%LO/7=I\D,C/MX?
<8,8 SQFMZBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  \ R(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#\HX!+,0>P ZFM(+XDL?%&F6XN4U#0IEE-Q-)"%GA8*-@)7"E2<\X!R .<T
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M6"V2.XN&N91UE954M^  %<WIMG)?P>)K6*Y>U,NHNID158X,4>1A@10!Y/\
M!;PW<Z_^SG86]OK5]9>:ER/+0IY3#S7RC_+NV'H<,#@GD5O_  D\51>+?AWX
M7N8=+MM+^R:J+)K:U&(041N4!Y (8=<\YY-=-X=^&Z:!X.7PQIOB#5HM)573
M"B(2[78E@)-F1]X\CD=JMP^&]+\)Z1X;T?0;5;6PM]03:@)))*2$L2>22>]
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M!57WK$TF-QC! XSG  )(H Z_2;S^T-*L[P(8Q<0I-L/5=R@X_6K5(H"J H
M& !VI: /SJ^/G_)9/%G_ %_-_(5D_#&]MM/\<Z9=7LD,=O$9"YF.$/[MA@GT
M)X_&OI_Q]^S4WBSQEJ^N_P#"3"U^WSF;R?L6_9GMG>,_E6!_PR2W_0WC_P
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M_:^FPZH8XVM[#4D%Y/K$>H22^9;N%1I$ P-WW0>[FO2O^&26_P"AO'_@!_\
M;*/^&26_Z&]?_ #_ .V4 ?/7C*Z@N8O#PMYHY3#I4,4FPYV.&?*GWY'YUW4
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MC@94Y_,C</QK0;48<Q7Q9/-NI5$\0ZJJY!R/0@K^1KN_^%-M_P!!H?\ @/\
M_94?\*;;_H-#_P !_P#[*O6>+P[=^8^2AE.81CRJG^*_S]?O.%:6UAC>)9XF
M.G(?)<'_ %S,,''KAB#]!38I;:2"-7GB5[^-89BQ_P!5L& Q],L%/T!KO/\
MA3;?]!L?^ __ -E1_P *;;_H-C_P'_\ LJ7UJA_,5_9>/O\ POQ7^?;0\\6Z
M":G<W$,WE1F*6&,J^#@)M7\^*ECG?RK21[D?9EMG613*#EB7XVYR2<CM7??\
M*;;_ *#0_P# ;_[*C_A3;?\ 0:'_ (#_ /V5-XO#_P WX,E93CU_R[_%?YG
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M% !1110 4444 %%%% !1110 50TK3_L$NH/YF_[7<FXQC&W*JN/?[OZU?HH
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
